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ABSTRACT 	  Ovarian	  cancer	   is	   the	  deadliest	  of	  all	   the	  gynecologic	   cancers	  and	   is	  known	  for	  its	  clinically	  occult	  and	  asymptomatic	  dissemination.	  	  Most	  ovarian	  malignancies	  are	   diagnosed	   in	   the	   late	   stages	   of	   the	   disease	   and	   the	   high	   rate	   of	   morbidity	   is	  thought	   to	   be	   due,	   in	   part,	   to	   the	   highly	  metastatic	   nature	   of	   ovarian	   carcinomas.	  	  Cancer	  metastasis	  relies	  on	  the	  ability	  of	  cells	  to	  migrate	  away	  from	  primary	  tumors	  and	   invade	   into	   target	   tissues.	   Though	   the	   processes	   are	   distinct,	   cancer	   cell	  invasion	  relies	  on	  the	  underlying	  migration	  machinery	  to	  invade	  target	  tissues.	  	  	  	   Cell	   migration	   requires	   the	   coordinated	   effort	   of	   numerous	   spatially-­‐regulated	   signaling	   pathways	   to	   extend	   protrusions,	   create	   new	   adhesion	   to	   the	  extracellular	  matrix	  (ECM),	  translocate	  the	  cell	  body,	  and	  retract	  the	  cell	  rear.	   	  Our	  lab	   established	   that	   the	   cyclic-­‐AMP	  dependent	   protein	   kinase	   (PKA)	   subunits	   and	  enzymatic	   activity	   are	   localized	   to	   the	   leading	   edge	   of	   migrating	   cells	   and	   are	  required	   for	   cell	   movement.	   Despite	   the	   importance	   for	   localized	   PKA	   activity	  during	  migration,	   neither	   its	   role	   in	   regulating	   ovarian	   cancer	   cell	   migration	   and	  invasion	   nor	   the	   mechanism	   regulating	   leading	   edge	   PKA	   activity	   have	   been	  determined.	   	   Therefore,	   the	   objective	   of	   the	   enclosed	   work	   is	   to	   establish	   the	  importance	  of	  PKA	  for	  ovarian	  cancer	  cell	  migration	  and	  invasion	  and	  elucidate	  the	  molecular	  mechanism	  governing	  leading	  edge	  PKA.	  	  	  	   We	  demonstrate,	  for	  the	  first	  time,	  that	  PKA	  activity	  and	  spatial	  distribution	  through	   A-­‐Kinase	   Anchoring	   Proteins	   (AKAPs)	   is	   required	   for	   efficient	   ovarian	  cancer	   cell	   migration	   and	   invasion.	   	   Additionally,	   we	   establish	   a	   link	   between	  leading	   edge	   PKA	   activity	   in	   migrating	   cells,	   ECM	   stiffness	   sensing,	   and	   the	  regulation	  of	  both	  PKA	  activity	  and	  ovarian	  cancer	  cell	  migration	  by	  the	  mechanical	  properties	  of	   the	  ECM.	   	  Finally,	  we	  delineate	   the	  hierarchy	  of	   cell	   signaling	  events	  that	   regulate	   leading	   edge	   PKA	   activity	   and,	   ultimately,	   the	   migration	   of	   ovarian	  cancer	  cells.	  	  Specifically,	  we	  elucidate	  a	  mechanism	  where	  leading	  edge	  protrusions	  elicit	   leading	  edge	   calcium	  currents	   through	   the	   stretch-­‐activated	   calcium	  channel	  (SACC)	  of	   the	   transient	   receptor	  potential	   family	  melastatin	  7	   (TrpM7)	   to	  activate	  actomyosin	  contractility.	  ECM	  substrate	  stiffness	  is	  sensed	  by	  the	  actin	  cytoskeleton	  and	  actomyosin	   contractility,	  which,	   in	   turn,	   regulates	   the	   activity	   of	   leading	   edge	  PKA	  activity.	  These	  studies	  have	  provided	  important	  insights	  into	  the	  regulation	  of	  cell	  migration	  and	  have	  established	  the	  mechanistic	  details	  governing	  leading	  edge	  PKA	  activity	  during	  cell	  migration.	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CHAPTER 1: LITERATURE REVIEW 
1.1 Introduction 	  
Cell migration is essential for the development and maintenance of normal tissues 
and organs, and aberrant cell migration can lead to several pathologies including vascular 
disease, chronic inflammation, neurological disorders, and cancer metastasis. The 
coordinated effort of numerous intracellular signaling processes, as well as the integration 
of signals received from the extracellular microenvironment, converge to extend 
protrusions at the cellular leading edge, make contact with and adhere cells to the 
extracellular environment, translocate the cell body, and retract the cell rear. Migration-
associated pathological conditions, such as cancer metastasis, exemplify the catastrophic 
effect of aberrant cell migration, emphasize the importance of migration in normal 
cellular functions, and stress the importance in understanding the underlying molecular 
mechanisms governing cell migration.  
   
1.2 Ovarian cancer 
1.2.1 Introduction to ovarian cancer 
  
Ovarian cancer is the deadliest of all of the female reproductive tract cancers with 
an estimated 22,240 new cases and 14,030 deaths in 2013 (American Cancer Society, 
Cancer Facts and Figures 2013).  Though ovarian cancer only accounts for 3% of the 
	   2	  
cancers in women, it is the 5th leading cause of cancer-related death among women. The 
cumulative, age-adjusted 5-year survival rate has risen only 10% (from 33.6% - 43.9%) 
over the last 40 years (American Cancer Society, Cancer Facts and Figures 2013; Jemal 
et al., 2008). The high morbidity and mortality of ovarian cancer is due, in part, to the 
asymptomatic progression of ovarian cancer in conjunction with the inability to detect 
ovarian cancer lesions early in the disease progression and the common recurrence after 
initial responses to chemotherapies (Hanprasertpong & Fujiwara, 2011; Pignata et al., 
2011; Ramirez, Chon, & Apte, 2011). Thus, most patients present with late-stage disease 
where the cancer cells have disseminated and often metastasized to sites distal form the 
primary tumor.  Although only 20% of ovarian cancers are diagnosed with the cancer 
confined to the ovary, the 5-year survival rate of women with tumors localized to the 
ovaries is greater than 90% (Jemal et al., 2008).  These staggering statistics highlight the 
importance of learning more about the fundamental cell biology that governs ovarian 
cancer in order to more effectively detect, diagnose, and treat the disease.    
1.2.2 Onset and progression of ovarian cancer 	  
It is thought that approximately 90% of primary ovarian malignancies are 
carcinomas (of epithelial origin) that arise from the ovarian surface epithelium (OSE) 
(Chioni, Shao, Grose, & Djamgoz) (Gubbels, Claussen, Kapur, Connor, & Patankar, 
2010). The OSE is highly responsive to environmental stimuli, including those associated 
with ovulation. Normally, the OSE is a monolayer of squamous-to-cuboidal epithelial 
cells that participate in the rupture and repair that accompanies every ovulation. Thus, the 
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OSE cells can-and-do differentiate from cuboidal epithelial cells to a mesenchymal 
phenotype in a process termed epithelial-mesenchymal transition (EMT) (Cho & Shih Ie, 
2009). The ability of the OSE to undergo EMT allows the normal OSE to remodel the 
extracellular matrix (ECM) and increase cell motility and cell proliferation in order to 
repair the post-ovulatory wound (Ahmed et al., 2006).  While this process is required for 
normal ovulation cycles, it is thought that ovarian malignancies on the OSE arise from 
unregulated EMT events that lead to cysts in the ovarian cortex, termed inclusion cysts. 
Inclusion cysts are lined by one layer of cells resembling the surface epithelium of the 
ovary and are formed by excessive ovulation (Meinhold-Heerlein & Hauptmann, 2014; 
Sharma et al., 2012).  This ‘incessant ovulation’ theory, first proposed by Fathalla in 
1971, is based on an epidemiologic study showing that women who are taking oral 
contraceptives, who have given birth, or are breastfeeding (and thus, have a reduction of 
ovulation events) are less likely to develop epithelial ovarian cancer (EOC) (Fathalla, 
1971, 2013).  
Another, related, theory on the genesis of ovarian cancer is the gonadotropin 
hypothesis (Akhmedkhanov, Toniolo, Zeleniuch-Jacquotte, Pettersson, & Huhtaniemi, 
2001; D. W. Cramer & Welch, 1983).  This hypothesis suggests that after menopause (the 
time when most women develop ovarian cancer) high levels of gonadotropins, mainly 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH), are released and these 
hormones stimulate ovulation-like processes including the expression of proteolyitic 
enzymes within the OSE (Akhmedkhanov et al., 2001; D. W. Cramer & Welch, 1983).  
The proteolytic degradation of the basement membrane can lead to inclusion cysts that 
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are, again, thought to lead to the transformation of cancer cells.  Though these two 
models differ in the hypothesis of how the inclusion cysts initiate, they agree that 
deregulated EMT-like processes within the OSE leads to the development of lesions on 
the surface of the ovary that give rise to cancer.  In addition to these theories, there are 
reports that show the origin of ovarian cancers is actually the fallopian tubes and not the 
ovaries themselves. 
As discussed above, normal OSE cells undergo EMT every ovulation cycle. EMT 
is a phenotypic conversion of polarized, non-motile epithelial cells into migratory 
mesenchymal cells (Hay, 1995). EMT is utilized in normal processes like embryonic 
development, wound healing and tissue regeneration, but is also involved in cancer 
progression and metastasis (Davidson, Trope, & Reich, 2012; Hay & Zuk, 1995; He & 
Magi-Galluzzi, 2014). One hallmark of EMT is the loss of expression of the cell-cell 
adhesion molecule, E-cadherin (Sun, McAlmon, Davies, Bernfield, & Hay, 1998). E-
cadherin assembles epithelial cells into a contiguous sheet and operates to maintain 
quiescence within the epithelial sheet. The expression of E-cadherin is regulated by 
numerous transcription factors including Twist and the Snail/Slug family transcription 
factors (D. Lopez, Niu, Huber, & Carter, 2009). These factors bind near the E-cadherin 
promoter and recruit transcriptional repressors and histone deacytlases to repress E-
cadherin expression. Due to their involvement in EMT, the loss of E-cadherin expression, 
and increased expression of Twist and Snail/Slug can be used as markers of cells that 
have undergone EMT and their expression has been linked to metastasis and poor 
prognosis in numerous cancers (Davidson et al., 2012; He & Magi-Galluzzi, 2014; 
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Marin-Aguilera et al., 2014; Pectasides et al., 2014). The composition of the extracellular 
matrix (ECM) such as collagen and hyaluronic acid (HA) and the density of the ECM can 
contribute to the induction of EMT (Kumar, Das, & Sen, 2014; Moustakas & Heldin, 
2014; Song, Jackson, & McGuire, 2000; Zeisberg et al., 2001). In addition to ECM 
proteins, numerous soluble factors including transforming growth factor-β (TGF-β), 
nuclear factor κB (NF-κB), epidermal growth factor (EGF), and tumor necrosis factor-α 
(TNF-α) have also been implicated in initiating EMT in ovarian cancer (Ahmed et al., 
2006; Cao et al., 2012; Cheng, Auersperg, & Leung, 2012a, 2012b; Salamanca, Maines-
Bandiera, Leung, Hu, & Auersperg, 2004). As alluded to above, one of the major 
characteristics of EMT is an increase cell migration, and the majority of this body of 
work will focus the regulation of cell migration in ovarian cancer cells.  
Epithelial ovarian cancer (EOC) encompasses four major types of epithelial-
derived tumors – endometrioid, clear cell, mucinous, and serous – with the most deadly 
being serous (D. W. Cramer & Welch, 1983; Gubbels et al., 2010; Meinhold-Heerlein & 
Hauptmann, 2014).  These classifications arise from histology samples that have certain 
characteristics and each will be discussed below. As the name suggests, endometrioid 
ovarian cancers resemble the endometrium and are characterized by the appearance of 
tubular glands, solid sheet-like growth, and the gross morphological appearance is that of 
a mass with both solid and cystic areas. Endometrioid ovarian carcinomas also have 
nuclear expression of the estrogen receptor (ER), progesterone receptor (PR), and β-
catenin. Clear-cell ovarian carcinomas are characterized by having a clear cytoplasm and 
large atypical nuclei with abnormally large nucleoli. Most clear-cell carcinomas are 
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associated with endometriosis and abnormal cell morphologies and do not overexpress 
p53. Mucinous ovarian carcinomas are the least common form of ovarian cancer 
accounting for less that 3% of all ovarian malignancies. Mucinous ovarian carcinomas 
are classified by identifying mucin distributed throughout the cytoplasm. In addition to 
overexpression of cytoplasmic mucin, mucinous ovarian carcinomas also display 
mutations in K-ras and lack mesothelin, fascin, and estrogen receptors. Lastly, the most 
prevalent and deadly of the ovarian cancer subtypes: serous ovarian carcinomas. Serous 
ovarian carcinomas cover a very broad spectrum of histological appearances that are 
thought to be due to the vast genetic heterogeneity found within serous ovarian 
carcinomas. They are typically columnar cells with a pink cytoplasm. Molecularly, they 
overexpress p53 and p53 mutations are common. Additionally, serous ovarian 
carcinomas retain BRAF and/or KRAS mutations. Though each type of ovarian cancer 
has its own independent criteria for diagnosis and outcome, they all have the propensity 
to disseminate and metastasize. The spread of ovarian cancer leads to its high morbidity 
and thus, a better understanding of the mechanism involved in the dissemination and 
metastasis of ovarian cancer has the potential to have a significant impact on the course 
of the disease.  
1.2.3 Mode of Metastasis 	  
Metastases are defined as the secondary malignant growths distant from a primary 
site of cancer (Chiang & Massague, 2008). For a cancer to metastasize and become 
malignant, it must invade beyond the basement membrane into the surrounding tissue 
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(Chiang & Massague, 2008; Klein, 2008). While primary EOC tumors are usually 
successfully removed by debulking surgery or cancer chemotherapies, metastases are 
more difficult to detect and treat (Fago-Olsen et al., 2013; Hanprasertpong & Fujiwara, 
2011; Pignata et al., 2011; Ramirez et al., 2011). Metastases that reach other organs can 
cause death by interfering with normal organ function or from complications related to 
treatment. In order for cancer cells to metastasize, tumor cells must first detach from the 
primary tumor, reattach to distal sites, and invade through the basement membrane of the 
target organ through the epithelial-mesenchymal transition process (Figure 1). While the 
mode of ovarian cancer metastasis is different than other cancers, such as breast cancer 
(as will be discussed below), there are similar cellular and molecular events that are 
common among all cancers. Specifically, cells must first detach from the primary tumor 
in order to spread to other organs. Detachment of epithelial cells is accomplished through 
the down regulation of cell-cell adhesion molecules including adherin junctions, tight 
junctions, and gap junctions. As noted above, in canonical EMT, expression of E-
cadherin, a mediator of cell-cell adhesion, is decreased and expression of N-cadherin is 
concomitantly increased.  E-cadherin mediates cell-cell adhesion in numerous cell types 
including the myocardium, connective tissue fibroblasts, and the ovarian surface 
epithelium (Morris et al., 2006; Patel, Madan, Getsios, Bertrand, & MacCalman, 2003). 
In ovarian cancer, there is a trend of decreased E-cadherin expression, but it is certainly 
not always the case (Davidson et al., 2000). This suggests that EOC cells undergo 
incomplete EMT and adds to the increased difficulty in both diagnosing and treating 
ovarian malignancies (Davidson et al., 2012).   
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EOC dissemination is mainly intra-abdominal and rarely leads to the invasion of 
the vasculature to produce truly distal malignancies (Naora & Montell, 2005). The most 
common route of dissemination is through the sloughing off of malignant cells into the 
peritoneal cavity where they can be further disseminated by the normal fluid flow within 
the peritoneal cavity. Malignant EOC cells often coalesce to form multicellular  
	  
Figure 1. Epithelial ovarian cancer dissemination. Primary epithelial ovarian cancer 
(EOC) tumors disseminate by sloughing multicellular aggregates, termed spheroids, into 
the peritoneal cavity. The peritoneum is a main target of EOC metastasis, and EOC 
spheroids are depicted attaching to and disaggregating on the peritoneal wall. 	  	  
aggregates, referred to as spheroids, and are thought to be the smallest metastatic unit of 
EOC (Shield, Ackland, Ahmed, & Rice, 2009).  The spread of EOC spheroids is aided by 
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the anatomy of the peritoneal cavity where there are no anatomic barriers between the 
ovarian cancer spheroids and the organs housed within the peritoneum.  These spheroids 
are thought to be important for numerous facets of ovarian cancer cell biology and 
pathology (Shield et al., 2009). The exfoliation process includes downregulation of cell-
cell adhesion molecules such as E-cadherin, but as mentioned before, the incomplete 
EMT contributes to the sloughing off of multicellular spheroids instead of individual cells.  
After exfoliation from the primary tumor, the next step in metastasis is to attach to 
and invade into neighboring tissues.  This requires the re-activation of adhesive 
molecules and the upregulation of genes that allow cells to degrade the ECM and acquire 
a motility phenotype. Importantly, EOC cells overexpress specific mucins (i.e. MUC16) 
that bind to mesothelin, a protein found on the surface of the mesothelial cell layer, which 
facilitates the peritoneal metastasis in ovarian tumors (Theriault et al., 2011). Moreover, 
EOC cells express high levels of the ECM-degrading metalloproteinases that allow them 
to degrade the basement membrane of the tissues on which they attach (X. Hu et al., 
2012). The specificity that an EOC tumor cell has for metastasizing to a particular 
location within the peritoneum is still largely unknown, but different cancers do have 
distinct patterns of metastasis. Through the work accomplished in this text, we 
hypothesize a model whereby ovarian cancer cells sense not only the chemical 
composition of their ECM, but also the mechanical properties of the ECM and this 
mechanical-sensing serves as a major determinant in EOC dissemination. To support this 
hypothesis, recent work demonstrated that EOC multicellular spheroids use force, 
generated through the interaction between the actin cytoskeleton and the molecular motor, 
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myosin, within EOC cells, to attach, infiltrate, and clear the mesothelial cell layer in the 
abdominal cavity (Iwanicki et al., 2011). Many laboratories have used multicellular 
spheroids to study the cell biology of ovarian cancer (Shield et al., 2009). Indeed, this 
model will be used in further chapters of this work to describe how ovarian cancer cells 
respond to mechanical stimuli in vitro.         
1.3 Cell Migration and Metastasis 
1.3.1 Introduction to cell migration 	  
Cell migration is the term used to describe the process in which cells move from 
one location to another.  Varying cell types migrate in response to numerous stimuli 
including those that generate new organs during embryogenesis and signal to induce 
wound healing and the immune response.  In addition to these normal cell processes, 
abnormal migratory signals can induce cells to migrate inappropriately and aid in 
numerous pathologies including rheumatoid arthritis, multiple sclerosis and cancer cell 
metastasis (R. Horwitz & Webb, 2003). Cell migration is a cyclical process that begins 
with the cell receiving an external signal that leads to the reorientation, polarization, and 
the extension of a protrusion in the direction of movement (Vicente-Manzanares, Webb, 
& Horwitz, 2005). For cells to continue to migrate, they must initiate contact to the 
substrate upon which they are moving.  These contacts, termed focal adhesions, serve as 
the link between the cell exterior and intracellular signals to promote adhesions, and their 
turnover are required for continued migration (Geiger & Yamada, 2011; Parsons, 
Horwitz, & Schwartz, 2010; Zaidel-Bar, Ballestrem, Kam, & Geiger, 2003). The 
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migratory process continues as cells utilize contractile machinery (actin-myosin 
interactions, discussed below) to contract and translocate the cell body (Giannone et al., 
2007; Svitkina, Verkhovsky, McQuade, & Borisy, 1997; Vicente-Manzanares, Zareno, 
Whitmore, Choi, & Horwitz, 2007).  Finally, the attachments at the cell rear detach and 
the rear retracts to complete the cycle (L. P. Cramer, 2013; Crowley & Horwitz, 1995).  
These particular migration-associated events occur within distinct subcellular locations 
that are unique in their morphologies, molecular and biochemical composition, and 
spatiotemporal regulation.  Specifically, protrusion occurs within the leading edge, 
adhesions are present throughout the cell periphery but their rapid turnover occurs mainly 
in the cell front, and contraction occurs at both the front and rear of the cell to both push 
the cell forward and retract the cell rear, respectively. The focus of the enclosed work is 
on mechanisms regulating the dynamics of the leading edge of migrating cells.  This is 
not meant to understate the importance of migration-associated events in other parts of 
the cell, as those mechanisms, too, are crucial for cell migration.  On the contrary, the 
focus at the leading edge (and the subsequent effects of perturbing leading edge dynamics 
on overall cell migration) emphasizes the importance in understanding the spatiotemporal 
regulation of signals governing cell migration on a subcellular level.  
The main focus of the enclosed dissertation is on a particular mechanism that 
regulates cell migration.  Specifically, this work will address how the 3’-5’-cyclic 
adenosine monophosphate (cAMP)-dependent protein kinase (PKA) is regulated during 
ovarian cancer cell motility.  PKA regulates several facets of cell migration that will be 
discussed in detail below, and so it is crucial to know the classical mechanisms that 
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govern cell protrusions, how the contractile machinery of the cell is known to regulate 
cell motility, how cellular adherence to the extracellular matrix (ECM) is regulated 
during cell motility, and how PKA is known to affect these processes.  
1.3.2 Molecular mechanisms governing cell protrusion and migration 	  
Cell protrusions are the initiating step in cell migration and are typically made in 
the direction of cell migration.  Protrusion requires the coordination of numerous cellular 
signaling pathways including actin polymerization, Rho-family GTPase activity, myosin-
II activity, integrin activation, and activation of the cAMP-dependent protein kinase, to 
name a few (Costa, Scales, Ivaska, & Parsons, 2013; Howe, Baldor, & Hogan, 2005; 
Humphries, Obara, Olden, & Yamada, 1989; C. D. Lawson & Burridge, 2014; Pollard & 
Cooper, 2009; Price et al., 1998).  Together, these signaling events advance the cell’s 
leading edge, establish contact with the substratum, and generate the force required pull 
the cell over these points of contact.  
Dendritic actin polymerization at the cell front generates the force required to 
deform and push the cell membrane forward (Pollard & Cooper, 2009).  Actin 
polymerization occurs when a free globular actin monomer (g-actin) bound to ATP binds 
to another actin monomer through the hydrolysis of ATP (Korn, Carlier, & Pantaloni, 
1987).  The ADP-Pi actin dimers continue to polymerize to form stable filaments. Release 
of the phosphate from the actin filament destabilizes the filament and allows for the 
depolymerization of the actin filament (Carlier, 1990). Depending on the number of 
filaments and the actin-bound proteins, actin can polymerize to either form long, stable, 
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unbranched actin filaments, or can form a highly branched network of smaller, more 
dynamic actin polymers. These differences in actin morphologies lead to the generation 
of distinct cellular structures at the leading edge of migrating cells including filopodia 
and lamellipodia (Mattila & Lappalainen, 2008; Mejillano et al., 2004). Filopodia are 
long, thin, unbranched actin-based protrusions that are used by cells to explore their local 
microenvironment. Conversely, lamellipodia are broad protrusions consisting of short, 
thin, branched actin filaments and usually exists within 1 µm of cell membrane (Ponti, 
Machacek, Gupton, Waterman-Storer, & Danuser, 2004). Immediately behind the leading 
edge lamellipodia is the lamella. Actin in the lamella is typically bundled and not as 
highly branched as in the lamellipodia (Ponti et al., 2004).  Mysoin-II interacts with the 
actin filaments in the lamella and produces contractile force to push the cell front in the 
direction of migration (Figure 2; J. I. Lim, Sabouri-Ghomi, Machacek, Waterman, & 
Danuser, 2010). Of particular import to these distinct actin structures is the mode in 
which they are regulated.  Specifically, the Rho-family of small GTPases regulates the 
specificity of actin structures that are generated at the leading edge of migrating cells and 
cell protrusion is tightly regulated by the spatiotemporal regulation of Rho-family 
GTPase activity.  
Rho-family GTPases are small enzymes that hydrolyze the gamma phosphate on 
guanosine-5-triphosphate (GTP) and whose actions are regulated by the hydrolysis of 
GTP. Inactive, guanisine-5-diphosphate-(GDP)-bound, GTPases are activated when 
guanine nucleotide exchange factors (GEFs) exchange the bound GDP for GTP.  Once 
GTP is bound, these proteins become active and can modulate specific effector proteins.  
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The GTPase activity can be enhanced, and thus the activity of the G-protein can be 
decreased, through the activity of GTPase activating proteins (GAPs). The regulation of 
GTPases is further modulated through GDP dissociation inhibitors (GDIs) that keep the 
G-protein bound to GDP and in an inactive state and sequester the G-proteins in  
	  
Figure 2. Protrusions in migrating cells. Unbranched actin polymerization facilitate the 
formation of filopdia. Dendritic actin polymerization at the leading edge of migrating 
cells is responsible for lamellipodial formation. Actin-myosin interactions in the leading 
edge lamella exist immediately behind the leading edge lamellipodia. 
 
  
subcellular space (Heasman & Ridley, 2008; Jaffe & Hall, 2005).  Cdc42, Rac, and RhoA 
were the first identified, and the three most common and abundant Rho-family GTPases 
that regulate cell migration (Nobes & Hall, 1995).  
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Cdc42 regulates filopodia formation through affecting numerous actin-associated 
proteins including a class of actin nucleating proteins called formins (Block et al., 2008; 
Mattila & Lappalainen, 2008).  Formins are responsible for the rapid polymerization of 
actin into long unbranched actin filaments that contribute to filopodia formation. Rac was 
first discovered as a key regulator of growth factor-induced membrane ruffling and is 
now known as the primary regulator of lamellipodia (Ridley, Paterson, Johnston, 
Diekmann, & Hall, 1992; Svitkina & Borisy, 1999). Some of Rac’s most notable 
effectors include the WASP family Verprolin-homologous/suppresser of cAR protein 
(WAVE/SCAR) complex and neural Wiskott-Aldrich syndrome protein (N-WASP) 
which control the activity the actin related protein 2/3 (Arp2/3), an actin nucleating 
protein (Law et al., 2013; Takenawa & Miki, 2001). Arp2/3 is responsible for nucleating 
branched actin on the sides of existing actin filaments and contributes to the formation of 
the broad, branched actin network found in the lamellipodium. In addition to being 
responsible for lamellipodial dynamics, a recent report demonstrated that Arp2/3 
regulates filopodial-dependent growth-cone guidance in neurons (San Miguel-Ruiz & 
Letourneau, 2014). These data suggest that Arp2/3 plays diverse roles in regulating actin 
dynamics. RhoA is most well known for its role in regulating actin stress fibers and 
retraction of the cell rear, however its importance at the leading edge of migrating cells is 
emerging as a crucial regulator of leading edge dynamics (Machacek et al., 2009; Ridley 
& Hall, 1994), and will be discussed in detail below.  Stress fibers are unbranched, 
antiparallel actin bundles that are decorated with myosin-II, a molecular motor 
responsible for generating the contractile forces associated with cell migration (Vallenius, 
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2013; Weber & Groeschel-Stewart, 1974). RhoA affects stress fiber dynamics by 
regulating proteins associated with stress fiber formation and contractions.  Notably, 
RhoA activates the Rho associated protein kinase (ROCK), which directly activates 
myosin-II by phosphorylating the myosin regulatory light chain (RLC) and 
phosphorylation-induced inactivation of myosin light chain phosphatase (MLCP). In 
addition to stress fiber formation, RhoA’s regulation of actomyosin contractility is also 
responsible for mediating rear retraction. Importantly, RhoA also regulates the 
actomyosin contractility localized to the leading edge lamella (Pertz, Hodgson, Klemke, 
& Hahn, 2006). In addition to regulating actomyosin contractility, RhoA has also been 
implicated in regulating the nucleation of actin filaments through its regulation of mDia1, 
a formin that regulates unbranched actin polymerization (Nakano et al., 1999).  
Recently, experiments utilizing the correlation of live-cell microscopic analysis of 
the spatiotemporal activity of Cdc42, Rac, and RhoA revealed that the activity of each 
GTPase is temporally correlated with the protrusion retraction cycle at the leading edge 
of migrating cells (Machacek et al., 2009).  Specifically, maximal RhoA activity was 
found to coincide with maximal protrusion velocity, and the maximal activation of both 
Rac and Cdc42 occurs after the maximum protrusive velocities.  This study reveals novel 
activities of each GTPase in the context of cell protrusions that had previously not been 
appreciated.  First, the coincidence of maximum RhoA activity with maximum edge 
velocity reveals that RhoA might have a primary function at the leading edge more as a 
regulator of actin nucleation and polymerization rather than regulating actomyosin 
contractility. Secondly, Rac1 and Cdc42 appear to be regulating adhesion dynamics 
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associated with protrusion more so than regulating actin dynamics.  These findings are 
important in accentuating new, important mechanisms for these classical proteins, but 
also must be taken in the context of method of measure.  The activities of these proteins 
are monitored only within 2 µm from the cell membrane, and there could be different 
effects as the activities are monitored further away from the cell edge.  Moreover, this 
paper (and others from the same laboratory) established the use of correlation microscopy 
as a valuable tool in dissecting molecular mechanisms governing complex cellular 
behaviors such as cell migration (Machacek et al., 2009; Pertz et al., 2006).      
Myosins are a unique class of molecules termed molecular motors.  They are one 
of the two contractile proteins in muscle cells, the other being actin (Huxley & 
Niedergerke, 1954). Myosins bind and hydrolyze ATP into ADP and inorganic phosphate 
(Pi).  Depending on the stage of the hydrolysis cycle, myosin is either very tightly or 
loosely bound to actin (Tyska & Warshaw, 2002). When ATP binds to myosin, the 
affinity of myosin for actin is low.  Upon hydrolysis, myosin becomes tightly bound to 
actin and the release of the inorganic phosphate from the active site elicits a 
conformational change in myosin that results in the pushing of actin; termed the power 
stroke. When ADP is released, myosin is still tightly bound to actin until another ATP 
molecule binds the active site and the cycle repeats. Myosin, much like actin, can exist in 
filaments, and the dynamic interaction of several tandem myosin motors with an actin 
filament can give rise to the contraction of the actin cytoskeleton upon myosin activation. 
Myosins are broken into several classes that perform unique tasks ranging from the 
transportation of cargo along actin tracks to actomyosin contractility (Hartman & 
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Spudich, 2012; J. L. Ross, Ali, & Warshaw, 2008). Non-muscle myosin-II is most well 
known for its role in regulating actomyosin contractility.  In the leading edge of 
migrating cells, the leading edge lamellipodium is devoid of myosin while the leading 
edge lamella (the area just behind the lamellipodium) is rife with non-muscle myosin-II.  
Recent studies have shown that the expression of specific myosin-II isoforms contribute 
to cell polarity and protrusion (Vicente-Manzanares, Ma, Adelstein, & Horwitz, 2009).  
Specifically, myosin-IIb establishes the cell rear and myosin-IIa localizes to both the rear 
and front of migrating cells (Vicente-Manzanares, Newell-Litwa, Bachir, Whitmore, & 
Horwitz, 2011). Additional recent work has described the requirement for myosin-
dependent traction forces for extracellular matrix degradation during cancer cell invasion 
(Jerrell & Parekh, 2014), and its activity is required for focal adhesion maturation 
(Stricker, Beckham, Davidson, & Gardel, 2013). Of particular relevance to this work, 
several cellular signaling pathways including the Rho-associated protein kinase, the 
cyclic AMP-dependent protein kinase, and integrins can regulate actomyosin contractility. 
The Rho-associated protein kinase (ROCK) is activated when active (GTP-bound) 
Rho interacts with the kinase displacing the autoinhibitory domain.  Once active, ROCK 
phosphorylates numerous downstream targets that regulate the cellular cytoskeleton 
including ezrin, radixin, moesin (ERM) proteins (Matsui et al., 1998), the LIM-kinase 
(Maekawa et al., 1999), myosin light-chain (MLC), and myosin light-chain phosphatase 
(MLCP) (Kimura et al., 1996).  The phosphorylation of MLC and MLCP by ROCK are 
key regulatory events governing actomyosin contractility.  Specifically, phosphorylation 
of MLC on Ser19 (the same reside phosphorylated by myosin light-chain kinase MLCK) 
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induces myosin’s hydrolysis of ATP and thus initiates the power-stroke cycle discussed 
above.  Dephosphorylation of MLC by MLCP, another substrate for ROCK, inactivates 
myosin. ROCK-dependent phosphorylation of MLCP inhibits its phosphatase activity and 
acts to increase myosin activity. In addition to MLC and MLCP, ROCK also 
phosphorylates LIMK, which, in turn, increases stress fiber formation through regulation 
of cofillin, demonstrating that activation of ROCK can elicit substantial activation of 
myosin and actomyosin-mediated cellular contractility.          
Cell adhesions are the physical interactions either between two cells or between a 
cell and the extracellular matrix (ECM). The distinct, localized pattern of these adhesions 
allowed them to be termed focal adhesions. Focal adhesions between cells and the ECM 
are essential for cell migration and are highly regulated during cell motility. They serve 
as the link between the actin cytoskeleton and the fibrils of the ECM, and interpret the 
chemical and mechanical composition of the ECM into intracellular signals. Depending 
on the state of focal adhesion maturity, the adhesions have unique molecular make-ups 
and, so, are named differently as nascent adhesions, focal contacts, and focal adhesions. 
Nascent adhesions are the first observable adhesion structures that are small and highly 
transient.  Nascent adhesions are localized to the lamellipodium, contain adhesion 
proteins such as FAK (Choi, Zareno, Digman, Gratton, & Horwitz, 2011; C. Lawson et 
al., 2012), talin (X. Zhang et al., 2008), and paxillin (Zimerman, Volberg, & Geiger, 
2004), and either turnover quickly during rapid cell migration or mature into focal 
contacts (Partridge & Marcantonio, 2006). Interestingly, strong propulsive forces have 
been measured in nascent adhesions suggesting that they are not merely an intermediate 
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step in adhesion maturation, but are required for actin-dependent protrusion (Beningo, 
Dembo, Kaverina, Small, & Wang, 2001). Focal contacts are larger than nascent 
adhesions and exist at the interface between the lamellipodium and lamella and their 
turnover is associated with rapid cell motility (J. I. Lim et al., 2010).  Focal contacts 
require myosin-II activity for their maintenance and can either turnover or further mature 
into focal adhesions (J. I. Lim et al., 2010; Pasapera, Schneider, Rericha, Schlaepfer, & 
Waterman, 2010). Focal adhesions are the most readily detectable adhesions and are 
associated with slow motility as high levels of adherence inhibit the cell’s ability to move. 
As mentioned above, the molecular composition of the different adhesions makes each 
adhesion classification different.  
As adhesions mature, the dependence on myosin-II signaling recruits specific 
tension-regulated adhesion molecules including zyxin, vinculin, and tensin (Kuo, Han, 
Hsiao, Yates, & Waterman, 2011). Focal adhesions are main sights of cellular force 
generation (Gardel et al., 2008), and force fluctuations within focal adhesions are 
required for rigidity sensing during cell migration (Plotnikov, Pasapera, Sabass, & 
Waterman, 2012). This topic will be expanded upon in greater detail below. Although 
there are distinct molecular compositions in different adhesions, there are common 
proteins that exist throughout the lifetime of focal adhesions. Specifically, integrins are 
the primary ECM ligand receptors that span the plasma membrane and serve as the 
physical link between the cell and the ECM and exist in all cell-ECM adhesions.  
Upon activation, integrins form large clusters through cytoplasmic tail-
crosslinking proteins. Clustering of integrins increases the avidity of the integrin receptor 
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to the ECM ligand and induces focal adhesion initiation.  Integrin avidity to ECM ligands 
is also enhanced through integrin activation via conformational changes in the integrin 
molecule that create a high affinity ECM binding state (Kim, Ye, & Ginsberg, 2011). 
Integrins exist as heterodimers consisting of an alpha and beta subunit.  The specific 
integrin heterodimer composition at sites of adhesion is dependent on the ECM ligand 
being bound. The cytoplasmic tails of the integrins serve as the scaffold for intraceellular 
signaling events and as the linkages to the actin cytoskeleton. Numerous adapter proteins 
bind to both the cytoplasmic tails of integrins and the actin cytoskeleton including talin, 
vinculin, FAK and alpha-actinin. A vast number of other molecules bind to integrin-
containing sites of adhesion and regulate cell-signaling events by scaffolding, 
phosphorylation, and actin crosslinking. Recent studies have elucidated the hierarchy of 
adhesion assembly in both space and time and accentuate the importance in 
understanding aberrant adhesion signaling (Kanchanawong et al., 2010).  
Of particular importance, adhesions initiate numerous signaling events that 
regulate cell migration through controlling actin polymerization, actomyosin-mediated 
cell body translocation, and focal adhesion assembly and disassembly. Moreover, 
adhesions serve as the physio-chemical sensors of the cell that allow a cell to discern both 
the physical and chemical make-up of their extracellular matrices. Targeting adhesions 
and adhesion-associated cellular events such as angiogenesis and cell migration is 
emerging as a novel therapeutic avenue in cancer (Hensley et al., 2014; Stone et al., 
2014). Though the main body of this work focuses on cellular signaling pathways 
associated with cell protrusion and not adhesion-mediated signaling, there are numerous 
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connections between the cell’s ability to protrude and proper adhesion signaling.  One 
such pathway with historical connection to adhesion signaling and a new-found 
connection with cell protrusion is the cAMP/PKA pathway.  
As stated before, the focus of this thesis is to discuss the regulation of 
cAMP/PKA during cell migration.  The following section will outline canonical 
activation of PKA and address how PKA is involved in the processes reviewed above, 
namely cell protrusion and cell adhesion.     
1.4 cAMP/PKA signaling 
1.4.1 Structure and regulation of PKA 	  
Protein kinases phosphorylate proteins by transfering gamma-phosphates from 
ATP to target proteins (Fischer, Graves, Crittenden, & Krebs, 1959).  Phosphorylation of 
proteins regulates nearly every aspect of cellular life and can modify the function of a 
protein in numerous ways including either increasing or decreasing its biological activity, 
stabilizing it or targeting it for destruction, enhancing or impeding its movement between 
cellular compartments, or facilitating or inhibiting its interactions with other proteins.  
Importantly, protein phosphorylation is reversible and the hydrolysis of phosphate groups 
from phospho-proteins is carried out by protein phosphatases (Ingebritsen & Cohen, 
1983). The relative abundance of ATP, the simplicity of the phosphorylation mechanism, 
and its reversibility make protein phosphorylation one of the most general regulatory 
mechanisms used in eukaryotic cells. Indeed, there are over 500 kinases encoded in the 
human genome and nearly 30% of all human proteins can be modified by kinase activity 
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(P. Cohen, 2002; Krebs, 1983). One such kinase is the cyclic-AMP dependent protein 
kinase (PKA) (Soderling et al., 1970; Walsh, Perkins, & Krebs, 1968).  
PKA, a serine/threonine kinase, is a member of the AGC family of protein kinases 
and phosphorylates proteins on a consensus site characterized by the presence of basic 
amino acids at the n - 2 and n - 3 positions, and hydrophobic residues at the n + 1 position 
(Daile, Carnegie, & Young, 1975; Kemp, Bylund, Huang, & Krebs, 1975). These 
observations lead to the identification of a general phosphorylation motif of X-R-(R/K)-
X-(S/T)-B where X is any amino acid and B is a hydrophobic amino acid (Daile, 
Carnegie, & Young, 1975; Kemp, Bylund, Huang, & Krebs, 1975). Though this 
generalized sequence motif describes the majority of phosphorylated PKA sites, there are 
other distinct sequences that be phosphorylated by PKA (Pinna	   and	   Ruzzene,	   1996). 
PKA exists in cells as an inactive heterotetrameric holoenzyme containing two regulatory 
(R) subunits and two catalytic (C) subunits. There are four genes that encode the 
regulatory subunits (RIα, RIβ, RIIα, and RIIβ) and three genes that encode for the 
catalytic subunits (Cα, Cβ, and Cγ). Two forms of the heterotetrameric PKA holoenzyme 
exist: type I (consisting of RIα and RIβ dimer subunits) and type II (consisting of RIIα 
and RIIβ dimer subunits). The R subunits are responsible for keeping the holoenzyme in 
an inactive state by inserting a substrate domain into the catalytic cleft of the catalytic 
subunit (Kim, Cheng, Saldanha, & Taylor, 2007; Kim, Vigil, Anand, & Taylor, 2006). 
Most importantly for enzymatic activity, the R subunits undergo drastic conformational 
changes that release the catalytic subunits after cooperatively binding two cAMP 
molecules for every R subunit associated with the holoenzyme. Additionally, the N-
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termini of the R subunits contain a dimerization and docking (D/D) domain that serves to 
facilitate assembly of the holoenzyme (Kim et al., 2006). The N-termini of the R subunits 
also facilitate the interaction of the holoenzyme with A-kinase anchoring proteins 
(AKAPs), which will be discussed in detail below.  	  
Edwin G. Krebs’ laboratory first identified PKA in 1968 as the kinase responsible 
for phosphorylating and activating phosphorylase kinase (the kinase that activates 
glycogen phosphorylase which, in turn, releases glucose-1-phosphate from glycogen) 
(Walsh et al., 1968).  These findings laid the groundwork for the study of the regulation 
of cellular events by PKA and indeed are the genesis of the effort described in this work. 
A great body of work and elegant experiments performed later established the mechanism 
of regulation for PKA whereby hormones bind to and activate G-protein coupled 
receptors (GPCRs) that are coupled to the small G-protein, Gαs (E. M. Ross & Gilman, 
1977; E. M. Ross, Howlett, Ferguson, & Gilman, 1978). Active Gαs activates adenylyl 
cyclases that catalyze the formation of cAMP from ATP (Sutherland, Rall, & Menon, 
1962). Two cAMP molecules bind to each of the regulatory subunits of the holoenzyme 
that cause the dramatic conformational change that releases the active catalytic subunits 
from the holoenzyme. The free catalytic subunits phosphorylate downstream substrates.  
PKA activity is moderated by the relative amounts of available cAMP, and 
phosphodiesterases (PDEs) hydrolyze cAMP into AMP and thus, decrease the 
availability of cAMP and the activity of PKA. In addition to its dependence on cAMP, 
PKA catalytic subunits also require autophosphorylation on Thr-197 in the catalytic cleft 
for maximal activity (Cauthron, Carter, Liauw, & Steinberg, 1998). Newer work has 
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added levels of complexity to this canonical activation scheme whereby PKA 
autophosphorylation of the RII subunit at Ser-95 regulates PKA-AKAP interactions and 
localized PKA activities (Manni, Mauban, Ward, & Bond, 2008) and, interestingly, 
growth factor-mediated activation of PKA can be modulated through direct tyrosine 
phosphorylation of the PKA catalytic subunit on Tyr-330 (Caldwell et al., 2012).  
In addition to regulation of its enzymatic activity, the spatial distribution of PKA 
is regulated in subcellular space through AKAPs (Carr, Hausken, Fraser, Stofko-Hahn, & 
Scott, 1992; Wong & Scott, 2004). While type I PKA is mostly cytosolic, nearly 75% of 
type II PKA associates with specific cellular structures and organelles (Corbin, Sugden, 
Lincoln, & Keely, 1977; Di Benedetto et al., 2008). These associations are largely 
regulated through scaffolding of PKA to subcellular compartments through PKA-AKAP 
interactions whereby the AKAPs tether PKA to distinct cellular structures. For example, 
PKA is localized to the actin cytoskeleton through PKA-WAVE1 (Westphal, Soderling, 
Alto, Langeberg, & Scott, 2000), PKA-Ezrin , PKA-Gravin (Nauert, Klauck, Langeberg, 
& Scott, 1997), and AKAP-KL (Dong, Feldmesser, Casadevall, & Rubin, 1998) 
interactions, and to the microtubule cytoskeleton through the microtubule-associated 
protein 2 (MAP2, (Salvador et al., 2004; Theurkauf & Vallee, 1982)). PKA can also be 
localized to the nucleus (Brown, August, Williams, & Moss, 2003), mitochondria (Q. 
Chen, Lin, & Rubin, 1997), and endoplasmic reticulum/sarcoplasmic reticulum (Huang et 
al., 1999). In each case of specific PKA-AKAP interactions, the AKAPs are thought to 
bring unique upstream activators and downstream targets in close proximity to allow 
precise special regulation of localized PKA signaling events.  Though dual specificity 
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AKAPs (AKAPs that anchor both type I and type II PKA) exist, there are reports of both 
type I- and type II-specific PKA anchoring proteins with the majority of AKAPs 
anchoring type II PKA (McConnachie, Langeberg, & Scott, 2006).   
AKAPs were first discovered as protein contaminants that co-purified with RII 
subunits on cAMP-agarose affinity pull-downs (Sarkar, Erlichman, & Rubin, 1984). 
AKAPs bind to the N-terminal dimerization and docking domain of the regulatory 
subunits of PKA and contain a conserved structural motif that is characterized by the 
formation of an amphipathic helix, with hydrophobic residues aligned along one face of 
the helix and charged residues along the other that binds on the hydrophobic helix-turn-
helix region of the R-subunit dimerization domain through direct helix-helix interactions 
(Wong & Scott, 2004).  The spatial control of PKA adds a level of specificity that allows 
this otherwise promiscuous and ubiquitous kinase to have specified effects in subcellular 
space in response to numerous stimuli. In addition to mediating the spatial localization of 
PKA, many AKAPs facilitate the assembly of multi-enzyme, pre-assembled signaling 
hubs that link upstream activators to downstream targets to allow exquisite spatial 
specificity to PKA kinase activity (Wong & Scott, 2004).  
Several AKAPs serve not only as scaffolding proteins, but also contain intrinsic 
enzymatic activity themselves that include but are not limited to GEF/GAP activity 
(AKAP-Lbc, Diviani, Soderling, & Scott, 2001), actin-binding and nucleating activity 
(WAVE, Dong et al., 1998; Nauert et al., 1997), DNA-binding (AKAP95, Brown et al., 
2003), and microtubule-binding (MAP-2, Theurkauf & Vallee, 1982). Numerous recent 
reports demonstrate how localized activation of PKA, mediated through AKAPs, regulate 
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many aspects of physiology including Ca2+-induced Ca2+-release in muscle contraction 
(Navedo et al., 2010), neuronal synaptic function (Sanderson & Dell'Acqua, 2011), and 
cell migration (C. J. Lim et al., 2007; C. J. Lim et al., 2008; Paulucci-Holthauzen et al., 
2009).    
1.4.2 PKA in cell migration 
1.4.2.1 Overview  	  
PKA activity has been shown to be both required for and deleterious for cell 
migration (Howe et al., 2005; Edin, Howe, & Juliano, 2001; Ou et al., 2014; Tkachenko 
et al., 2011; Ydrenius, Molony, Ng-Sikorski, & Andersson, 1997). A recent study 
elegantly demonstrates that hyper-activation of PKA, through increases in cAMP, have 
strong negative effects on pancreatic ductal adenocarcinoma cell migration and invasion 
(Burdyga et al., 2013). These negative effects were mainly due to a decrease in both actin 
and focal adhesion dynamics. These findings support previous work that showed an 
inverse correlation between PKA activity and stress fiber formation (Liu, Verin, Borbiev, 
& Garcia, 2001), and other work that has shown the negative effects of PKA on integrin-
dependent cell migration (Spina et al., 2012). The requirement for PKA activity for 
numerous aspects of cell migration has also been extensively studied. Specifically, PKA 
activity facilitates leading edge actin-based membrane ruffles (Deming, Campbell, 
Baldor, & Howe, 2008), regulates adhesion-related proteins including Fyn (Yeo et al., 
2011), VASP (Howe, 2004; D. Zhang et al., 2010), and α4 integrin (C. J. Lim et al., 
2007; C. J. Lim et al., 2008), and regulates numerous migration-associated 
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regulator/signaling proteins including members of the Rho-family GTPases (Bachmann 
et al., 2013; Howe et al., 2005) that maintain consistent protrusion/retraction cycles at the 
leading edge (Tkachenko et al., 2011). These opposing roles for PKA exemplify the 
balance of PKA kinase activity that is required to maintain complex cellular functions 
like cell migration and demonstrate that it not simply a question of, “is PKA on or off?” 
but, “where, when, and how is PKA activity regulated?” that is crucial for efficient cell 
migration (Howe et al., 2005). 
1.4.2.2 PKA and focal adhesions 	  
There is a rich history connecting PKA activity with cell adhesion and its activity 
is tightly controlled by integrin activation. Interestingly, PKA is activated following both 
integrin-mediated cell-ECM adhesion and also by cell detachment in a number of cell 
types in an ECM ligand dependent manner (Gauthier et al., 2005; Howe & Juliano, 2000; 
O'Connor & Mercurio, 2001; Whittard & Akiyama, 2001). Specifically, PKA activity is 
suppressed when endothelial cells attach to collagen I (engaging integrin α1β1), and this 
suppression is required for actin polymerization and the angiogenic endothelial cell 
morphology (Whelan & Senger, 2003). An elegant example demonstrating the dynamic 
regulation of PKA activity by detachment, adherence, and cell spreading, shows that 
activation of PKA following detachment leads to phosphorylation of the vasodilator-
stimulated phosphoprotein (VASP, Howe & Juliano, 2000). Interestingly, PKA activity 
during initial adhesion was low but later increased and returned to baseline after the cells 
had spread. Additionally, the PKA RII subunit was shown to colocalize with integrins 
(Whittard & Akiyama, 2001), and indeed, be anchored by integrin α4 at sites of α4-
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containing cell-ECM attachment (C. J. Lim et al., 2007). The tight control of PKA 
activity by cell adhesion and the storied connections between cell-ECM adhesion and cell 
migration laid the groundwork for studying the role of PKA during cell migration. 
Several studies have linked PKA’s influence over regulators of cell protrusion to cell-
ECM adhesions, and will be outlined below.  
The vasodilator-stimulated phosphoprotein (VASP) is a member of the 
Ena/VASP protein family and contains several protein-protein interaction domains 
including an Ena/VASP homology 1 (EVH1) domain that localizes VASP to focal 
adhesion and the cell membrane, a proline-rich domain (PRD) that binds SH3 domains, 
and an EVH2 domain that contains domains that bind G-actin, F-actin, and a domain 
required for tetramerization and is known to regulate cytoskeletal dynamics and cell 
migration (Krause, Dent, Bear, Loureiro, & Gertler, 2003). VASP binds, bundles and 
nucleates actin through its interactions with actin in the EVH2 domain . PKA is known to 
phosphorylate VASP on Ser-153 but reports show differing consequences of this 
phosphorylation (Doppler & Storz, 2013; Halbrugge, Friedrich, Eigenthaler, 
Schanzenbacher, & Walter, 1990). In neuronal cells, phosphorylated VASP had a 
positive role for filopodia formation (Lebrand et al., 2004) while overexpression of a 
non-phosphorylatable VASP showed no significant effect on membrane ruffling or 
filopodia formation in in spreading fibroblasts. Other studies show that phosphorylation 
of VASP negatively regulates membrane protrusion (Bear et al., 2002; Krause et al., 
2004). Indeed, phosphorylation of VASP by PKA at Ser-153 decreases actin binding, 
bundling, and nucleating and also inhibits VASP SH3 domain-protein-protein 
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interactions (Barzik et al., 2005). Another recent paper showed that PDGF-stimulated 
epithelial cell migration was inhibited in the presence of overexpressed non-
phosphorylatable VASP (D. Zhang et al., 2010). The seemingly disparate roles for VASP 
gave rise a model of VASP function whereby VASP is targeted to leading edge 
protrusions and binds to the barbed ends of actin. Once bound to actin, VASP inhibits 
capping proteins to increase actin elongation. Though VASP leads to actin 
polymerization, the resulting protrusions are unstable and do not lead to cell translocation 
(Bear et al., 2002; Gomez & Robles, 2004).  
In addition to VASP, Fyn, a member of the Src-family non-receptor tyrosine 
kinases, is also phosphorylated by PKA (Yeo et al., 2011). Integrin signaling requires the 
activation of Src-family kinases to phosphorylate key tyrosine residues on specific focal 
adhesion proteins including the focal adhesion kinase (FAK), p130cas, and paxillin. Fyn 
phosphorylation by PKA at Ser-21 is required for Fyn kinase activity. When Ser-21 was 
mutated to Ala (Ser-21-Ala), there was a marked decrease in both PKA’s ability to 
phosphorylate Fyn and Fyn’s kinase activity showing that direct phosphorylation of Fyn 
on Ser-21 by PKA was crucial for Fyn’s tyrosine kinase activity (Yeo et al., 2011). 
Moreover, expression of a phospho-mimetic (Ser-21-Asp) rescued Fyn kinase activity. 
Interestingly, phospho-FAK (Tyr-397), focal adhesion dynamics, and cell motility were 
all decreased with overexpression of phospho-resistant (Ser-21-Ala) Fyn.    
Lastly, there is a connection between α4 integrin and PKA activity during cell 
adhesion and cell migration. Specifically, PKA phosphorylates α4 integrin on Ser-988 
during sheer-stress orientation of epithelial cells (Goldfinger et al., 2008). Importantly, 
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expression of a phospho-resistant α4 integrin was unable to be phosphorylated by PKA 
and cells expressing the mutant were unable to align in response to sheer-stress. Later 
work from the same lab showed that the cytoplasmic tails of α4 integrins serve as type-I 
A-kinase anchoring proteins (AKAPs) and that anchoring of PKA to the integrin is 
required for α4 integrin phosphorylation and directional persistence of cell migration (C. 
J. Lim et al., 2007). Moreover, the same lab demonstrated that leading edge PKA was 
mediated through the activity of α4 integrins at the leading edge of migrating cells (C. J. 
Lim et al., 2008). In addition to directly phosphorylating adhesion-related proteins, the 
PKA regulation machinery, namely G-protein coupled receptors, G-proteins, and 
phosphodiesterases, have been found in sites of adhesion (Alenghat, Tytell, Thodeti, 
Derrien, & Ingber, 2009; Serrels et al., 2010). Specifically, G-proteins upstream of 
cAMP/PKA were activated by magnetic twist of integrin-coated magnetic beads 
(Alenghat et al., 2009). Additionally, PDE4 is localized to focal adhesions through a 
complex containing FAK and RACK1 to promote cell polarity (Serrels et al., 2010). 
These examples demonstrate the ability of PKA to regulate the phosphorylation of 
proteins involved in adhesion signaling, and suggest that (not surprisingly) the potential 
discrete molecular effects of leading edge PKA activity are many. Indeed, many other 
migration-associated proteins unique from adhesion molecules are also regulated by PKA 
during cell migration. 
1.4.2.3 PKA and signaling proteins 	  
As described above, the Rho-family of small GTPases are crucial for regulating 
cell protrusion and the regulation of their activities during cell migration is an area of 
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intense investigation in many laboratories.  PKA plays a seminal role in either positively 
or negatively regulating the activity of various members of the Rho-family GTPases. In 
particular, PKA activity is required for activation of both Rac (Bachmann et al., 2013; 
O'Connor & Mercurio, 2001) and Cdc42 (Feoktistov, Goldstein, & Biaggioni, 2000), but 
inhibits the activity of Rho (Qiao et al., 2008) and the p21-activated kinase (Tsigginou et 
al.) (Howe & Juliano, 2000). Previous work from our lab showed that Rac activity was 
increased in the chemotactic leading edge of migrating cells and that inhibition of PKA 
inhibited Rac activity through increasing the activity of Rac-GAP and decreasing the 
activity of Rac-GEF (Howe et al., 2005). Other recent studies demonstrate the cross-talk 
between PKA activity, Rho-family GTPase activity, and the regulation of the actin 
cytoskeleton (Aburima et al., 2013). Specifically, PKA inhibits Rho activity through at 
least two mechanisms. First, direct phosphorylation of RhoA by PKA at Ser-188 
promotes the interaction of RhoA with Rho-GDI (Forget, Desrosiers, Gingras, & 
Beliveau, 2002; Lang et al., 1996), and thus, inactivates and displaces RhoA from the 
membrane. Secondly, PKA was recently shown to phosphorylate and activate RhoGDI at 
the leading edge of migrating cells contributing to the regulation of leading edge 
protrusion-retraction cycles (Tkachenko et al., 2011).  The authors show that when PKA 
was inactivated, there was a disruption in normal protrusion-retraction cycles. 
Specifically, leading edge dynamics were significantly slowed when PKA was inhibited. 
The authors show that PKA activity is required to activate RhoGDI, which inactivates 
RhoA and promotes leading edge protrusion. The authors offer little alternative 
explanations and no other possible leading edge substrates for PKA and their potential 
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cross-talk with leading edge dynamics. As promiscuous and ubiquitous as PKA is, it is 
difficult to imagine that RhoGDI is the sole PKA substrate responsible for governing 
PKA’s effects on cell migration. The list of proteins that are both known PKA substrates 
and that also regulate some aspect of cell migration was been reviewed extensively 
(Howe, 2005) and continues to grow.  
LIM-kinases are ubiquitously expressed kinases that regulate actin dynamics 
through phosphorylating and inactivating the actin depolymerization proteins 
ADF/cofilin (Yang et al., 1998). Cofilin is an actin severing protein involved in 
depolymerizing actin filaments, has been implicated in cell migration and invasion 
(Bravo-Cordero, Magalhaes, Eddy, Hodgson, & Condeelis, 2013) and is inactivated by 
phosphorylation on Ser-9 by LIMK (Yang et al., 1998).  The LIM kinases are classically 
activated by through the Rac-PAK or Rho-ROCK pathways where either PAK or ROCK 
phosphorylates and activates the LIM kinases on specific threonine residues within the 
LIMK activation loop (Amano, Tanabe, Eto, Narumiya, & Mizuno, 2001; Ohashi et al., 
2000). Interestingly, a recent report showed that PKA phosphorylates the kinase domain 
of LIMK1 at Ser-596 and at Ser-323 and modulates its activity. The authors showed that 
specific phosphorylation of LIMK by PKA at both Ser-596 and Ser-323 increased the 
relative amount of phosphorylated (inactive) cofilin present in the cells, whereas the non-
phosphorylatable mutants elicited a significantly lower level of phosphorylated cofilin. 
Concurrent with the decrease in phosphorylated cofilin in the non-phosphorylatable 
LIMK mutant cells, the authors noted that there was significant decrease in actin stress 
fiber formation (presumably due to overactive, non-phosphorylated cofilin). Conversely, 
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phosphomimetic LIMK constructs led to an increase in stress fiber formation through 
inhibition of cofilin activity (Nadella et al., 2009).  
Non-muscle myosin-II is an essential regulator of the actin cytoskeleton during 
cell migration (Vicente-Manzanares et al., 2007), and its activity is closely coupled to 
numerous aspects of cytoskeletal dynamics including stress fiber formation 
(Chrzanowska-Wodnicka & Burridge, 1996; Tojkander et al., 2011), lamellar contraction 
leading to membrane protrusion (Koestler, Auinger, Vinzenz, Rottner, & Small, 2008; 
Ponti et al., 2004), and rear retraction (Crowley & Horwitz, 1995). Recent studies 
elegantly described the spatial distribution of the different myosin isoforms during cell 
migration that give rise to cell polarity. Specifically, myosin-IIb is enriched in the cell 
front and myosin-IIa accumulates at the cell rear (Vicente-Manzanares et al., 2007). This 
segregation of myosin isoforms suggests that there might be different modes of regulating 
actomyosin contractility at the cell front versus the cell rear. Myosin activity is positively 
regulated through the phosphorylation of the regulatory light chain (MLC) associated 
with the myosin motor domain (the heavy chain, MHC). Primarily, MLC phosphorylation 
is mediated by myosin light chain kinase (MLCK) and myosin light chain phosphatase 
(MLCP) (Griffith, Downs, & Spudich, 1987). Phosphorylation of MLC at Ser-19 by 
MLCK activates myosin and removal of the phosphate on Ser-19 inactivates myosin, as 
described above. Regulation of MLCK and MLCP is quite complex, but there are discrete 
examples of PKA regulating the activity on both the kinase and phosphatase sides of 
MLC regulation. Specifically, the calcium/calmodulin complex binds to and activates 
MLCK and PKA can phosphorylate MLCK in the CaM binding site (Verin, Gilbert-
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McClain, Patterson, & Garcia, 1998). This phosphorylation would serve to occlude CaM 
from binding and activating MLCK and effectively reduce myosin activity. Additionally, 
MLCP is inactivated by phosphorylation by ROCK and phosphorylation of MLCP leads 
to overall activation of myosin through maintaining the phosphorylated (active) state of 
MLC (Totsukawa et al., 2000). ROCK activity is dependent on Rho activity and PKA-
mediated phosphorylation negatively regulates Rho activity, as described above (Qiao et 
al., 2008). The net effect of PKA activity on myosin activity would be negative, as both 
PKA-dependent phosphorylation of MLCK and Rho would serve to inhibit MLC 
phosphorylation/activation. In addition to regulating actin dynamics through 
phosphorylating actin-regulatory proteins, PKA can also elicit effects on the actin 
cytoskeleton through direct phosphorylation of actin (Ohta, Akiyama, Nishida, & Sakai, 
1987).  
1.4.2.4 PKA and ion channels 	  
Cell migration requires the coordination of numerous cell-signaling pathways 
including ion channels (Schwab & Stock, 2014).  Ion channels create pores in the plasma 
membrane through which ions can pass. All cell-types utilize ion channels to allow the 
passage of ions and their function is most storied in the regulation the electrical activity 
of many excitable cells in the nervous and cardiovascular systems.  Reports within the 
past 15 years have identified the importance of the regulation of ion (most notably, Ca2+) 
flow in migrating cells.  Calcium influx through calcium ion channels is at the core of 
numerous neuronal and vascular activities.  Specifically, cells have low cytoplasmic 
calcium levels compared to the extracellular space, and when calcium is conducted 
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through an ion channel into the cytoplasm, small changes in calcium concentrations can 
lead to drastic changes in cellular behavior.  In smooth muscle cells, large increases in 
calcium are associated with muscle cell contraction.  Elegant work in this field has 
identified numerous specific calcium events through particular calcium ion channels that 
regulate distinct facets of muscle cell biology (Hill-Eubanks, Werner, Heppner, & Nelson, 
2011). It is not surprising, then, that calcium channels could regulate processes, like cell 
migration, in non-excitable cells.  Indeed, readily detectable calcium events in migrating 
fish keratocytes were shown to coordinate with the generation of traction forces between 
the cell and the extracellular matrix (A. D. Doyle & Lee, 2002; A. Doyle, Marganski, & 
Lee, 2004).  The identity of the channel responsible for the calcium signals leading to 
increased traction force has remained unknown. There have been, however, specific ion 
channels identified in migrating fibroblasts that exhibit leading edge calcium events, 
termed ‘flickers’ that are mediated by the activity of the stretch-activated calcium channel, 
TrpM7 (Wei et al., 2009; Wei, Wang, Zheng, & Cheng, 2012). It was shown that these 
specific calcium events were localized over focal adhesions and thought to promote 
traction force generation (Wei et al., 2009; Wei, Wang, Zheng, & Cheng, 2012). Another 
report showed calcium events at the leading edge of migrating endothelial cells that were 
mediated by calcium release from the ER through the activities of STIM1 and Orai1 (Tsai 
et al., 2014). Interestingly, preliminary data from our lab has shown that PKA can 
phosphorylate both TrpM7 and Orai1 (Howe, 2011).  Though the functional consequence 
of this phosphorylation during cell migration remains to be tested, the ability of PKA to 
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phosphorylate calcium channels known to regulate cell migration is a tantalizing area of 
investigation.  
A vast array of ion channels permeable to ions other than calcium have also been 
implicated in cell migration (Lagana et al., 2000; Potier et al., 2006; Schwab, Fabian, 
Hanley, & Stock, 2012; Schwab, Wojnowski, Gabriel, & Oberleithner, 1994), and a 
subset of those have been shown to substrates for PKA. Specifically, the voltage-gated 
potassium channels Kv1.1, Kv1.3, and Kv11.1 have all been implicated in cell migration 
and are known substrates for PKA (Chung & Schlichter, 1997; Donovan, Lansu, 
Williams, Denning, & Gentile, 2012; Winklhofer et al., 2003). Additionally, the calcium-
dependent potassium channels KCa1.1 and 3.1 are both PKA substrates and have been 
implicated in cell motility (Chimote et al., 2013; Schwab, Schuricht, Seeger, Reinhardt, 
& Dartsch, 1999; Schwab et al., 2006; Steinle et al., 2011; Tian et al., 2004; Weaver, 
Bomben, & Sontheimer, 2006). Interestingly, a recent report demonstrated that the 
activity of the voltage-gated sodium channel (VGSC) Nav1.5 is regulated by PKA during 
breast cancer cell migration and invasion (Chioni et al., 2010). This study showed that 
PKA phosphorylates cytoplasmic Nav1.5 and facilitates its transport to the cell 
membrane. Additionally, Na+ entry through Nav1.5 may also activate specific adenylyl 
cyclases through membrane depolarization leading to a positive feedback loop where the 
activity of Nav1.5 is sustained by continuous trafficking of the channel to the membrane. 
Moreover, the authors showed that inhibition of VGSC with tetrodotoxin significantly 
inhibited breast cancer cell migration and invasion (Chioni et al., 2010). This particular 
study did not include any experiments where the specific PKA-phosphoryation site on 
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Nav1.5 was mutated or where Nav1.5 was specifically knocked down. These limitations 
not withstanding, the observations described in this paper further that PKA can alter the 
activity of ion channels to elicit changes in the migratory machinery.  
Though the functional and mechanistic consequences of PKA-ion channel 
crosstalk role in regulating ion channels during migration is largely unknown, the 
possibility that PKA could be regulating migration through cross-talk with other second-
messenger systems is a very attractive area of research. Indeed, there is established 
communication between PKA and calcium signals. Indeed our lab has outlined the 
potential connections between localized calcium signals and PKA activity during cell 
migration (Howe, 2011). Calcium transients in cell migration have been documented, but 
the source and consequences of these calcium fluctuations are only just being elucidated. 
For example, calcium currents have been shown to precede increases in traction forces in 
migrating fish karatocytes (A. D. Doyle & Lee, 2002; A. Doyle et al., 2004) but the 
source of these discrete calcium events have remained unknown. Additionally, a recent 
report by Tsai et al. showed that store-operated Ca2+ entry (SOCE) via STIM1 and Orai1 
was localized to the leading edge of leader cells during endothelial sheet migration in 
response to growth factor stimulation (Tsai et al., 2014), but the mechanistic 
consequences of these localized calcium increases remain unknown. An interesting 
connection between the two reports is that both TrpM7 and STIM1-Oria1 mediate 
calcium entry and are implicated in cellular force generation (Y. T. Chen et al., 2013; 
Clark et al., 2006). These findings in conjunction with the possible regulation of ion 
channel activity through PKA allow for the speculation that PKA might also be required 
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for or regulated by cellular force generation. As alluded to above, an enticing hypothesis 
is that these localized calcium transients regulate PKA activity during cell migration. 
Importantly, Ca2+ can activate several AC isoforms through Ca2+-calmodulin and other 
AC isoforms are inhibited by Ca2+ (Halls & Cooper, 2011). Calcium entry through 
Orai1-STIM1 has been shown to regulate AC8 activity and Orai1 has recently been 
shown to bind directly to AC8 and confer specificity between localized Ca2+ signals and 
increases in cAMP (Martin et al., 2009; Willoughby et al., 2012). Though there are 
reports that elegantly demonstrate that Ca2+ oscillations also regulate the PKA activation 
machinery, the co-regulation of Ca2+ and PKA activity during cell migration has only 
just begun to be investigated. Importantly, the storied cross-talk between Ca2+ and 
cAMP can be mediated by AKAPs (Delint-Ramirez, Willoughby, Hammond, Ayling, & 
Cooper, 2011) and AKAPs are necessary for maintaining leading edge PKA activity 
gradients (Howe et al., 2005; McKenzie, Campbell, & Howe, 2011) These findings 
provide an enticing explanation for the requirement of both localized Ca2+ signals and 
PKA-AKAP interactions at the leading edge of migrating cells.   Of particular interest is 
the potential role for AKAPs in generated signaling hubs that tightly regulate PKA/Ca2+ 
dynamics during cell migration.   
One class of molecules that is universally affected by perturbations in ion 
signaling and that has several candidate and confirmed PKA substrates is the focal 
adhesome (Giannone, Ronde, Gaire, Haiech, & Takeda, 2002). Several members of the 
adhesome have recently been reported to be phosphorylated by PKA (described above), 
and the dependence for both calcium and PKA activity on focal adhesion dynamics is, 
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indeed, a part of the work done in herein. Ion channel activities in migrating cells have 
been shown to regulate several facets of migration including leading edge directionality, 
rear retraction, adhesion dynamics, and osmotic pressure regulating cytoplasmic motility. 
The ability of ion channels to regulate these immensely diverse functions during cell 
migration and the ability of PKA to regulate the function of several of these ion channels 
makes for an interesting hypothesis where PKA is required for cell migration to regulate 
ion channel function in nearly every aspect of cell motility. While the importance for 
PKA activity in cell migration is well know, its role in regulating ovarian cancer biology 
is an emerging field.   
  
1.4.3 PKA in ovarian cancer 	  
Of particular importance to this work, aberrant PKA signaling is known to 
contribute to numerous pathologies including cancer (Stratakis, 2013; Stratakis & Cho-
Chung, 2002). Over-expression of various PKA subunits is a hallmark of numerous 
human cancers, including ovarian cancer (Alper, Hacker, & Cho-Chung, 1999), and often 
correlates with more severe pathology and poorer prognosis (Nesterova & Cho-Chung, 
2005; Tsigginou et al., 2012). Specifically, tumors containing genetic mutations in the RI 
subunits exhibit chemoresistance to the DNA-crosslinking anticancer drug cisplatin, 
while the gene encoding RI is responsible for the multiple endocrine neoplasia syndrome 
known as Carney complex (Cvijic & Chin, 1998; Kirschner et al., 2000). Moreover, 
breast, prostate, and colorectal cancers overexpress PKA subunits in comparison to 
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normal tissue, and PKA RI mRNA levels are decreased in breast tumors responding to 
tamoxifen (Bradbury, Carter, Miller, Cho-Chung, & Clair, 1994; Khor et al., 2008; Shi et 
al., 2004). In ovarian cancer, treatment of ovarian cancer cells with antisense 
oligodeoxynucleotides targeted at RIα decreased RIα expression, inhibited cell growth, 
increased apoptosis, and decreased MAPK activities (Alper et al., 1999; Nesterova & 
Cho-Chung, 2005).  Other reports demonstrate that increased expression of RIα is 
associated with advanced stage ovarian cancer and an increase in ovarian cancer cell 
proliferation and differentiation. In addition to its effect on cell proliferation, numerous 
reports have also demonstrated a role for PKA in promoting invasion and metastasis in 
numerous tumor models including lung, breast, and endometrial cancer (Beristain et al., 
2014; Shi et al., 2004; Tsigginou et al., 2012). Because of the already established 
importance for PKA in regulating ovarian cancer pathologies, the unique mode of ovarian 
cancer dissemination described above, and the fact that PKA activity is required for 
efficient cell migration, a natural connection between PKA activity and ovarian cancer 
metastasis can be hypothesized. Indeed, this hypothesis, that ovarian cancer cell 
migration and invasion is dependent upon localized PKA activity, is the very foundation 
for this work and is outlined in detail in chapter 2. 
 
1.5 Mechanobiology 
1.5.1 Introduction to mechanobiology 	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Mechanotransduction is the ability of cells to convert a mechanical input into a 
biochemical signal that induces a cellular response. Physical inputs in the form of forces 
can either be generated from extracellular or intracellular sources (Ricca, Venugopalan, 
& Fletcher, 2013). Extracellular forces originate from sheer, compressive, and tensile 
stresses from the extracellular environment. Intracellular forces arise from osmotic 
pressure, from the polymerization of cytoskeletal filaments and the activity of the 
associated motor proteins such as actomyosin interactions and kinesin/dynein acting on 
microtubules, as described above (Butcher, Alliston, & Weaver, 2009). Cells use physical 
cues from the extracellular matrix to sense, interpret, respond, and contribute to the 
mechanical properties of their extracellular environment. Mechanosensation occurs 
through the coordinated effort of complex signaling networks That can comprise several 
specific proteins involved in cell-ECM adhesion (i.e. integrins), the cytoskeleton (i.e 
actin, intermediate filaments, and microtubules), and an array of signaling factors (i.e 
non-receptor tyrosine kinases and Rho-family GTPases). Mechanosensing regulates 
nearly aspect of cellular life including morphogenesis (Krieg et al., 2008) and cell 
migration. During cell migration, cells produce two main sources of force-generation: 
dendritic actin polymerization (Butcher et al., 2009; Ji, Lim, & Danuser, 2008) and 
actomyosin-mediated traction force (Fournier, Sauser, Ambrosi, Meister, & Verkhovsky, 
2010). The general proposed mechanism of the integration of these two forces is that 
actin polymerization pushes the leading edge membrane forward while traction forces are 
the forces generated from the cell onto the extracellular matrix. Recent work has also 
shown that retrograde flow of actin within the leading edge is bipahsically linked to 
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traction force generation through focal adhesions where fast retrograde flow at the 
lamellipodium is correlated with low traction force generation and slow retrograde actin 
flow within the lamella correlates with high traction force generation(Gardel et al., 2008). 
These findings demonstrate that the pushing force of polymerizing actin and the 
interaction of actin with focal adhesions work together to generate protrusive and traction 
forces required for cell migration. The ability of the cell to generate both pushing force 
and traction force is crucial for cell migration and the molecular mechanisms governing 
each process are areas of active investigation.   
Actin dynamics are at the core of protrusive forces at the leading edge 
lamellipodium and the interactions of actin polymers with myosin motors are the major 
force-generating reactions in the cytoskeleton. At the leading edge lamellipodium, 
branched actin networks polymerize to push the cells edge forward, as discussed above. 
Immediately behind the lamellipodium is the leading edge lamella that is rich in 
polymerizing actin and actomyosin contractility (Ponti et al., 2004). The force generated 
by leading edge actin polymerization and actomyosin contractility regulates numerous 
proteins including stretch-activated ion channels (J. Lee, Ishihara, Oxford, Johnson, & 
Jacobson, 1999) and mechanically regulated adhesion proteins such as vinculin, talin, and 
zyxin (Kuo et al., 2011). The mechanical properties of the ECM can affect actin 
dynamics (Yeung et al., 2005), adhesion dynamics (Schlunck et al., 2008) and overall 
cellular migration dynamics (Lo, Wang, Dembo, & Wang, 2000) and the mechanisms 
that govern how ECM rigidity regulates cell behavior is an area of intense investigation. 
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Of particular interest in deciphering the cellular response to changes in ECM tension are 
the roles of the cell-ECM adhesions and actomyosin contractility. 
Integrin-mediated cell-ECM adhesions are the primary mechanoreceptors 
responsible for sensing, interpreting, and responding to the physiochemical composition 
of the extracellular matrix (Marjoram, Lessey, & Burridge, 2014; T. D. Ross et al., 2013; 
Schiller & Fassler, 2013). Integrins were first identified as proteins that bound to the 
RGD region of fibronectin and served as the integral membrane protein linking the 
extracellular matrix to the cytoskeleton (Pytela, Pierschbacher, & Ruoslahti, 1985; 
Tamkun et al., 1986). They are heterodimers that serve at the adhesion receptors on the 
surface of the cells that link the ECM to the actin cytoskeleton.  The integrin family is 
comprised of eighteen α subunits and eight β subunits and 24 unique integrin 
heterodimers are formed each containing an α and β subunit (Plow, Haas, Zhang, Loftus, 
& Smith, 2000; van der Flier & Sonnenberg, 2001). Integrins exist in either low-affinity 
(inactive) or high affinity (active) states depending on if the specific integrin ligand is 
bound or if intracellular signals have activated the integrins. Integrins link the 
extracellular matrix to the cellular cytoskeleton by binding to extracellular matrix 
proteins on their extracellular face and the actin cytoskeleton (and associated cytoskeletal 
proteins) on their intracellular tail (Plow et al., 2000). As the primary receivers of signals 
through the extracellular matrix, integrins are poised to be integral members of sensing 
not only the chemical make-up, but also the physical properties of the ECM.  Indeed, 
integrins are primary sensors of ECM rigidity and confer changes in ECM rigidity to 
biochemical signals through several mechanisms (T. D. Ross et al., 2013). Integrins, 
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themselves, can undergo conformational changes in response to increased force.  
Interestingly initial integrin binding is weak, but is enhanced when forced is applied to 
the integrin (W. Chen, Lou, Evans, & Zhu, 2012). Another study expanded the idea of 
force-strengthened integrin activity and showed that integrins responded to rapid 
increases in force and the strength of their bonds is enhanced under cyclical force 
application (Kong et al., 2013). Additionally, other studies have shown that applying 
force to integrins can convert integrins from the aforementioned low-affinity to high-
affinity states and promote integrin-ECM interactions.  
In addition to direct conformational changes that increase ligand-integrin 
interactions, force application recruits specific cytoskeletal proteins to adhesions to 
reinforce the integrin-actin interaction. Specifically, increased force application to 
integrins recruits talin (S. E. Lee, Kamm, & Mofrad, 2007), vinculin (Carisey et al., 
2013), and filamin A (Kuo et al., 2011). Talin is a focal adhesion protein that contains a 
head domain that interacts with the cytoplasmic tail of β-integrins (Calderwood, 2004) 
and a rod domain that contains numerous actin-binding domains (Hemmings et al., 1996). 
When mechanical forces are applied to integrin-containing focal adhesions, the 
interaction between integrins and actin is strengthened and there is a concurrent 
recruitment of talin to focal adhesion complexes (Galbraith, Yamada, & Sheetz, 2002). 
These data suggested that strengthening of integrin-cytoseketon interactions was due to, 
at least in part, the recruitment of talin to focal adhesions. Vinculin, another focal 
adhesion protein, works with talin to strengthen integrin-cytoskeleton interactions (A. 
Horwitz, Duggan, Buck, Beckerle, & Burridge, 1986). Vinculin contains head and tail 
	   46	  
domains and binds to talin through vinculin’s head domain (D. M. Cohen, Chen, Johnson, 
Choudhury, & Craig, 2005). The tail domain of vinculin binds to F-actin and paxilin, 
another focal adhesion protein, and serves as another link between integrin-containing 
focal adhesions and the actin cytoskeleton (Johnson & Craig, 1995). Vinculin’s 
recruitment to focal adhesions and association with talin is inhibited when either internal 
force is decreased (Pasapera et al., 2010). Importantly, cells deficient in vinculin have 
cell spreading and migration defects and also generate lower traction forces compared to 
normal cells (Mierke et al., 2010; Saunders et al., 2006; Varnum-Finney & Reichardt, 
1994). A recent paper elegantly described how and when force is transmitted across 
vinculin and confirmed the requirement for vinculin in reinforcing integrin-cytoskeletal 
interactions (Saunders et al., 2006).  
Cells sense, respond, and contribute to the mechanical properties of the ECM 
through integrin-containing focal adhesions (T. D. Ross et al., 2013). Importantly, cells 
sense changes in the rigidity of the ECM through a process termed rigidity sensing and 
can migrate in the direction of increased ECM stiffness in a process termed durotaxis.(Lo 
et al., 2000).  Myosin, a molecular motor that interacts with actin to create force and 
motion, plays a central role in rigidity sensing through integrins (Schiller et al., 2013). 
Cells adapt to changes in the stiffness of the ECM by reprogramming their own state of 
contractility and stiffness in through a phenomenon termed tensegrity. For example, on 
soft substrates, traction forces (mediated by myosin activity) are canonically decreased 
whereas on stiff substrates, myosin activity and traction force generation are high (Lo et 
al., 2000). This results in cells exerting lower traction forces and containing smaller focal 
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adhesions on softer substrates and exerting higher traction and containing larger focal 
adhesions on stiff substrates. Elegant reports have demonstrated that this rigidity sensing 
and reinforcement of adhesion strength on stiff substrates requires integrin activity, focal 
adhesion kinase (FAK) activity, vinculin, and paxillin and suggests that integrins are the 
primary sensors of substrate rigidity (T. D. Ross et al., 2013).  
Importantly, rigidity sensing goes beyond the sites of contact with the ECM.  The 
transcription factors Yes-associated protein (YAP) and transcriptional coactivator with 
PDZ-binding motif (TAZ) have ben shown to localize to the nucleus in response to 
increased ECM tension (Dupont et al., 2011; Maller, DuFort, & Weaver, 2013).  Also, 
YAP and TAZ have been shown to be crucial for determining cell morphology, survival, 
and mesenchymal stem cell differentiation in response to changes in ECM rigidity 
(Dupont et al., 2011; Raghunathan et al., 2013). Mechanobiology has emerged as a 
crucially important aspect of nearly ever facet of cell biology and aberrant 
mechanotransduction has been implicated in numerous diseases included including heart 
failure, hypertension, asthma, pulmonary hypertension, and, most important for this work, 
cancer and metastasis.  
 
1.5.2 Mechanobiology in cancer 	  
The mechanisms governing cancer initiation and metastasis are areas of intense 
investigation and mechano-regulation of cancer cell biology has emerged as important 
area of research. An established contributor to tumor progression in breast cancer (Barcus, 
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Keely, Eliceiri, & Schuler, 2013; Levental et al., 2009; J. I. Lopez, Kang, You, 
McDonald, & Weaver, 2011; Provenzano, Inman, Eliceiri, & Keely, 2009; Schedin & 
Keely, 2011) and an emerging contributor to other cancers (Hoyt et al., 2008; Liou et al., 
2014; Tilghman et al., 2010; Zhao et al., 2010) is the role of mechanical properties of the 
tumor microenvironment. As cancer invasion and metastasis give rise to the high 
morbidity and mortality associated with cancer, and there have been significant strides 
made in understanding how cell mechanics and mechanobiology regulate cancer cell 
invasion and metastasis, this section will focus on the mechano-regulation of cancer cell 
invasion and metastasis. Tumors and the tumor-associated stroma are known to be stiffer 
than their normal host tissues (Paszek et al., 2005) and tumor cells themselves are known 
to reorganize and remodel their ECM (Egeblad, Rasch, & Weaver, 2010; Provenzano et 
al., 2006; Samuel et al., 2011). This firm and reorganized tumor-associated ECM is 
referred to as stromal desmoplasia. Stromal desmoplasia is associated with increased 
angiogenesis, fibrin and collagen I deposition, and myofibroblast composition, all of 
which are important for tumor cell invasion and metastasis (Walker, 2001). The 
deposition of collagen I and the ability of myofibroblasts, and the tumor cells themselves, 
to reorganize, crosslink, and degrade the ECM facilitate in creating a mechanically 
distinct tumor microenvironment that promotes cell migration and invasion (Egeblad et 
al., 2010; Gilkes et al., 2013; Paszek et al., 2005; Provenzano et al., 2006; Samuel et al., 
2011; Xiong, Deng, Zhu, Rychahou, & Xu, 2014). Most cancer cells that are 
mechanically stimulated respond to increases in mechanical stiffness by reinforcing 
integrin-containing focal adhesions and fortifying the cellular cytoskeleton to become 
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adapted for motility. One hypothesis that has arisen is that primary tumors excrete matrix 
cross-linking enzymes to reorganize the ECM and increase the stiffness of the tumor 
stroma, which, in turn, activates the migration machinery to induce cancer metastasis 
(Hoshino et al., 2012; Levental et al., 2009; Pickup et al., 2013). This hypothesis, along 
with several supporting reports, suggest that the tumor stroma is not merely a bystander 
in tumor progression, but plays an active role in promoting tumor cell differentiation, 
invasion, and metastasis. 
Indeed, much is known about the role of increased ECM tension in the malignant 
phenotype of breast cancer, and elegant work has provided strong evidence for the 
dependence of breast tumors to be able to manipulate and utilize the tumor stroma in 
order to enhance the metastatic phenotype (Fouchard, Mitrossilis, & Asnacios, 2011; 
Paszek et al., 2005). Specifically, matrix metalloproteinases (MMPs) degrade the 
extracellular matrix and matrix reorganizing proteins such as lysyl oxidases (LOXs) 
increase collagen cross-linking and, thus, increase tissue tensile strength (Paszek et al., 
2005). The stiffened ECM actively signals to promote integrin-dependent focal adhesions 
and enhance the activity of pro-migratory signaling pathways such as PI3K (Levental et 
al., 2009). Most cancers respond to changes in ECM stiffness and studying the 
mechanobiology of tumors is a growing field of research.  Particularly interesting is the 
fact that though mechanobiology is important for several types of cancer, its importance 
in ovarian cancer has only just begun to be realized (McGrail, Kieu, & Dawson, 2014).  
Since primary epithelial ovarian tumors metastasize by sloughing off of the 
surface of the ovary and enter the peritoneum via normal peritoneal fluid flow, EOC 
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tumor cells have the ability to spread to a wide variety of organs that have a wide range 
of stiffness (i.e. diaphragm and omentum) (Naora & Montell, 2005). A recent article 
showed that EOC cells exert higher traction forces and migrate more efficiently on softer 
substrates (McGrail et al., 2014). Though this is counter to the canonical role of ECM 
tension on the migratory phenotype, it suggests that the mechanical microenvironment 
also regulates EOC cell behavior. Other evidence supports the notion that EOC cells can 
increase ECM tension to promote cell migration and indeed, work herein supports that 
notion. Specifically, in highly aggressive ovarian cancers, the expression of remodeling 
proteins such as lysyl oxidase 1 (LOX1) and tissue transglutaminase 2 (TGT2) is 
increased (Sodek, Ringuette, & Brown, 2009), and EOC cells require MMP activity to 
efficiently invade through a basement membrane extract (X. Hu et al., 2012). The exact 
contribution of ECM stiffness stromal remodeling on EOC cell migration and invasion 
will be discussed in detail in Chapter III of this work.  
1.5.3 Mechanoregulation of PKA 	  
PKA is a ubiquitous and promiscuous kinase whose activity is required for 
numerous facets of cellular life including glucose production, exocytosis, vasodilation, 
regulating calcium signaling, and cell motility. Moreover, PKA is canonically part of the 
oldest known mechano-responsive signaling pathway (Rodan, Bourret, Harvey, & Mensi, 
1975). These early studies established that applying either compressive or hydrostatic 
forces to cells could alter the levels of cyclic nucleotide production. More recent work 
has shown that application of forces through integrins, via ECM-coated magnetic beads 
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and twisting cytometry, can elevate Gαs activity and increase cAMP levels and CREB 
accumulation in the nucleus (Alenghat et al., 2009). These were the first observations to 
implicate PKA in a mechanosensitive pathway that involved integrins and provides an 
interesting connection between the cAMP second messenger system and the molecular 
machinery involved in cell adhesion and migration. Other reports have previously 
described a role for PKA activity in response to cell adhesion whereby anchorage-
dependent signaling to the mitogen-activated protein kinase (MAPK) is inhibited either 
when cells are non-adhered or when PKA activity is high (Howe & Juliano, 2000). 
Together, these reports demonstrate that PKA activity, integrin-mediated cell adhesion, 
and force transmission across integrins could be coupled. Additionally, PKA activity is 
increased when acute mechanical stretch is applied to endothelial cells and the effect of 
acute mechanical stretch applied to endothelial cells is specific to PKA and Akt (Z. Hu et 
al., 2013). In addition to being directly activated by mechanical stimuli, PKA can 
regulate numerous mechanosensitive proteins including myosin, stretch activated ion 
channels, and integrins as discussed above.    
1.6 Summary and perspectives 	  
Taken together, this review outlines the importance in understanding the 
pathology and cell biology of ovarian cancer and describes the implications for localized 
PKA activity on regulating EOC cell migration and invasion. In an effort to explain how 
PKA might regulate cell migration, this review offers numerous mechanisms through 
which PKA could be asserting its effects such as regulation of the canonical migration-
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associated signaling pathways governing cell protrusion, adhesion dynamics, ion channel 
activity, and mechanosensing. Assimilating this information, we hypothesize that 
localized PKA activity to the leading edge of migrating cells is required for EOC cell 
migration and invasion and that PKA activity is required for normal adhesion dynamics. 
Moreover, we hypothesize that this specific pool of PKA is regulated through a 
mechanism involving the mechanosensory machinery of the cells whereby actomyosin 
contractility is regulated by localized increases in Ca2+ concentrations (through stretch-
activated calcium channels) and is required for leading edge PKA activity. We also 
hypothesize that if actomyosin contractility is required for leading PKA activity, then 
actomyosin contraction will converge on the PKA activation machinery to elicit localized 
PKA activity events at the leading edge of migrating cells. The chapters herein test these 
hypotheses in an effort to more fully understand how PKA activity is regulated during 
cell migration.  	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CHAPTER II: PROTEIN KINASE A ACTIVITY AND ANCHORING ARE 
REQUIRED FOR OVARIAN CANCER CELL MIGRATION AND INVASION 	  
2.1 Introduction 
Epithelial ovarian cancer (EOC) is the fifth most common cause of cancer deaths 
in women in the United States and has the highest mortality rate of all gynecologic 
cancers (1). Approximately 80% of patients present with late stage disease and less than 
25% of those women are cured. EOC constitutes the overwhelming majority (>90%) of 
ovarian malignancies and is unique in its clinically occult dissemination and metastasis 
(2). In contrast to most other types of carcinoma, dissemination of EOC through the 
vasculature and formation of truly distal metastases is a rare occurrence. EOC cells shed 
from the primary tumor on the surface of the ovary and exfoliate into the peritoneal 
cavity. The anatomic placement of the ovaries facilitates local spread of EOC, which can 
occur by direct migration and invasion of tumor cells to and into adjacent organs, as well 
as through transport of exfoliated tumor cells throughout the peritoneal cavity by normal 
peritoneal fluid flow (2,3). Because of this unique and furtive mode of dissemination, 
efforts in developing methods for early detection of EOC have been largely unsuccessful 
(4-6). Despite cytoreductive surgery, combination chemotherapies and strategies for 
determining serum biomarkers, local and disseminated chemoresistant cells persist and 
eventually flourish, leading to the high recurrence and <25% five-year survival rate of 
patients with EOC (3,5,7-9). Thus, a better understanding of the cellular and molecular 
mechanisms governing EOC dissemination and invasion has the potential to have 
significant impact on the course of the disease.  
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Due to the dependence of EOC dissemination and metastasis on cellular migration 
and invasion, our laboratory has endeavored to understand the mechanisms underlying 
these processes in EOC. Cell migration is a highly ordered process that requires 
coordinated effort between numerous proteins in distinct subcellular regions (10-12). We 
have previously shown that the cAMP-dependent protein kinase (PKA) is important for 
cell migration and leading edge dynamics in a number of cells (13-15). PKA is a 
heterotetrameric kinase that can exist in two isoforms, type I and type II, depending of 
the regulatory (RI and RII) subunit associated with the holoenzyme. PKA has numerous 
targets associated with actomyosin based cell movement (16) and early studies showed 
that hyper-activation or inhibition of PKA inhibited chemotactic cell migration (16-18). 
This seemingly contradictory role for PKA was clarified upon the demonstration that in 
addition to overall activity, localization of PKA in subcellular space, mediated primarily 
through anchoring of PKA R subunits to A kinase anchoring proteins (AKAPs; (19,20)), 
regulates cell migration (13,21,22). Specifically, it has been shown that PKA is both 
enriched and activated in protrusive structures at the leading edge of migrating cells, and 
that inhibition of AKAP function in general (13,21), or of specific anchoring proteins (e.g. 
AKAP-Lbc; (22)), inhibits migration. These and other reports (reviewed in (23,24)), 
establish the importance of localizing PKA activity to distinct subcellular locations 
during normal cell migratory processes.  
Underscoring the potential importance of PKA in ovarian cancer pathogenesis are 
the observations that PKA activity and subunit expression are often dysregulated in EOC. 
Expression of the PKA catalytic subunit (25) and regulatory RI subunit (26-28) correlates 
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with advanced stage and/or more aggressive EOC. Moreover, the mRNA levels of 
AKAP3 (aka AKAP110 or fibrous sheath protein of 90 kDa (FSP90)) in ovarian tumors 
positively correlate with disease stage and poor prognosis (29,30). Despite these 
observations, the functional significance PKA and AKAP signaling in metastatic EOC 
cells has not been well investigated. 
Given the importance of PKA and AKAP function for cell migration and their 
dysregulation in EOC, we investigated the spatial regulation of PKA activity in migrating 
EOC cells and determined whether PKA activity and anchoring are required for EOC cell 
migration. Here, we report that PKA activity is up-regulated in the leading edge of EOC 
cells not only during migration but also during extracellular matrix invasion, as well. 
Further, inhibition of PKA activity and AKAP function blocks EOC cell migration and 
invasion. We show that either inhibition of PKA activity or the spatial distribution of 
PKA leads to defects in focal adhesion dynamics that contribute to the inhibition of 
motility. These observations demonstrate, for the first time, the importance of PKA 
anchoring for matrix invasion and establish the importance of spatially regulated PKA 
activity in the migration and invasion – and thus perhaps metastasis – of EOC cells. 	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2.2 Materials and methods 
2.2.1 Reagents and Cell Culture 
COS-7 and SKOV-3 cells were obtained from American Type Culture Collection 
and maintained in antibiotic-free Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (vol/vol) fetal bovine serum (FBS). HIO-80 cells were a 
generous gift from Dr. Andrew Godwin (Department of Molecular Oncology, Fox Chase 
Cancer Center) and were maintained in a 1:1 mixture of antibiotic-free Medium 
199:MCDB-105 supplemented with 4% FBS and 0.2 U/ml porcine insulin. All cells were 
grown at 37°C in a humidified incubator containing 5% CO2. 
2.2.2 Plasmids and Transfection 
The plasmid encoding mCherry-tagged PKI has been described previously (14), 
while plasmids encoding GFP-tagged superAKAP-in silico (sAis; (31)) and RI anchoring 
disrupter (RIAD; (32)) peptides, as well as corresponding scrambled (scr) negative 
controls, were generated using the 5’ phosphorylated oligonucleotides (synthesized by 
Invitrogen) listed in Supporting Table S1. Specifically, complementary oligos were 
annealed, generating 5’ SalI and 3’ BamHI sticky ends, then ligated directly into 
SalI/BamHI-digested pEGFP-N1 (Clontech). For transfection and transient expression of 
proteins, cells were transfected using Fugene6 (Roche) according to the manufacturer’s 
protocol. Briefly, 6µl of Fugene6 was added to 100µl serum and antibiotic free DMEM, 
briefly vortexed, and incubated at room temperature for 5 min. A total of 1.5µg DNA was 
added to the mixture, briefly vortexed, and incubated at room temperature for 15 min. 
	   57	  
The mixture was then added drop-wise to a 35mm dish containing cells at between 80-
90% confluence, allowed to stand at RT for 2-3 min, then returned to the incubator. All 
experiments were done between 24-48 h after transfection. 
2.2.3 Immunofluorescence 
For visualization of, actin, fibronectin, and paxillin, cells were fixed in 3.7% 
formaldehyde in PBS for 10 min, permeabilized for 10 min in PBS containing 0.25% 
triton X 100, blocked with PBS containing 3% BSA either for 1 h at RT or overnight at 
4°C then incubated with anti-fibronectin (1:400, BD Transduction) or anti-paxillin (1:500, 
BD Transduction) primary antibodies for 1 h at RT. After washing 3 x 5min with PBS, 
cells were incubated with Alexa-594 coupled donkey anti-mouse secondary antibody 
(1:400) and Alexa-488 conjugated phalloidin (1:100) for 1 h at RT. Coverslips were 
mounted onto glass microscope slides (33) using a small volume of PermaFluor mountant 
(Thermo Scientific). Epifluorescence images were captured though 10, 20, 40, and 60X 
Plan Apo objectives on a Nikon Eclipse TE-2000E inverted microscope using the 
appropriate fluorophore-specific filters (Chroma Technology Corp, Rockingham, VT) 
and a CoolSnap HQ camera (Photometrics, Tucson, AZ) controlled by Elements (Nikon) 
software. 
2.2.4 Fabrication of silicone gaskets 
Forty g of Sylgard 184 silicone elastomer (Dow Corning) and 4 g of Sylgard 184 
elastomer curing agent (10:1, w/w) were rigorously mixed until cloudy with bubbles. The 
cloudy mix was poured into a sterile 10cm tissue culture dish to a depth of 2-4mm in 
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height. Bubbles were removed by placing the dish in an 850ml Desi-Vac container (33) 
and evacuating the chamber 60 times and allowing the chamber to stand for 10 min. This 
step was repeated twice or until the mixture was free of bubbles. The silicone mixture 
was allowed to cure at room temperature for 48hrs or for an hour on an 84°C hot plate 
until completely polymerized. The silicone template was gently removed from the dish 
and placed on a clean dry surface suitable for cutting. To fabricate the donut-shaped 
gasket, a 6mm biopsy punch was used to generate a silicone cylinder, and a 2mm biopsy 
punch was used to make a smaller hole inside of the 6mm cylinder. The silicone “donuts” 
were then washed in Liquinox (diluted 1:10 in nanopure water) for 15 min, rinsed 10 
times with nanopure water, washed with 70% EtOH for 15 min, then stored in fresh 70% 
EtOH until needed. 
2.2.5 Donut Migration/Invasion Assay 
Glass coverslips were sterilized by consecutive soaking in 30 min intervals in 
increasing concentrations (70, 95, 100%) of EtOH. The coverslips were removed from 
EtOH and air-dried in the tissue culture hood. Once dried, the sterile coverslips were 
coated in 20µg/ml human fibronectin (BD Transduction) diluted in sterile PBS either 
overnight at 4°C or 2 h at 37°C. Clean, sterile silicone donuts were allowed to air dry 
before placing onto the coated coverslips. A change in refraction at the donut-coverslip 
interface can be seen as the donut adheres by conformal contact. Subconfluent cells were 
serum-starved the night before the assay. The cells were trypsinized and resuspended in 
the appropriate serum free medium containing 1% BSA and counted using a 
hemocytometer. Cells were plated at confluence (6000 cells/donut for SKOV-3, COS-7, 
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and HIO-80) in a 10µl volume using a sterile gel-loading tip into the center of the donut-
shaped gasket so as to contain them within a confined area. The number of cells required 
to form a confluent monolayer depends on the ECM chosen, the size of the donut, and the 
spreading ability of the cells, and thus needs to be determined empirically for each cell 
line. Sterile PBS was added around the gasket to prevent evaporation of the small volume 
of media. After adhering overnight, the PBS was aspirated, and the donuts were carefully 
removed using sterile forceps. The nuclei were stained using Hoescht 33342 nuclear stain 
(Invitrogen, 1:2000 in media) for 15 min at 37°C. The staining media was removed and 
replaced with either complete media or media containing pharmacologic agents as 
described in the figure legends. For invasion assays, the Hoescht-stained monolayer was 
overlaid with phenol-red free Matrigel (BD) and incubated for 15 min at 37°C to allow 
polymerization of the Matrigel. The cells were then supplemented with complete or 
treated media as in the migration assay. Initial images were acquired through a 2X 
PlanApo objective on a Nikon Eclipse TE-2000E inverted microscope as described above. 
Cells were either treated with 10ng/ml EGF or high serum (10%) to stimulate migration. 
Additional pictures were acquired after the indicated times and initial and final state 
image pairs were analyzed using the default settings of the DonutQuant ImageJ macro 
(available as Supporting File S1). Briefly, the macro centers and thresholds both initial 
and final state images and far-outlier cells, i.e. cells outside the circular monolayers that 
are too far to be attributable to migration (e.g. cells that have loosened and floated in 
from another area of the dish) are removed. A mask of the centered, initial image is then 
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created and superimposed on the final state image and all of the nuclei outside the border 
of the initial image mask are counted as migrated cells.     
2.2.6 Wound-healing migration assay 
Sterile glass coverslips were coated with 20µg/ml fibronectin as described above. 
A confluent monolayer of cells was seeded onto ECM conjugated coverslips and allowed 
to adhere overnight. A wound was made in the monolayer by scraping a p200 pipette tip 
across the cells, and the coverslips were washed once with sterile PBS to remove any cell 
debris. Images were acquired using a 10x Plan Apo objective on the Nikon Eclipse TE-
2000E inverted microscope as described above. 
2.2.7 Trypan Blue Exclusion Assay 
To assess cell viability at the front of the donut or wound-heal assay a 1:1 mixture 
of trypan blue (0.4%, Sigma) and serum free medium containing 1% BSA was added to 
the cells and incubated at room temperature for 10 min immediately after either removing 
the donut or creating the wound in the monolayer. Images were taken of the periphery of 
the donut and along the entire margin of the wound using a 10X Plan Apo objective on 
the Nikon Eclipse TE-2000E as previously described. 
2.2.8 FRET Imaging 
SKOV-3 cells expressing the PKA biosensor, pmAKAR3 (34,35) were rinsed and 
maintained in Leibovitz L-15 medium for FRET recording. Cells were imaged on a 
Nikon Eclipse TE-2000E microscope with a 60×/1.4NA Plan Apo oil-immersion 
objective lens and cooled CCD camera. CFP, YFP and FRET images were acquired 10 
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hrs after the start of the assay. The acquisition was set with 700 ms exposure and 2x2 
binning for all three acquisitions. Images in each channel were subjected to background 
subtraction, and ratios of yellow-to-cyan color were calculated using the FRET Analyzer 
ImageJ plugin. Pseudocolor images were generated using the ImageJ ‘Ratio’ look up 
table. 
 
2.2.9 Focal Adhesion Analysis 
 SKOV-3 cells expressing mCherry-paxillin were monitored by live cell 
microscopy as described above.  Images were acquired every minute for 30-60 min with 
exposure times between 300-500 ms. Once time-lapse movies were generated, the movies 
were imported into the Focal Adhesion Analysis Server (Gomez) for quantification of 
focal adhesion intensity, size, lifetime, and assembly and disassembly rates. To monitor 
focal adhesion dynamics in the presence of inhibitors of PKA activity and anchoring, 
SKOV-3 cells were co-transfected with mCherry-paxillin and either empty eGFP, eGFP-
PKI, eGFP-SuperAKAPis, eGFP-RIAD, or the respective scrambled controls, and 
analyzed as described above.  
2.2.10 Immunofluorescence 
Cells were fixed in 3.7% formaldehyde in Tris-buffered saline (TBS) for 10 min, 
permeabilized for 10 min in TBS containing 0.25% triton X100, blocked with TBS 
containing 5% BSA for 1 hr at RT then incubated with anti-paxillin (1:500, BD 
Transduction) or anti-ppMLC (1:500, Cell Signaling) primary antibodies for 1 hr at RT. 
	   62	  
After washing with TBS, cells were incubated with Alexa-647 coupled donkey anti-
mouse, Alexa-596 coupled donkey anti-rabbit secondary antibodies (Invitrogen, 1:400) 
and Alexa-488 conjugated phalloidin (Invitrogen, 1:100) for 1 hr at RT. Coverslips were 
washed then mounted onto slides using PermaFluor (Thermo Scientific). Epifluorescence 
images were captured though a 60X Plan Apo oil immersion objective on a Nikon 
Eclipse TE-2000E inverted microscope using the appropriate fluorophore-specific filters 
(Chroma Technology Corp) and a CoolSnap HQ camera (Photometrics) controlled by 
Nikon Elements software. Images were analyzed in ImageJ.  
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2.3 Results 
2.3.1 PKA activity is increased at the leading edge of randomly migrating SKOV-3 cells 
Previous work had demonstrated discrete activation of PKA in the migratory 
leading edge of many (13,21,22) but not all (36) cell types. To determine if PKA was 
activated at the leading edge of migrating EOC cells, SKOV-3 human EOC cells were 
transfected with pmAKAR3, a FRET-based reporter of PKA activity (21,35), then plated 
on FN-coated glass coverslips, stimulated with 10ng/ml EGF for 4-6 hrs (to promote 
random, chemokinetic migration), and monitored by live-cell imaging. PKA activity (as 
indicated by elevated FRET ratios) was, indeed, discretely and dynamically elevated 
within the leading edge of migrating SKOV-3 cells (Fig. 1A). To assess cell motility, an 
outline of the cell edge was tracked over time (Fig. 1B). Leading edge PKA activity 
events, as defined by FRET ratios that were above ½ the maximal FRET ratio for any 
given experiment, showed predictable frequency (~25 events/minute) and size (~4µm2). 
Moreover, there was a well-defined gradient in PKA activity where the highest PKA 
activity existed within 10µm of the leading edge. This suggested that local increases in 
PKA activity play a role in regulating leading edge dynamics, and thus the migration of 
actively migrating EOC cells.  
This hypothesis was supported by early experiments in which SKOV-3 cells were 
subject to wound-healing or scratch migration assays in the absence or presence of H89 
(a kinase inhibitor with modest specificity for PKA (37)), mPKI (a myristoylated peptide 
from the PKA inhibitor protein, PKI), or StHt31 (a stearated peptide from Ht31/AKAP-
Lbc). Examination of cell morphology shortly after the start of these assays showed 
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significant effects of these inhibitors on leading edge morphology and migration (Fig. 2). 
Specifically, untreated cells migrated into wounded areas efficiently and with broad, 
ruffling lamellipodia (Fig. 2A and D). In contrast, cells in which PKA activity was 
inhibited with H89 or mPKI did not migrate efficiently and barely entered the wound 
space, exhibiting leading edge structures devoid of ruffles but with rife focal adhesions – 
evoking an adhesive, spreading phenotype more than one of migration (Fig. 2B and D). 
Cells in which PKA anchoring was disrupted by StHt31 entered the wound space to a 
greater extent than H89- or mPKI-treated cells, but, unlike control cells, exhibited 
multiple, erratically-spaced ruffling edges per cell (Fig. 2C and D). Together, these 
results further supported the hypothesis that EOC cell migration might require PKA 
activity and anchoring.  
 
2.3.2 EOC cell migration is regulated by activity and anchoring of PKA 
Wound-healing migration assays, while inexpensive and easy to implement, 
suffer from several limitations, not the least of which are fatal injury to cells along the 
assay front and removal of the underlying extracellular matrix (ECM). Thus, an 
experimental condition that results in inefficient migration in this assay may reflect, for 
example, heightened sensitivity to bystander damage or failure to produce de novo matrix 
on which to migrate. Therefore, to further and better explore the requirement of PKA 
activity and anchoring specifically for EOC cell migration, we developed an improved 
version of a previously described migration assay (38) that easily and accurately 
measures the number of cells migrating in a radial manner from a defined circular 
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monolayer (Fig. 5; see Materials and Methods for details). Our assay – coined the ‘donut 
assay’, after the donut-shaped silicone gaskets used to establish the monolayer – is 
reliable, inexpensive, easy to implement, applicable to nearly any cell type, and scalable 
to achieve relatively high throughput and statistical significance using a small number of 
cells (~6000), relative to other comparable ‘release’ assays (e.g. wound-healing assays). 
In addition, unlike wound-healing assays, our approach significantly reduces both the 
denuding of the ECM protein covering the migration surface (Fig. 3) and the fatal injury 
to cells on the assay periphery (Fig. 4). To increase the utility and ease of implementation 
of the assay, we developed an ImageJ macro to quickly and automatically quantify 
migration. Briefly, the macro subtracts an initial, ‘time=0’ image (taken immediately 
after donut removal) from a later or final image and counts the nuclei outside the ‘time=0’ 
area (Fig. 5C and D). Experiments using cytochalasin D to inhibit actin dynamics (Fig. 
5C and D) as well as mitomycin C to inhibit cell cycle progression (data not shown) have 
confirmed that the assay measures migration and not simply displacement of the 
monolayer by cell division. We have used this assay to measure migration in a wide 
variety of cell types (including CHO-K1, COS7, HIO-80, HUVEC, MCF7, MCF10A, 
MDA-MB-231, MDCK, NIH3T3, REF52, and SKOV-3) with comparable ease and effect 
(A. McKenzie, S. Campbell, A. Howe, unpublished observations).  
Using this assay, we investigated the effects of inhibiting PKA or AKAP function 
on EOC cell migration by transfecting SKOV-3 cells with plasmids encoding fluorescent 
proteins (EGFP, mCherry) fused to peptide inhibitors of PKA activity or anchoring. 
Specifically, we used mCherry fused to the 14-27 pseudo-substrate region of the heat 
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stable PKA inhibitor protein (mCherry-PKI) and EGFP fused to the RIAD (32) and 
superAKAPis (31) peptides, which inhibit type I and II PKA anchoring, respectively. 
Plasmids encoding mCherry alone or EGFP fused to scrambled superAKAPis or RIAD 
sequences (see Materials and Methods) were used as negative controls. After transfection, 
cells were subjected to the donut migration assay and, after 24hrs, the number of 
transfected cells that migrated, as well as the total number of transfected cells and total 
number of migrated (transfected and non-transfected) cells was quantified (Fig. 6). 
Acquisition of these three numbers allows the expression of migration as the percentage 
of migrated, transfected cells over the total migrated cells (‘MX/TM’) or, to control for 
differences in transfection efficiency between plasmids, the percentage of migrated, 
transfected cells over the total number of transfected cells (‘MX/TX’). Using this method, 
SKOV-3 migration was significantly attenuated when either PKA activity (Fig. 6A and 
B) or anchoring (Figure 6C) was inhibited. Interestingly, migration was inhibited almost 
equally by disruption of anchoring through either RI or RII subunits (Fig. 6C), consistent 
with previous reports establishing the importance of both type I and type II PKA in the 
migration of other cell types (13,21,22,39). In summary, these data establish the necessity 
for PKA activity and anchoring for the migration of EOC cells.  
 
2.3.3 PKA is activated at the invading front of SKOV-3 EOC cells 
After detachment from the primary tumor in situ, malignant EOC cells degrade 
and invade through the ECM in order to invade neighboring tissues (2,40); this invasive 
metastasis is the deadliest facet of EOC. Invasion through a three-dimensional matrix is a 
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highly ordered process that is unique in both mode and mechanism of action from two-
dimensional migration. Importantly, the localization of PKA activity and role of PKA 
anchoring in cancer cell invasion have never been directly investigated. Thus, to assess 
whether PKA activity and AKAP function were required for EOC cell invasion, as well 
as migration, we modified our migration assay to measure invasion by overlaying cell 
monolayers, immediately after donut removal, with Matrigel - a basement membrane 
extract commonly used in invasion assays (Fig. 7A). While similar approaches have been 
taken with other chemokinetic migration/invasion assays (41), initial experiments were 
performed to ensure that this modification assessed true invasion. Specifically, donut 
migration and invasion assays using the HIO-80 human immortalized ovarian epithelial 
cell line (42) showed that these non-transformed, non-tumorigenic cells migrate 
efficiently on a two-dimensional ECM, but are completely incapable of navigating 
through the three-dimensional Matrigel overlay (Fig. 7B). In contrast, metastatic SKOV-
3 cells exhibited readily-detectable migration through the Matrigel overlay (Fig. 7C). The 
efficiency of movement through the three-dimensional ECM was expectedly lower than 
across a two-dimensional surface, consistent with an increased ‘barrier’ function 
attributable to the Matrigel. Furthermore, inhibition of MMPs with GM6001 significantly 
reduced the ability of SKOV-3 cells to invade through the Matrigel (Fig. 7C), suggesting 
that the movement of cells was indeed due to invasion rather than simply migration under 
the Matrigel. Unexpectedly, while GM6001 inhibited invasion, it also significantly 
enhanced the migration of SKOV-3, but not HIO-80 cells (Fig. 7B and C); we have found 
no precedent and currently have no explanation for this. Finally, the performance of our 
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assay was comparable to or better than that seen with a traditional modified Boyden 
chamber/Transwell™ invasion assay; while SKOV-3 cells showed comparable invasive 
potential, the non-invasive HIO-80 cells also showed low but significant ability to 
navigate through Matrigel-coated Transwell™ membranes in our hands (data not shown). 
Taken together, these observations validate this new method as an effective assay to 
measure tumor cell invasion.  
To assess the localization of PKA activity during EOC cell invasion, we 
transfected SKOV-3 cells with the pmAKAR3 PKA biosensor, subjected them to the 
donut invasion assay as described above, and acquired FRET images of invasive cells on 
the assay periphery 18 h after Matrigel overlay (Fig. 8). Cursory microscopic analysis of 
invasive cells revealed elongated morphologies with narrower leading edge structures 
(compare Fig. 8A-D to Fig. 1), often containing multiple filopodia (Fig. 8C and D); 
morphologies consistent with three-dimensional invasion compared to two-dimensional 
migration. Importantly, the vast majority of invasive cells exhibited either discrete or 
broad areas of increased PKA activity within their invasive leading edges (Fig. 8A-D). 
To quantify the percentage of cells exhibiting invasive edge PKA activity, the average 
FRET ratio at the invasive leading edge (FRETLE; measured 5-25µm from the front of the 
cell) was measured in proportion to the FRET ratio in the cytoplasm (FRETcyto; measured 
25-50µm from the front of the cell  (Figure 5E)). Ratio values were binned into high 
(FRETLE/FRETcyto ≥1.5), moderate (FRETLE/FRETcyto between 1.2 and 1.5), and no 
(FRETLE/FRETcyto <1.2) leading edge PKA activity. Using these strict parameters, > 80% 
of the imaged cells displayed an increase in invading edge PKA activity (Fig. 8F). 
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Leading-edge, as well as and global PKA activity was all but eliminated by co-expression 
of pmAKAR3 with mCherry-PKI, confirming the specificity of the pmAKAR reporter 
for PKA activity in this assay (Fig. 9). These data are the first to show localization of 
PKA activity during matrix invasion. In so doing, they also establish that EOC cell 
invasion, like migration (21), displays a back to front gradient of PKA activity.  
 
2.3.4 EOC cell invasion requires PKA activity and anchoring.  
The previous observations demonstrated that PKA was activated at the leading 
edge of EOC cells during matrix invasion. To determine whether this localized PKA 
activity was actually required for invasion, SKOV-3 cells were transfected with 
pmCherry-PKI, pEGFP-superAKAPis or pEGFP-RIAD (as described for Fig. 6) and 
subjected to the donut invasion assay (as described in Fig. 7) for 24 h. As observed for 
migration, inhibition of PKA activity and type-II PKA anchoring significantly attenuated 
SKOV-3 cell invasion (Fig. 10A and B, white & black bars). Initial analysis of the effect 
of RIAD-mediated disruption of type-I PKA anchoring showed a trend toward decreased 
invasion, although this was not statistically different from the scrambled control (Fig. 
10A, gray bars; P=0.097); however, upon normalizing the data for transfection efficiency 
(i.e. invading, transfected cells over total transfected cells, or ‘IX/X’), there was indeed a 
statistically significant (P<0.05) inhibition of invasion caused by disruption of RI 
anchoring (Fig. 10B, gray bars). Thus, as for migration, PKA activity and AKAP 
function are required for the invasion of SKOV-3 cells into a three-dimensional ECM.  
 
	   70	  
2.3.5 PKA activity and anchoring regulate EOC cell focal adhesion dynamics. 
 In an effort to elucidate a mechanism through which PKA could be 
regulating EOC cell migration, we sought to determine the effect of inhibiting PKA 
activity and anchoring on focal adhesion dynamics.  Integrin-mediated focal adhesions 
serve as the link between the ECM and intracellular signaling.  During migration, these 
adhesions undergo dynamic assembly and disassembly cycles.  If cell-matrix adhesions 
are too strong, the cell is unable to disassemble the adhesions quickly and thus migration 
is impeded.  Conversely, weak cell-matrix adhesions are also deleterious for cell 
migration.  A change in focal adhesion morphologies was readily apparent in cells 
expressing PKA activity/anchoring inhibitors. The average focal adhesion size was 
significantly reduced when either PKA activity or anchoring was inhibited.  To 
investigate the specific deficit in focal adhesion dynamics, the lifetimes and rates of 
assembly and disassembly were measured in cells expressing PKA activity and anchoring 
inhibitors. Under normal conditions, focal adhesions had complete lifetimes, from 
initiation and assembly through disassembly, of ~19 min (Fig. 11C). Cells expressing 
mCherry-PKI had significantly higher lifetimes with an average of 26.65 min (Fig. 11C). 
In addition to PKA activity, AKAP-PKA interactions through either RI or RII were also 
required for normal adhesion lifetimes.  Specifically, cells expressing either the RI-
anchoring disruptor (RIAD) or the RII-specific anchoring disruptor (SuperAKAPis) had 
significantly longer lifetimes of 24.84 min and 35.25 min, respectively (Fig. 11C). These 
data suggest that localized PKA activity is required for maintain proper focal adhesion 
dynamics. Inhibition of PKA activity and anchoring through both RI and RII significantly 
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reduced the average size of the focal adhesions.  The decreased size and increased 
lifetime was accompanied by a significantly slower rate of focal adhesion assembly when 
compared to control cells Fig. 11D). Likewise, inhibition of PKA anchoring through RII 
inhibited focal adhesion disassembly (Fig. 11E). Interestingly, there was no significant 
effect on the rate of focal adhesion disassembly when cells were expressing PKI or the 
type-1 PKA anchoring inhibitor (Fig. 11E). Other preliminary studies showed that focal 
adhesions contained phosphorylated PKA substrates (pPKA subst., Fig.1F), as there was 
coincidence in both pPKA subst. and paxillin staining. Importantly, pPKA substrates 
were localized at sites of focal adhesion even after unroofing the cells to deplete the 
membrane and cytoplasm (Fig. 11G). These data, though only correlative, suggest that 
PKA could be regulating cell migration not only by shaping the kinetics of leading edge 
dynamics, but also by regulating focal adhesion dynamics.   
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2.4 Discussion 
Although it only accounts for approximately 3% of all cancer diagnoses in the 
United States, ovarian cancer is the 5th leading cause of death among women (1). This is 
largely due to the fact that most ovarian cancer patients become symptomatic - and are 
therefore diagnosed - after the tumor has metastasized. The metastatic spread of EOC, 
like other cancers, is completely dependent on the acquired ability of tumor cells to 
undergo invasive cell migration (2). In this work, we have shown that both migrating and 
invading EOC cells exhibit enriched PKA within their leading edge and that both PKA 
activity and its localization through AKAPs regulate both the migration and invasion of 
EOC cells and further demonstrate that localized PKA activity regulates focal adhesion 
dynamics. This is the first demonstration of the association of localized PKA activity and 
the process of matrix invasion. More importantly, these observations add important new 
molecular insight into some of the most clinically relevant cellular behaviors associated 
with the pathogenesis of EOC. To be certain, the in vitro mode of matrix invasion 
assessed in the current study does not recapitulate the full course and associated 
mechanisms of EOC metastasis in vivo. Especially relevant in this regard are the complex 
biology of both the interaction of metastatic EOC cells with their target 
microenvironment, consisting of mesothelial cells and fibroblasts in addition to ECM 
components (40,43), and of multicellular tumor spheroids, regarded as the minimal 
metastatic unit of EOC (44). Although inhibition of PKA activity and anchoring 
significantly altered focal adhesion dynamics, the discrete molecular targets for PKA that 
regulate adhesion dynamics and overall motility remain largely unknown. Nonetheless, 
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the current studies provide a solid foundation that justifies the further exploration of the 
role of PKA and AKAP function in higher-order models of EOC metastasis. The 
following chapters of this work will addresses both how the mechanical properties of the 
extracellular matrix regulate ovarian cancer cell motility and the role of multicellular 
tumor spheroids in sensing and responding to changes in the compliance of extracellular 
matrices, and so, will be discussed in greater detail in those chapters.  
Over-expression of various PKA subunits is a hallmark of a vast array of human 
tumors(45-47)), including ovarian cancer (26-28), and often correlates with more severe 
pathology and poorer prognosis. In this regard, PKA is classically thought to enhance 
mitogenic signal transduction and promote early cell cycle transition. However, a number 
of reports have also established a role for PKA in promoting invasion and metastasis in a 
number of tumor models (48-52); however, this line of investigation had not been 
extended to EOC until now. Our results clearly demonstrate that spatial regulation of 
PKA activity is a critically important facet of the invasion – and thus, perhaps the 
metastasis – of EOC cells. 
Previous work has demonstrated enrichment of PKA in the leading edge of 
migrating cells, with the most detailed descriptions being in fibroblasts (13,21) and breast 
and colon carcinoma cells (22). Our data now extends this paradigm to EOC cells and 
expands the paradigm in an important and substantive way by demonstrating localization 
of PKA to the leading edge during three-dimensional matrix invasion. In support of this 
localized PKA activity, we have also demonstrated the requirement for AKAP function 
for the migration of EOC cells, as has been demonstrated for other cell types (13,39,53). 
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Furthermore, we have also demonstrated – for the first time - the requirement for AKAP 
function for cancer cell invasion of a three-dimensional ECM. A number of previous 
reports have implicated a variety of AKAPs as positive or negative regulators of invasion 
and metastasis: these include AKAP9/yotiao (54); AKAP12/SSeCKS/gravin (55,56); 
AKAP13/AKAP-Lbc (57); the erzin/radixin/moesin and merlin protein family (58-60), 
the WAVE (Wiskott-Aldrich syndrome/verpolin-homologous) -1 and 2 proteins (61,62). 
Without exception, however, those reports dealt with gain- or loss-of-function of their 
respective AKAPs as a whole and did not specifically target only the PKA anchoring 
domain. This is an important corollary, as the overwhelming majority of known AKAPs 
– and essentially all of those previously implicated in metastasis – have important 
functions beyond their ability to anchor PKA (19,20). Thus, complete gain- or loss-of-
function studies, i.e. over-expression or silencing of an entire AKAP, would affect all of 
its potential functions. In many cases, the functions other than PKA anchoring are quite 
powerful – e.g. guanine nucleotide exchange for Rho family GTPases (AKAP-
Lbc/AKAP13); scaffolding other kinases and enzymes (AKAP9, AKAP12); coupling 
membrane receptors to the cortical actin cytoskeleton (ezrin family proteins); dendritic 
actin nucleation (WAVE1 and 2) – and could readily contribute to invasion and 
metastasis in their own right. In the current study, however, we globally inhibited only 
the ability of AKAPs to anchor PKA; thus, to our knowledge, ours is the first report to 
establish a role specifically for PKA anchoring in events related to metastasis. 
While we have clearly demonstrated that PKA and AKAP function are both 
required for EOC cell migration and invasion, the discrete molecular targets for PKA and 
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the specific AKAP(s) responsible for PKA localization in these cells and in these 
respective activities are unknown. Delineation of specific signaling pathways that link 
PKA to migration and invasion is made difficult by the considerable and growing number 
of cytoskeleton- and/or migration-associated PKA substrates (16,23) and anchoring 
proteins (19,20,24). It is further complicated by the fact that, as we show here, inhibition 
of either type-I or type-II PKA anchoring blocks migration and invasion. This is, at the 
same time, both reassuring and vexing, as both type I and II PKA have been previously 
implicated in cell migration (13,21,22,39), but it is becoming increasingly clear that the 
two types of PKA have non-overlapping targets and functions (20,46,63). Given our 
growing appreciation of the differences between cell migration in two-dimensions vs 
three-dimensions (64,65) and the differences between normal and tumor cell migration 
(66,67), it would not be surprising if distinct (but, likely, at least partially-overlapping) 
sets of PKA substrates and anchoring proteins were called upon to specifically regulate 
EOC cell migration compared to invasion. Nonetheless, the identification of the 
substrates and anchoring proteins for PKA that are relevant to migration and invasion are 
an ongoing focus for several laboratories. 
An interesting hypothesis that arises from this data is the possibility that PKA 
could phosphorylate target proteins that are associated with focal adhesion complexes 
and regulate migration through the direct phosphorylation of key adhesion proteins.  
Indeed, there are reports of PKA-mediated phosphorylation of adhesion proteins 
including α4 integrin, VASP, and Fyn, but the enclosed data is the first to show that bulk 
phosphorylated PKA substrates localize to sites of cell-ECM adhesion. As cell-ECM 
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adhesions are the primary receptors for both the chemical and physical properties of the 
ECM, it is tempting to hypothesize that PKA activity at the leading edge could be either 
regulating, or be regulated by, changes in the mechanical properties of the ECM.  This 
hypothesis is the basis for chapter IV of this work and the data from this chapter helped 
shape the notion that leading edge PKA activity could be mechanically regulated during 
cell migration. 
The majority of women with ovarian cancer are diagnosed after the disease has 
metastasized – a point at which the long-term survival rate is poor. Therefore, a greater 
understanding of the molecular mechanisms through which ovarian cancer metastasizes 
may present new opportunities for detection and treatment. Given the importance of both 
PKA and AKAP function for EOC cell migration and invasion demonstrated in the 
current work, it is not unreasonable to postulate that targeting a AKAP/PKA/target 
signaling axis may be a worthwhile avenue for development of novel therapeutics (47,68) 
used to decrease the dissemination and invasion of EOC. 
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2.6 Figures and Figure Legends 



















Figure 1. PKA is activated at the leading edge of migrating SKOV3 cells. (A) SKOV-
3 cells were transfected with pmAKAR3, plated onto fibronectin-coated dishes overnight, 
stimulated with 10ng/ml EGF for 4-6 h, and then imaged by FRET microscopy. Images 
were captured every 30 sec, then pseudocolored according to FRET ratio (color scale 
shown in frame 0’): this montage depicts frames 30 sec apart. Scale bar = 10 µm. (B) 
Leading edge dynamics were visualized using QuimP11 software and edge position over 
time is shown by overlaying subsequent cell outlines in different colors (color scale 
shown at top). (C) FRET activity as monitored over time and the frequency and size of 
leading edge PKA activity events (white and black bars, respectively) were quantified. 
(D) The change in PKA activity (∆FRET) starting at the cell centroid and moving toward 
the cell front was quantified.	  
 
 



























Figure 2. PKA activity and anchoring are required for normal leading edge 
morphology in migrating SKOV-3 cells. (A-C) Confluent monolayers of SKOV-3 cells 
plated on FN-coated coverslips were wounded by scratching and re-fed with media 
containing DMSO (A, Ctrl), 10 µM H89 (B), or 50 µM StHt31 (C). Cells were allowed to 
migrate into the wound for 4 h before fixation and staining to visualize F-actin (green) 
and the focal adhesion proteins VASP (red) and vinculin (blue). (D) SKOV-3 cell 
monolayers were cultured and wounded as described above, then treated with DMSO 
(Ctrl), H89, StHt31, or 25 µM mPKI. After 4 h, the cells were fixed and stained as above 
and the number of leading edge lamellipodia in cells at the wound edge was quantified. 
Values represent the means ± S.E. from at least three experiments (n > 100; * = P<0.001). 	   	  














Figure 3. The donut migration assay preserves ECM protein coating better than 
scratch assays. (A) COS-7 cells were plated on coverslips coated with 20 µg/ml FN and 
subject to either the donut migration assay or a scratch migration assay for 2 hrs. 
Coverslips were fixed and processed for immunofluorescence using an antibody against 
FN, fluorescent phalloidin to stain F-actin, and DAPI to stain nuclei, then examined by 
fluorescent microscopy. White arrows depict regions used for linescan analysis. (B) 
Linescan analysis, showing the relative intensity (arbitrary units) of FN fluorescence, of 
the regions depicted in (A). (C) The bar graph represents the average ± S.E. of the 
percent FN preserved at the assay front from multiple linescans across three separate 
donut and scratch migration assays (* = P<0.001). 	   	  




































Figure 4. The donut migration assay preserves cell viability on the assay periphery. 
(A) COS-7 cells were plated on FN-coated coverslips and subject to either donut or 
scratch migration assays. The panels depict phase contrast images of representative fields 
along the periphery of both assays after staining with trypan blue immediately after donut 
removal or wounding of the monolayer. (B) The data represent the average ± S.E. 
number of cells that retained the trypan blue stain per 10x field on the assay periphery (* 
= P<0.001). 	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Figure 5. A modified radial migration assay – the Donut assay. (A) A schematic 
representation of the donut migration assay in which cells are seeded at confluence on an 
extracellular matrix-coated glass coverslip within a donut-shaped silicone gasket. After 
the cells have stably adhered, the gasket is removed, allowing the cells to migrate radially. 
Images of the monolayer are captured immediately after donut removal and at any time 
point thereafter that is suitable to allow migration of a given cell line. A custom ImageJ 
macro uses the initial image as a subtractive mask to determine the number of migrated 
cells in the final image taken at the end of the assay. Details are given in Materials and 
Methods. (B) A picture of five donut gaskets on a single 25 mm coverslip; this allows 
facile setup of replicate assays to increase throughput and generate statistically significant 
data. (C) COS-7 cells were subject to the donut migration assay in the presence of 2 µM 
cytochalasin D (cytoD) or DMSO as a vehicle control. Representative images taken at the 
beginning (0 h) and end (20 h) of the assay, as well as masked (final minus initial) images 
depicting migrated cells are shown. (D) The number of migrated COS-7 cells was 
calculated using the ImageJ macro as described in Materials and Methods. Data represent 
the mean ± S.E. of five donuts per coverslip with three separate coverslips per treatment. 
(* = P<0.001).	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Figure 6. PKA activity and anchoring are required for SKOV-3 cell migration. (A) 
SKOV-3 cells were transfected with either empty mCherry plasmid or mCherry-PKI, 
then subject to donut migration assays. Representative thresholded images of the 
migrated cells (Migrated, with nuclei pseudocolored green), the total population of 
transfected cells (Transfected), and an overlay of these two images are shown. Insets 
depict enlargements of the areas indicated by the squares in the top panels. Thus, the total 
migrated cells (‘TM’) are depicted in green, the total transfected cells (‘TX’) are depicted 
in red, and the yellow nuclei depict transfected cells that migrated, i.e. migrated and 
transfected cells (‘MX’). (B) For cells transfected with either empty mCherry (mCh) or 
mCherry-PKI (PKI), the average percent (± S.E.) of migrated transfected cells over the 
total number of migrated cells (‘MX/TM’) was calculated. To normalize for transfection 
efficiency, average percent (± S.E.) of migrated transfected cells over the total number of 
transfected cells (‘MX/TX’) was also calculated. (* = P<0.05) (C) SKOV-3 cells were 
transfected with plasmids encoding EGFP fused to inhibitors of type-I (RIAD) or type-II 
(sAis) PKA anchoring, or their respective scrambled controls (RIAD_scr, sAis_scr), then 
subject to donut migration assays and analysis as described in (A and B). (** = P<0.001)	   	  






















Figure 7. A modification of the donut assay allows measurement of matrix invasion. 
(A) A schematic representation depicting the donut invasion assay. After removal of the 
silicone gasket, the cell monolayer is covered with a Matrigel overlay, and invasion is 
analyzed as described for Figure 2. (B, C) Migration and Matrigel invasion of non-
tumorigenic human immortalized ovarian (HIO-80) epithelial cells (B) and tumorigenic 
SKOV-3 (C) was assessed at 24, 36, and 48 h after donut removal, in the presence or 
absence of the matrix metalloprotease inhibitor GM6001 (25 µM). Graphs represent the 
mean ± S.E. of the number of migrated or invaded cells. (*=P<0.05) 	   	  

































Figure 8. PKA is activated at the leading edge of invading SKOV-3 cells. (A-D) 
SKOV-3 cells transiently expressing pmAKAR3 were subject to the donut invasion assay 
and images of cells on the monolayer periphery were acquired 10 h after gasket removal. 
Pseudocolored FRET images are shown, with insets depicting enlargements of the areas 
indicated by the white rectangles in each panel. White arrows indicate the direction of 
invasion with respect to the cell monolayer. Scale bar = 10 µm. (E, F) to quantify the 
number of invading cells exhibiting leading edge PKA activity, the average FRET ratio 
was measured by linescan in the leading edge (LE) and the cytoplasm (Cyto) of cells and 
a ratio of these values (FRET(LE/Cyto)) was determined. (F) shows the percentage of cells 
exhibiting low (≤1.2), medium (1.2<x<1.5), or high (≥1.5) LE/Cyto FRET ratios (n=28 
from four separate experiments). 	   	  





































Figure 9. Biosensor activity of pmAKAR3 is PKA-specific. SKOV-3 cells were 
transfected with plasmid expressing pmAKAR3 alone or co-transfected with plasmids 
expressing pmAKAR3 and pmCherry-PKI, and 24 h later were subjected to the donut 
invasion assay as described for Figures 4 and 5. FRET ratio images were taken of cells 
along the perimeter of the monolayer 8 h after the start of the assay. The direction of 
invasion is indicated by the white arrow.	   	  


































Figure 10. PKA activity and anchoring are required for SKOV-3 cell invasion. (A, 
B) SKOV-3 cells were transiently transfected with plasmids to inhibit PKA activity or 
anchoring (mCh-PKI, GFP-RIAD, GFP-sAis) or their respective controls (Empty 
mCh,GFP-RIAD_scr, GFP-sAis_scr), then subject to invasion analysis as described in 
Figures 3 and 4. (* = P<0.01; ** = P<0.05). In parallel to the method described in Figure 
3, invasion was calculated as the average percentage (± S.E.) of invading transfected cells  
over the total number of invading cells (A; ‘IX/I’) or, to normalize for transfection 
efficiency, the average percentage of invading transfected cells  over the total number of 
transfected cells (B; ‘IX/X’).	   	  

















Figure 11. PKA activity and anchoring regulate focal adhesion dynamics. SKOV-3 
cells co-expressing eGFP-paxillin and the indicated inhibitors of PKA activity or 
anchoring fused to mCherry (mCh; A) were analyzed using the Focal Adhesion Analysis 
Server. The average size of the adhesions (B), adhesion lifetime (C) the rate of assembly 
(D), and the rate of disassembly (E) were quantified.  Assembly and disassembly rates are 
depicted as box and whisker plots.  The mean is shown using the ‘+’ and is written above 
each treatment. (F) immunofluorescent images of phosphorylated PKA substrates (pPKA 
subst.) and paxillin in intact (top) and unroofed (bottom) cells. (G) Linescans of the 
coincidence of pPKA subst. and paxillin staining in intact and unroofed cells. 	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CHAPTER III: EXTRACELLULAR MATRIX TENSION REGULATES 
OVARIAN CANCER CELL MORPHOLOGY, MIGRATION AND 
MULTICELLULAR SPHEROID DISAGGREGATION 
3.1 Introduction 
 Cells interpret and respond to the mechanical properties (e.g. stiffness and 
topology) of the extracellular matrix (ECM) by exerting contractile force and sensing 
counter-tension through mechanocellular systems (1).  These complex mechanosensitive 
systems include integrins, focal adhesion complexes, the actin cytoskeleton, and 
associated molecular motors (1), and serve to interpret both intrinsic and extrinsic 
mechanical forces into diverse signaling events such as ion flux and phosphorylation 
cascades.  The translation of mechanical forces into biochemical signals – 
mechanotransduction – has been shown to regulate nearly every facet of cellular life, 
including shape, migration, survival, proliferation, and differentiation(2-6).  Cancer 
pathogenesis relies heavily on mechanotransduction and many of the aforementioned 
cellular processes are crucial for tumorigenesis (7-9).  Tumor stroma is often 
characterized by ECM remodeling and stiffening and tissue fibrosis, and increases in 
mammographic density are associated with an increased risk for breast cancer (9,10).  
Additionally, nonlinear optical imaging methods, such as multiphoton microscopy 
(MPM) and second harmonic generation (SHG) imaging, have been used to visualize 
local changes in collagen fibril density around invasive breast tumors (11,12).  Breast 
tumor associated increased collagen fibrils appear to facilitate the local tumor cell 
invasion and navigation towards blood and lymph vessels (11,12).  Moreover, increased 
ECM stiffness can disrupt the morphogenesis of normal tissue (9) and also enhances the 
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survival, growth and migration of cancer cells (7,13).  Importantly, reduction of increased 
cell-ECM tension can repress the malignant phenotype of transformed mammary 
epithelial cells and can normalize the behavior of primary breast cancer cells in culture 
(9).   
 Several observations suggest that ECM tension and mechanical forces may 
similarly affect ovarian cancer.  As in the breast, ovarian tumors and their peritoneal 
implants are often fibrotic and surrounded by reactive, desmoplastic stroma (14,15).  
Additionally, second harmonic generation imaging of ovarian cancer associated 
extracellular matrices reveal altered collagen density and higher levels of both collagen 
fibrils and fibers (16).  Unique from breast cancer, the minimal metastatic unit of EOC is 
thought to be a multi-cellular aggregate, or spheroid, that exfoliates from the primary 
tumor and moves throughout the peritoneal cavity by normal peritoneal fluid flow (14,17).  
These spheroids are thought to use myosin-generated force to clear the mesothelium of 
peritoneal organs and attach to the submesothelial connective tissue (15,18,19).  Tumor 
spheroids formed from highly invasive ovarian cancer cells show increased expression of 
the collagen cross-linking enzymes lysyl oxidase (LOX1), which is critical for promoting 
matrix stiffness and invasion in breast cancer, and tissue transglutaminase (TG2), which 
also promotes ECM polymerization and cross-linking (20-22). These considerations lead 
us to hypothesize that the metastatic behavior (migration and dispersion) of ovarian 
cancer cells and multi-cellular spheroids is regulated by the stiffness of the ECM. Though 
much is known concerning the effect of matrix stiffness on breast cancer pathology, little 
is known concerning the role of ECM tension and cellular contractility in ovarian cancer.   
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Other efforts in the laboratory have focused on characterizing the mechanical 
properties (specifically, the stiffness) of normal tissues that become sites of metastasis for 
epithelial ovarian cancer (EOC) cells. The goal of these efforts is the characterize the 
stiffness of the normal tissues that metastatic EOC cell would encounter in an effort to 
investigate the cell biology of cells grown on ECM substrates that mimic the mechanical 
properties of these tissues.  One such tissue that has high rate of EOC cell metastasis is 
the peritoneum. The peritoneum is the membrane that forms the lining of the abdominal 
cavity and is composed of a layer of mesothelium and a thin layer of connective tissue. 
Mice that have given EOC develop large metastases on the peritoneum and the other 
organs housed within the peritoneal cavity. To approximate the stiffness of mouse 
peritoneum, small dissections of mouse peritoneum were analyzed by atomic force 
microscopy. Atomic force microscopy utilizes a small probe mounted on the end of a 
flexible cantilever with a known spring constant to interrogate the mechanical properties 
of tissues and other samples. For our studies, a 5 µm spherical probe was used to obtain 
force-deflection curves from normal mouse peritoneum. Numerous curves (at least 100) 
were obtained from any one sample, and at least three separate samples were tested.  The 
average Young’s modulus was calculated to be 4.33 ± 0.095 kPa. Interestingly, there 
were regions of increased stiffness that were well above one standard deviation from the 
mean.  These stiffness “hot spots” show that there is heterogeneity in the mechanical 
properties of mouse peritoneum, and justify using a range of stiffness values when 
mimicking normal peritoneal tissue. Specifically, we utilize 3 kPa and 25 kPa compliant 
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ECMs compared with glass (~1G Pa) to test the effect of matrix stiffness on EOC cell 
morphology and migration.   
Here, we have utilized polymer hydrogels to modulate the stiffness of the ECM 
and investigated the role of ECM stiffness in ovarian cancer cell morphology and 
migration.  We show that cell morphology, focal adhesion dynamics, and intracellular 
contractility of SKOV-3 epithelial ovarian cancer cells are all regulated by ECM tension.  
We provide evidence that increased ECM stiffness corresponds with a decrease in the 
number of protrusive lamellepodia and an increase in directional single cell migration. 
Moreover, we demonstrate that localized increases in ECM tension via mechanical 
stretch induce SKOV-3 cell migration in the direction of stretch. Lastly, we establish that 
the ability of EOC spheroids, the minimal metastatic unit of metastatic ovarian cancer, to 
disperse is dependent upon the stiffness of the ECM. Specifically, EOC cells 
preferentially disaggregate and disperse on stiffer extracellular matrices.  Importantly, 
there were significant morphological and migratory effects observed on ECMs whose 
stiffness was within the range of normal mouse peritoneum, suggesting that fluctuations 
in ECM stiffness, even in the normal tissue, can regulate EOC cell behavior. This 
regulation might be important in processes involving the metastasis and implantation of 
ovarian tumor spheroids onto organs in the peritoneal cavity and could give insight into 
possible treatment of not only the tumors themselves, but also the remodeled stroma 
associated with EOC metastases. 
	   103	  
3.2 Materials and methods 
3.2.1 Reagents and cell culture 	  
 Human epithelial ovarian cancer (SKOV-3) cells were purchased from American 
Type Culture Collection and were maintained in a humidified incubator at 37˚C 
containing 5% CO2 in DMEM supplemented with 10% Fetal Bovine Serum. OvCa429, 
OvCa433, and DOV13 human EOC cell lines were generous gifts from Nadine Hempel 
(College of Nanoscale Sciences and Engineering, University at Albany), and Susan 
Murphy (Duke University) and were cultured as previously described (32). Cells were 
trypsinized and split 1:5 every 3-4 days to maintain at subconfluencey. Acrylamide and 
N,NI-methylenebisacrylamide were purchased from National Diagnostics. TEMED 
(tetramethylethylenediamine), ammonium persulfate (APS), and bovine serum albumin 
(BSA) along with other sundry chemicals were purchased from Sigma (St. Louis, MO). 
Glass coverslips (25 mm; Fisher Scientific) were sterilized by sequential 30 min soaks in 
70%, 95%, and 100% EtOH and then air-dried in a tissue culture hood. 
3.2.2 Fabrication of polyacrylamide hydrogels 	  
 Polymer hydrogels were made as previously described (5).  Briefly, 25 mm 
coverslips (23) were flamed, placed in a parafilm lined dish, and incubated with 0.1 N 
NaOH for 5 min at room temperature.  Excess NaOH was removed via aspiration and the 
coverslips were then incubated with 3-aminopropyltriethoxysilane (APTMS, Sigma) for 3 
min at room temperature.  The coverslips were then moved to 6-well dishes (Nunc) and 
washed 5x5 min with ddH2O.  After washing, the cells were placed in a dish lined with 
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fresh parafilm, then incubated with 0.5% glutaraldehyde (Sigma) for 30 min at room 
temperature.  Activated coverslips were either used immediately or stored desiccated for 
up to 2 weeks.  Polyacrylamide gel solutions were made in 400 µl aliquots to a final 
concentration of 7.5% acrylamide and either 0.5% or 0.05% bis-acrylamide.  
Polymerization was induced with 2.5 µl 10% APS and 0.5 µl TEMED.  Gels were cast 
onto activated coverslips by adding a 10 µl drop of the gel solution onto the coverslip and 
overlaying the drop with a 25 mm coverslip treated with RainX.  The excess gel solution 
was used to monitor polymerization, and once the gels were polymerized the top 
coverslip was removed and the gels were washed 3x5 min in phosphate buffered saline 
(PBS).  The gels were then incubated with 50 mM Sulfo-SANPHA for 10 min under 364 
nm UV light.  Activated gels were then washed 3x5 min in 50 mM HEPES pH 8.6 and 
incubated with 20 µg/ml fibronectin diluted in 50 mM HEPES pH 8.6 for 3 hr at 37˚C.  
Coated gels were washed 3x5 min in PBS and either used immediately or stored at 4˚C 
for up to 1 week.  The stiffness values of the gels were approximated against published 
literature using acrylamide/bis concentrations equivalent to the concentrations used in 
this work (2).     
3.2.3 Immunofluorescence and image analysis 	  
 For visualization of, actin, paxillin, and phospho-Myosin Light Chain (ppMLC 
Thr18/Ser19) cells were fixed in 3.7% formaldehyde in TBS for 10 min, permeabilized 
for 10 min in TBS containing 0.25% triton X 100, blocked with TBS containing 5% BSA 
for 1 h at RT then incubated with anti-paxillin (1:500, BD Transduction) or anti-ppMLC 
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(1:500, Cell Signaling) primary antibodies for 1 h at RT. After washing 3x5 min with 
TBS, cells were incubated with Alexa-647 coupled donkey anti-mouse, Alexa-596 
coupled donkey anti-rabbit secondary antibodies (Invitrogen, 1:400) and Alexa-488 
conjugated phalloidin (Invitrogen, 1:100) for 1 h at RT. After washing 3x5min in PBS 
and one rinse in ddH2O, coverslips were mounted onto glass microscope slides (23) using 
a small volume of PermaFluor mountant (Thermo Scientific). Epifluorescence images 
were captured though a 60X Plan Apo oil immersion objective on a Nikon Eclipse TE-
2000E inverted microscope using the appropriate fluorophore-specific filters (Chroma 
Technology Corp, Rockingham, VT) and a CoolSnap HQ camera (Photometrics, Tucson, 
AZ) controlled by Elements (Nikon) software.  Immunofluorescent Images were 
analyzed in ImageJ.  For cell area, a mask was created using the phalloidin staining and 
area was determimed using the measure tool in ImageJ.  The obtain focal adhesion size, 
paxillin images were analyzed using the Focal Adhesion Analysis Server. To assess 
lamelipodial structures, images of paxillin and actin were contrast enhanced and areas at 
the cell periphery that were both devoid of actin stress fibers and contained branched 
actin networks and nascent focal adhesions were counted as lamellipodia. 
3.2.4 Western blotting and antibodies 	  
 Cells plated on fibronectin coated polyacrylamide gels or glass coverslips were 
lysed in 100 µl of Triton X-100 lysis buffer (1% Triton X-100; 50 mM Tris pH 7.2; 10% 
glycerol; 25 mM ß-glycerophosphate; 2 mM EDTA; 2 mM EGTA) containing protease 
and phosphotase inhibitors by inverting the gels/coverslips on a 100 µl drop of the lysis 
	   106	  
solution on a piece of parafilm. After incubating on ice for 10 minutes, the gels/coverslips 
were then gently scraped into microcentrifuge tubes and incubated on ice an additional 10 
min.  The lysates were then cleared by centrifugation (14000 RPM for 10 min) and 
protein concentrations of the cleared lysates were determined by bicinchoninic acid assay 
(BCA) kit (ThermoFisher). For direct immunoblotting, aliquots of lysates were mixed 
with 5x Laemmli sample buffer and boiled for 10 min before loading on 15% SDS-PAGE 
gels.  Separated proteins were transferred to PVDF membranes and subsequently blocked 
in blocking buffer (1.5% gelatin in TBS-T for ppMLC and MLC) then incubated with 
primary antibodies against ppMLC (Cell Signaling, 1:500), or MLC (Cell 
Signaling1:500) for 1 hr at room temperature.  The membranes were then washed 5x5 
min in TBST before being incubated with horseradish peroxidase-conjugated secondary 
anti-rabbit secondary antibodies (1:5000 Calbiochem) for 30 min.  After washing 5x5 
min in TBS-T, the membranes were incubated with epichemiluminscence (ECL) 
substrate (ThermoFisher) for 3 minutes before being exposed to film.     
2.2.5 Live-cell imaging 	  
 Cells were plated on flexible substrates or glass coverslips and incubated 
overnight in complete media.  The cells were then rinsed twice in Ringer’s buffer (10 
mM HEPES; 10 mM Glucose; 155 mM NaCl; 5 mM KCl; 2 mM CaCl2; 1m MMgCl2) 
and re-fed with Ringer’s buffer supplemented with 40 ng/ml epidermal growth factor 
(EGF) for imaging. Images were acquired every 30 sec using the fluorophore-specific 
filters as described above. 
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3.2.6 Cell tracking 	  
 Cells plated on hydrogels or glass coverslips were incubated overnight in 
complete media then rinsed twice in Ringer’s buffer (10 mM HEPES; 10 mM Glucose; 
155 mM NaCl; 5 mM KCl; 2 mM CaCl2; 1 mM MgCl2) and re-fed with Ringer’s buffer 
supplemented with 40 ng/ml epidermal growth factor (EGF) for imaging. For cell 
tracking, 3.5 x 104 cells were plated onto the substrates and incubated overnight. The 
nuclei were then stained with Hoechst 33342 (1:2000 in complete media; Invitrogen) for 
15 min at 37˚C followed by washing and re-feeding with Ringer’s buffer + EGF. The 
gels/coverslips were mounted in Attofluor cell chambers (Invitrogen) containing 0.5 ml 
of Ringer’s media + EGF, overlayed with mineral oil, and monitored by live cell 
microscopy for 10 hr using a 20x Plan Apo dry objective as described above. The cells 
were maintained at 37˚C using an ASI 400 Air stream Incubator (NevTek) and 
transmitted light as well as fluorescent images of nuclei were captured every 5 min for 
the duration of the experiment. The ImageJ MTrack2 plugin was used to track individual 
nuclei and obtain (x,y) coordinates to calculate displacement, total distance traveled, and 
cell speed. Directionality was calculated as displacement (the Euclidean distance between 
the origin and final x,y coordinates) divided by total distance migrated (the entire length 
of the migration track). Migratory speed was calculated as the average change in 
Euclidean distance between nuclei between two frames divided by time interval between 
the frames, i.e.  (∆!)! + !(∆!)!∆! ! . 
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3.2.7 Cell stretching 	  
 Cells were seeded, mounted, and maintained on the microscope as above and 
were manipulated with a glass microneedle as described previously (24).  Micro-
manipulators were fashioned by pulling borosilicate glass capillaries (World Precision 
Instruments, Sarasota, FL) on a two-stage Pul-2 pipette puller (World Precision 
Instruments, Sarasota, FL).  The pulled capillary tube was then mounted on a Narishige 
MF-900 microforge to form the tip into a hook with a round, blunted end that could be 
used to engage the polyacrylamide hydrogels without tearing.  Once made, the forged 
microneedle was mounted on a micro-manipulator adjacent to the microscope.  To stretch 
cells, the microneedle was lowered onto the gel surface approximately 20 µm away from 
the cell.  Once engaged with the gel, the manipulator was pulled approximately 20 µm in 
a direction perpendicular to the cell edge.  This was enough to cause a substantial 
deformation of the cell without causing any damage to the cell or the hydrogel.  
Quantification of response to stretch was calculated using custom written ImageJ macros 
designed to calculate the percent of cell area protruding, retracting, and remaining the 
same as the cell moves.   
3.2.8 Spheroid dispersion assay 	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 EOC multi-cellular spheroids were generated using the hanging drop method as 
previously described (21,25).  In brief, OvCa cell lines were trypsinized, counted and 
resuspended in enough complete growth medium to obtain a cell count of 100,000 
cells/ml.  20 µl drops of the cell suspension were then placed on the inside of a lid from a 
10 cm polystyrene dish and the lid was immediately inverted onto the dish filled with 10 
ml PBS to prevent evaporation of the small volume of cell suspension.  The cell 
suspension was incubated under normal growth conditions for 72 hr to allow the 
aggregates to form at the bottom of the hanging drop.  After 72 hr, the spheroids were 
harvested using a p20 pipette tip being careful not disrupt the aggregate with sheer forces.  
Individual spheroids were placed on either polymer hydrogels or glass coverslips and 
allowed to attach for 3 hr before imaging with transmitted light as described above with a 
10x Plan Apo air objective.  The cells were then incubated overnight in complete medium 
and images were taken 16hr after the initial images.  To quantify the degree of dispersion, 
images were thresholded using ImageJ to outline the periphery of the aggregate, and total 
area of the 16 hr image was compared to the total area of the initial image to get a percent 
increase in area over the allotted time.            
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3.3 Results 
3.3.1 Extracellular matrix tension regulates epithelial ovarian cancer cell morphology, 
focal adhesion dynamics, and lamellipodial structures in SKOV3 cells. 	  
 Cells sense and respond to changes in the mechanical properties of the ECM (1).  
Several studies have shown that cell spreading and morphology as well as focal adhesion 
maturation are regulated by the rigidity of the ECM in a variety of cells (2,26,27). 
Though this phenomenon appears to be common in a myriad of cell types, we sought to 
determine if ECM tension specifically regulated EOC cell morphology and focal 
adhesion dynamics. 
To assess the effects of matrix stiffness on SKOV3 cell morphology, cells were 
plated on soft (~3.06 kPa) or stiff (~25.65 kPa) gels coated with 20 ug/ml fibronectin and 
compared to those plated on 20 ug/ml fibronectin-coated glass coverslips.  After 
overnight incubation on the specified substrata, the cells were fixed and processed for 
immunofluorescence to illuminate the actin cytoskeleton, phospho-myosin light chain, 
and paxillin as described in Materials and Methods (Fig. 1A).  Morphological changes 
were readily observed in cells plated on substrates of varying compliance. The most 
striking observation was the matrix stiffness-dependent decrease in cell surface area. 
Specifically, cell plated on glass, stiff and compliant gels spread with significantly 
different average surface areas of 5020 ± 1005 µm2, 1673 ± 186 µm2, and 111 ± 15 µm2, 
respectively (mean±S.E.M., Fig. 1B). Though cells plated on loose gels did not spread 
and remained spherical they were, indeed, stably adherent as changing the media and 
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processing for immunofluorescence did not dislodge the cells. Cells plated on glass and 
25 kPa gels both showed dense actin stress fibers that co-localized with phosphorylated 
(active) myosin (ppMLC, Fig. 1A), however, both the fluorescence intensity (Fig. 1E and 
F) and width (Fig. 1C) of the stress fibers was significantly decreased in cells plated on 
stiff but compliant substrates. Cells plated on 3 kPa gels did not display actin stress fibers, 
but did have dense actin rings surrounding the cells that were coincident with ppMLC, 
suggesting that cells, though spherical and not spread, did contain low levels of 
actomyosin contractility. In addition to changes in cell size and actomyosin staining, 
there was a drastic change in the staining pattern of the focal adhesion protein, paxillin, 
as a function of matrix stiffness (Fig. 1A). Specifically, as matrix stiffness increased there 
was increase in the presence and size of mature paxillin-containing focal adhesions (Fig. 
1G), suggesting that focal adhesion dynamics are regulated by the stiffness of the ECM in 
SKOV3 cells. These results demonstrate, for the first time, that changes in the mechanical 
properties of the ECM can influence ovarian cancer morphology, and establish the 
importance for studying the role of ECM tension-regulated processes in ovarian cancer 
cells.  
3.3.2 Non-muscle myosin II activity is regulated by extracellular matrix tension 	  
 Extracellular forces are sensed and interpreted into chemical signals through the 
activity of mechanically sensitive proteins.  Class II myosins have long been studied for 
their roles in mechanosensing, mainly in muscle contraction, and their activity has also 
been used as a marker of intracellular contractility (28).  The contractile nature of cells is 
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known to regulate cell shape and cytoskeletal dynamics (28), and thus, could be 
responsible for the drastic changes in morphology seen in SKOV3 cells (Fig. 1). Because 
there is reported reciprocity between the rigidity of the ECM and the contractile nature of 
the cell, we sought to determine the effect of ECM tension on the regulation of 
intracellular actomyosin contractility.       
Immunofluorescent images showed a decrease in the both actin and ppMLC 
intensity when cells were grown on more compliant matrices (Fig. 1E-G).  These results 
suggested that the activity of myosin, that is needed to generate stress fibers and 
intracellular contractility, could be regulated by the mechanical properties of the ECM in 
SKOV3 cells. To determine if ECM compliance regulated the intracellular contractile 
machinery (namely, actomyosin contractility) cell lysates were generated from cells 
plated either on glass or gels of varying compliance as described in Materials and 
Methods.  The lysates were immunoblotted for the double phosphorylated (Thr18/Ser19) 
form of the regulatory light chain of non-muscle myosin II total MLC or total MLC to 
mark for congruency in protein loading (Fig. 2).  Phosporylation of the regulatory light 
chain at Thr19 and Ser19 increases myosin II activity and thus increases intracellular 
contractility, and relative changes in the phosphorylation state of MLC can give insight to 
the contractile state of the cell.  When probed, lysates showed an ECM-tension dependent 
increase in ppMLC protein expression (Fig. 2, A upper pannel).  These results were 
confirmed by densitometric analysis of the immunoblots (Fig. 2B). Moreover, the 
immofluorescent-staining pattern of ppMLC was similar in cells plated on glass and stiff 
gels (albeit, at a lower intensity on 25 kPa gels), but was drastically different in cells 
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plated on 3 kPa gels (Fig. 1).  Specifically, on stiff substrates (glass and 25 kPa gels), the 
ppMLC staining decorated the actin stress fibers and dense staining was present in both 
cases at the lamella/lamellipodia transition.  However, cells plated on soft gels did not 
display any dense actin stress fibers and were unable to spread to an extent capable of 
forming lamellipodia.  These data show that myosin activity is dynamically regulated in 
cells grown on substrates within a range of compliance comparable to that found 
physiologically.  These data establish, for ovarian cancer cells, a paradigm that has been 
reported in other cell types, where the mechanical properties of the ECM regulate cell 
shape through modulation of the contractile nature of the cell.  Though cells plated on 
stiff substrates had modest but significant differences in intracellular tension compared to 
those on glass, there were considerable differences in the morphology of leading edge 
structures of cells plated on either glass or 25 kPa gels.  
Studies have shown that the formation and protrusion of lamellipodial structures 
make use of the intracellular force generating machinery and exert traction forces onto 
the ECM (29,30). Analysis of the immunofluorescent images of cells plated on either stiff 
gels or glass showed an increase in the number of lamellipodia per cell in cells plated on 
25 kPa gels compared to the cells on glass (Fig. 3A, arrowheads, and B). Conversely, 
there was an absence of any lamellipodia or lamellipodia-like structures in the cells 
plated on loose gels (Fig. 1). The presence of lamellipodial structures was determined by 
the concurrent staining of both mature focal adhesions and branched actin networks 
devoid of stress fibers at the cell periphery. The increased number of lamellipodial 
structures suggests that the cells are sending out numerous processes to explore their 
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substrata.  We have previously shown that inhibition of PKA anchoring to AKAPs also 
increases the number of leading edge lamellipodia, and have correlated the increase in 
protrusive structures to a decrease in migratory directionality (31).  If an increase in 
protrusive lamellipodial structures correlates with an inability for cells to persistently 
migrate and decreasing ECM stiffness increases protrusive lamellipodia, then decreased 
ECM stiffness should decrease persistent directional migration. 
3.3.3 Increased extracellular matrix tension regulates SKOV-3 cell migratory speed and 
directionality 	  
 Ovarian cancer is known for its abstruse and aggressive metastatic nature.  
Previous reports have shown that inhibition of key migratory and tension-sensing 
proteins (i.e. PKA, RhoA, actin, etc.) have a deleterious effect on EOC cell migration 
(31,32).  In an effort to further understand the mechanisms that govern EOC cell 
migration and metastasis, we investigated the role of matrix tension on ovarian cancer 
cell migratory speed and directionality.  Cells were plated on 20 ug/ml Fibronectin coated 
substrates with varying stiffness and were monitored via time-lapse microscopy for 10hr 
in the presence of 40 ng/ml EGF to promote persistent directional migration.  Cell speed 
and directionality were measured by tracking Hoechst 33342 stained nuclei using the 
MTrack2 ImageJ plugin.  The initial X and Y coordinates were set to (0,0) and all 
subsequent coordinates were normalized to (0,0) so that all traces would have the same 
origin.  Representative traces of cells migrating on various substrates are shown (Fig. 3C).  
Directionality was calculated by dividing the displacement (the distance of the straight 
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line between the origin and final x,y coordinates) by the total distance migrated (complete 
length of migratory track).  Using these calculations, a cell that migrated in a straight line 
would have a directionality of 1 and a cell that deviated from that line would have 
directionality between 0 and 1.  Cells plated on glass, a 25 kPa gel, and a 3 kPa gel had a 
directionality of 0.499±0.167, 0.240±0.130, and 0.098±0.025 respectively (Fig. 3D). 
There was an obvious and significant ECM stiffness-dependent increase in directionality 
that was due to an increase in the total distance traveled and a decrease in cell 
displacement in cells plated on 25 kPa and 3 kPa gels, respectively (Fig. 3F).  Migratory 
speed was calculated as described in the materials and methods.  Cells on glass had a 
significantly lower average speed of 0.338±0.124 µm/sec than the average of the 
velocities of cells on either a 25 kPa or 3 kPa (Fig. 3E). Interestingly, cells plated on 
either 25 kPa or 3 kPa gels displayed very similar migratory velocities of 0.554±0.098 
and 0.444±0.105 µm/min, respectively, that were not significantly different (Fig. 3E). 
Though the velocities were not different, there was an obvious and significant deficit in 
the mean total distance traveled cells plated on 3 kPa (Fig. 3A and D).  These results 
show that cells that are either not capable of forming any proper lamellipodia or form 
multiple lamellipodia are incapable of persistent directional migration.  These data 
demonstrate that ECM stiffness not only regulates cell morphology, adhesion dynamics, 
and intracellular contractility, but also regulates migratory velocity and directionality and 
establish a possible role for ECM tension in regulating ovarian cancer cell migration and, 
possibly, metastasis.  If cell migration can be modulated by gross changes in the 
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mechanical properties of the ECM, then local manipulation of the mechanical properties 
of the cellular microenvironment should be able to modulate EOC cell migration. 
3.3.4 SKOV-3 cells migrate in the direction of mechanical stretch 	  
 A local change in the stiffness of ECM substrates has been shown to modulate 
migration in numerous cell types.  This process, coined durotaxis, has been demonstrated 
to be a crucial regulator of normal migration and inhibition of key mechanosensitive 
proteins has been shown to negatively effect migratory responses to changes in local 
substrate rigidities (6,24,33). Though the effect of changes in local matrix tension have 
been observed and characterized in other cell types, it has yet to be described in the 
context of EOC.  In an effort to test if discrete, local changes in the stiffness of the ECM 
would elicit migratory responses, EOC cells were plated on flexible hydrogels and 
subject to mechanical stretch by engaging the hydrogel with a glass pipet as described in 
Materials and Methods.  To stretch cells, the micromanipulator was gently lowered onto 
the hydrogel adjacent to migrating cells.  Once engaged with the hydrogel, stretch was 
induced by moving the micromanipulator perpendicular to the direction of migration.  
EOC cells subject to mechanical stretch responded by migrating in the direction of 
applied stretch.  Phase microscopy images were acquired before stretch and for 80 
minutes after stretch (Fig. 4A). To quantify the direction and extent of migration, cells 
were divided into quartiles and protrusion-retraction analysis maps were generated from 
images acquired immediately after stretch and 80 min after stretch using a custom written 
ImageJ macro (Fig. 4B).  The percent of protrusion area (green) was measured in each 
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quartile and shows that over 60% of the total area of cellular protrusion exists in the 
direction of mechanical stretch (Fig. 4C).  These results show, for the first time, that EOC 
cells respond directly to local increases in ECM tension by migrating in the direction of 
local stretch.  It stands to reason that if single cells are fine-tuned to sense and respond to 
changes in the mechanical properties of their ECM microenvironment, then multicellular 
EOC aggregates, the smallest metastatic unit in EOC, might also be regulated by changes 
in ECM tension.  
3.3.5 Extracellular matrix tension regulates epithelial ovarian cancer multicellular 
spheroid disaggregation 	  
 Studies have shown that the minimal metastatic unit of EOC is not a single cell, 
but rather a small multi-cellular aggregate (34,35) and several studies have utilized 
spheroid disaggregation and mesothelial clearance as a read out of metastatic potential 
(15,21,36).  These spheroid aggregates can contain anywhere from 100 to 10,000 cells 
and are thought to slough away from the primary tumor and enter the peritoneal cavity 
through normal peritoneal fluid flow. Ovarian cancer spheroids are known to interact 
with and attach to both the mesothelium and components of the ECM (i.e. fibronectin, 
type IV collagen, and lamanin) (35), and recent observations suggest that when spheroids 
attach to the target tissue, they use actomyosin generated force to clear the mesothelium 
and adhere to the underlying basement membrane (15).  Furthermore, the ability of 
ovarian cancer cells to form spheroids is connected with the contractile nature of the cell 
and invasiveness (21,37). These studies did not, however, show a matrix stiffness 
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dependence on spheroid adhesion, disaggregation, or dispersion and thus, we sought out 
to determine the role of matrix stiffness on EOC spheroid disaggregation and dispersion.   
Multi-cellular spheroids from numerous ovarian cancer cell lines were generated 
using the hanging drop method as previously described.  A total of 2,000 cells were 
placed inside of each drop were allowed to form for 72 hr before harvesting and re-
plating on collagen-I coated substrates with varying compliance. Collagen-I was used 
because all of the cell lines readily attached, spread, and proliferated to similar extents on 
collagen-I (data not shown). Images of the spheroids were taken 1hr after seeding to 
allow attachment. The spheroids were allowed to disaggregate overnight and final state 
images were taken after 16hr. Representative images of SKOV-3 spheroids are shown in 
Fig. 5A.  The images were binarized and made into masks and area measurements were 
taken from three different spheroids from three separate experiments.  The fraction of the 
area from 16hr/1hr is depicted in the bar graph (Fig. 5B). Ovarian cancer cells tended to 
show an ECM tension-dependent increase in spheroid disaggregation. There were, 
however, slight differences in disaggregation between the different cell lines. Specifically, 
SKOV-3 spheroids disaggregated equally on both glass and a 25 kPa gel and significantly 
lower on 3 kPa gels. Conversely, OvCa433 and DOV13 cells showed high dispersion on 
glass and low dispersion on either 25 kPa or 3 kPa gels. Interestingly, OvCa429 cells 
showed a step-wise decrease in dispersion as ECM tension decreased. The aggregates 
that did not have a high degree of dispersion were, indeed, stably adhered, as numerous 
washes were unable to dislodge the spheroids.  These data suggest that even though 
spheroids from all cell lines tested displayed high disaggregation on glass and low 
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disaggregation on 3 kPa gels, there appears to be different set-points for optimal ECM 
stiffness for the different cell lines. These results demonstrate, for the first time, the ECM 
stiffness-dependent dispersion of ovarian cancer spheroids, and show that there are cell 
type-specific set points that influence how ovarian cancer cell spheroids disperse on 
compliant substrates. Importantly, the dispersion of the spheroids occurred on substrates 
that mimic both the average compliance of the peritoneal cavity and the average peak 
stiffness measured in normal peritoneum. Together these results establish a role for ECM 
tension in regulating the migratory behavior of not only single cells, but also multi-
cellular aggregates known to be the smallest metastatic unit in EOC.  
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3.4 Discussion 	  
The current work provides new insights into the regulation of tension-mediated 
cellular behavior in EOC cells. To our knowledge, the current study is the first to 
investigate the mechanical regulation of EOC cellular behavior using physiologically 
relevant values derived from the peritoneum, an organ targeted during EOC metastasis. It 
is important to note, however, that the elastic modulus values reported here are for 
murine peritoneum; efforts are currently underway to extend our analysis to normal 
human peritoneum. This caveat notwithstanding, we demonstrate here that changes in the 
mechanical properties of the ECM have the ability to significantly alter cellular behaviors 
associated with the invasive phenotype of human EOC cells.  
The mechanical properties of the ECM regulate the morphology, focal adhesion 
dynamics, and lamellipodial formation of EOC cells in an intracellular tension dependent 
manner. Cells experiencing low levels of extracellular matrix compliance displayed an 
increase in area as well as an increase in the presence of mature focal adhesions. 
Additionally, high ECM tension increased actomyosin contractility. Interestingly, cells 
plated on stiff, but compliant substrates displayed a higher number of lamellipodial 
structures compared to those on stiff, non-compliant substrates. The increase in 
protrusive structures provoked both an increase in migratory speed and a decrease in 
migratory directionality. EOC cells displayed rapid and dramatic responses to local 
changes in the mechanical properties of the ECM as stretching the cells evoked 
significant protrusions in the direction of the stretch. Moreover, multi-cellular spheroids 
showed an ECM tension-dependent increase in their ability to disaggregate. These 
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experiments demonstrate that EOC cells sense and respond to changes in the mechanical 
properties of the ECM and these changes alter the migratory phenotype of EOC cells. 
The altered migratory phenotype we observe in vitro may be relevant to human tumors, 
as it has been shown that the disaggregation of ovarian cancer spheroids is correlated 
with both the contractile nature and the invasive potential of the cancer.  
In contrast to other epithelial tumors, ovarian cancers predominantly metastasize 
by sloughing away from primary tumors and moving throughout the abdominal cavity in 
ascites fluid with the normal peritoneal fluid flow (35). The mesothelium and the 
basement membrane beneath the mesothelial cell layer contain numerous ligands that 
support adhesion and migration such as fibronectin, laminin, type IV collagen and 
mesothelin. Spheroid disaggregation has been observed on a wide variety of ECM 
proteins (37) and the generation of spheroid aggregates requires cellular contractility and 
correlates with the contractile nature and invasive phenotype of the EOC itself (21,37,38). 
Iwanicki et al demonstrated that EOC spheroids exert myosin-dependent mechanical 
force on underlying mesothelial cells, leading to disruption and displacement of the 
mesothelial monolayer and providing the EOC cells access to the underlying matrix (39). 
The current work suggests, however, that even after the mesothelial barrier is breached, 
the mechanical properties of the underlying extracellular matrix may contribute to EOC 
spheroid disaggregation and local invasion. 
Much is known about the role of increased ECM tension in the malignant 
phenotype of breast cancer, and elegant work has provided strong evidence for the 
dependence of breast tumors to be able to manipulate and utilize the tumor stroma in 
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order to enhance the metastatic phenotype (9,40). However, the role of matrix tension in 
regulating the metastatic behavior of other cancers is less well understood. The anatomic 
placement of the ovaries allows for either the direct spread of primary tumor cells to 
adjacent organs, or the sloughing off of primary tumor cells into the peritoneal cavity. 
Thus, ovarian malignancies are capable of attaching and spreading to a variety of target 
organs that have a wide range of stiffness values (i.e. diaphragm and omentum) via the 
normal peritoneal fluid flow. It stands to reason that the mechanical properties (stiffness) 
of the target organs might influence the adhesive and dispersive nature of the tumors.  
Conversely, the role that EOC cells have in shaping the mechanical properties of 
the sites of metastases remains to be investigated. The effect of tumor cells on 
remodeling the ECM has been extensively studied in breast cancer where matrix 
metalloproteinases (MMPs) degrade the extracellular matrix and matrix reorganizing 
proteins such as lysyl oxidases (LOXs) increase collagen cross-linking and, thus, increase 
tissue tensile strength (9). The stiffened ECM actively signals to promote integrin-
dependent focal adhesions and enhance the activity of pro-migratory signaling pathways 
such as PI3K (20). We have previously shown that SKOV-3 cells require MMP activity 
to degrade the ECM during invasion through matrigel and that leading edge protein 
kinase A signaling is required for SKOV-3 cell migration and invasion (31). Other 
studies have shown that the expression of ECM remodeling proteins such as LOX1 and 
TGT2 are increased in highly aggressive ovarian cancers (22).  Given the fact that EOC 
cells sense, respond, and can contribute to the mechanical properties of the ECM, it is 
tempting to hypothesize a mode of metastasis in which, after dissemination, EOC 
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spheroids not only attach to and clear the mesothelium, but also instigate a program of 
ECM remodeling characterized by MMP-mediated matrix degradation, LOX1/TG2-
mediated matrix cross-linking, and consequent or parallel initiation of a localized 
inflammatory response (14,35,41). These and other events would, based on prior 
observations in the context of invasive breast cancer, cause an increase in ECM stiffness 
which would, in turn, activate integrin signaling, promote focal adhesions, and activate 
migration-associated signaling pathways and ultimately reinforce the locally invasive 
behavior of EOC cells. Current efforts are underway to assess the ability of EOC 
spheroids to induce mechanical changes in the peritoneal microenvironment and the 
contribution of such changes to the local invasion – and ultimately the widespread 
dissemination – of EOC in vivo.   
The molecular mechanism that couples actomyosin contractility to cell migration 
is an area of intense investigation.  Myosin activity is required for focal adhesion 
maturation and turnover, propulsion force at the leading edge used to push the membrane 
forward, and retraction force required to translocate the cell rear.  There is intimate 
communication between myosin and effectors of cell motility including the Rho-family 
of small GTPases, migration-associated ion channel activity, and cell-ECM matrix 
adhesion proteins. An interesting hypothesis is that decreases in stiffness alters the 
spatiotemporal regulation of the GTPases, Rac, RhoA, and CDC42 (regulators of 
protrusion dynamics) that could explain the variations seen in leading edge lamellipodia 
and migratory directionality defects in cells plated on compliant substrates.  Another 
tempting hypothesis connects separate ongoing efforts in the laboratory investigating the 
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role of subcellular calcium events on cell migration.  Given the dynamic nature of these 
events and the storied reciprocity between calcium and cellular tension/contractility in 
muscle cell contraction and in cell migration, it is tempting to hypothesize that 
tension/stretch-dependent calcium transients guide rigidity sensing during cell migration 
through the regulation of calcium-dependent governance of the actomyosin cytoskeleton, 
focal dynamics, and regulators of lamellipodial protrusion/retraction cycles.    
The following chapter establishes the involvement of the cAMP-dependent 
protein kinase in a mechanosensitive pathway that governs cell migration.  This chapter 
serves as a link between chapters 2 and 3 and fills numerous knowledge gaps present in 
the literature concerning how localized PKA activity at the leading edge of migrating 
cells is regulated and how EOC cells are able to turn mechanical stimuli into cell 
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3.6  Figures and Figure Legends 	  	  






















Figure 1. ECM tension regulates SKOV-3 cell morphology, stress fibers, and focal 
adhesion dynamics.  SKOV-3 cells plated on glass (A, top row) or gels (A, middle and 
lower rows) coated with 20 µg/ml fibronectin were fixed and stained for actin (A, left 
column), ppMLC (A, middle column), and paxillin (A, right collumn).  Merged images 
are shown as an RGB-merged image (A, right column). Focal adhesion size (B), stress 
fiber width (C), and cell surface area (D) were anlalyzed for cells adhered to the specified 
substrates. Linescans (red lines in A) of actin and ppMLC show the covariance of actin 
and ppMLC immunofluorescence in cells on glass (E), a 25 kPa gel (F), or a 3 kPa gel (G, 
green = actin, red = ppMLC). * = p<0.05 for cells on glass compared to a 25 kPa gel 
**=p<0.05 for cells on a 25 kPa gel compared to 3 kPa gel. n= 17 cells/condition.	    



































Figure 2. ECM tension regulates Myosin Light Chain phosphorylation. SKOV-3 
cells were plated on 20µg/ml fibronectin coated gels (25 kPa or 3 kPa) or glass coverslips 
and allowed to adhere overnight.  (A) Whole cell lysates were separated by SDS-PAGE 
and probed with antibodies against the phosphorylated form of myosin light chain 
(Thr18/Ser19) and total myosin light chain as a loading control.  (B) Relative 
ppMLC/MLC densitometry is depicted in the black bar graph (B, n=3 blots form 3 
independent experiments). * = p <0.05 ( One way ANOVAfor cells on glass compared to 
a 25 kPa gel, ** = p <0.05 for cells on a 25 kPa gel compared to 3 kPa gel).	   	  






Figure 3. ECM tension regulates lamellipodial formation and migratory velocity 
and directionality in SKOV3 cells.   (A) SKOV3 cells plated on the indicated substrates 
were fixed and stained for paxillin (blue), actin (green), and ppMLC (red) and 
representative merged images of cells on glass and a 25 kPa gel are shown.  (B) The 
number of lamellipodia per cell was counted and is represented in the bar graph.  *, p < 
0.05 (One-Way ANOVA). (C) Cells plated on the indicated ECM-stiffness were stained 
with Hoescht 33258 nuclear dye and were monitored by live cell microscopy for 10hr and 
nuclei were tracked using the MTrack2 ImageJ macro. The X and Y coordinates were 
normalized to (0,0) so that all of the tracks started at the origin. (D) Persistent 
directionality, (E) speed, and (F) the total distance traveled were calculated from cell 
migrating on the specified ECM substrates. *, p < 0.05 (One-Way ANOVA) for cell on 
glass compared to the cells on the gels. n = 10 cells from each condition.	   	  



































Figure 4. EOC cells display a durotactic response to acute directional stretch.  
SKOV-3 cells plated on 25 kPa gels were monitored by live-cell microscopy.  (A) Images 
were acquired every 60 sec for 90 min and representative images from 10 minutes before, 
1 minute before, at, and 80 min after stretch are shown. (B) Using a custom written 
protrusion retraction analysis map (PRAM) ImageJ macro, the cells were segmented into 
areas of protrusion (green), retraction (red), and non-changed overlap (white). To analyze 
the extent of protrusion in the direction of stretch, the cells were segmented into quartiles 
B, yellow lines) and the percent protrusion was measured in each quartile  (C).	   	  



































Figure 5. ECM tension regulates EOC spheroid dispersion. SKOV-3, OvCa433, 
OvCa429, and DOV13 spheroids were generated via the hanging drop method and 
subsequently plated onto either glass coverslips, 25 kPa, or 3 kPa hydrogels and allowed 
to adhere for 1hr.  The spheroids were then incubated an additional 15 hr and final state 
images were acquired. Representative spheroid images of SKOV-3 cells are shown in A.  
Images were quantified by generating masks of the aggregates and calculating the area 
(pixel2) after 16 hr as a fraction of the area at 1 hr (B).  n = 3 spheroids from each 
gel/coverslip from 3 independent experiments.  
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CHAPTER IV: LEADING EDGE PROTEIN KINASE A ACTIVITY IS 
REGULATED BY CELL-ECM TENSION DURING CELL MIGRATION  
4.1 Introduction 
Precise regulation of cell migration is crucial in normal cellular processes like 
wound healing and embryogenesis as well as pathologies such as inflammation and 
cancer metastasis.  The activity of the cAMP-dependent protein kinase (PKA) is a key 
regulator of cell migration and cytoskeletal dynamics and the proper localization of PKA 
signaling to the leading edge by A-kinase anchoring proteins (AKAPs) is necessary for 
the migration of numerous cell types (1-4).  Specifically, we have previously shown that 
PKA subunits and kinase activity are localized to the leading edge of various cell types 
(1) and that localized PKA signaling through A-kinase anchoring proteins (AKAPs) is 
required for efficient ovarian cancer cell migration and invasion (3). Hence, how 
localized PKA activity is regulated during cell migration is crucial for our understanding 
of normal and pathological cell behaviors. 
PKA exists in cells as an inactive heterotetrameric holoenzyme containing two 
regulatory subunits and two catalytic subunits. Canonical activation of PKA occurs 
through the activation of heterotrimeric G-protein coupled receptors (GPCRs) linked to G
αS. Upon activation, GαS binds to and activates adenylyl cyclases (ACs) resulting in the 
synthesis of 3'-5'-cyclic adenosine monophosphate (3).  The binding of cAMP to the 
regulatory subunits of the PKA holoenzyme elicits a conformational change that releases 
the active catalytic subunits that phosphorylate target proteins on specific serine or 
threonine residues.  PKA phosphorylates numerous migration-associated proteins 
including actin, alpha-4 integrins, vasodilator-stimulated phosphoprotein (VASP)(5), 
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myosin light chain (MLC), and members of the Rho family GTPases, among others 
(reviewed extensively (6)). In addition to having numerous migration-associated targets, 
reports have described the regulation of leading edge PKA activity by integrin-mediated 
cell adhesion, and changes in integrin expression and ECM ligands influence the patterns 
of PKA activity during cell migration (4,7-13).  
Cells respond not only to the chemical composition of the ECM, they also sense, 
respond, and contribute to the mechanical properties of their ECM, and integrins are key 
regulators in translating the mechanical properties of the ECM into biochemical signals 
within the cell (14-17).   One such signal that occurs downstream of initial integrin 
engagement, clustering, and focal adhesion maturation is the generation of cellular forces 
through actomyosin contractility (18-20). Actomyosin-mediated cellular tension is known 
to regulate numerous facets of cell biology including migration (21,22). Notably, in 
addition to being activated by canonical GPCR-AC pathways, PKA was the first 
described mechanosensitive pathway (23). Despite the importance for leading edge PKA 
activity during cell migration and insights into the molecular machinery influencing 
leading edge PKA activity, the discrete molecular mechanism governing its activity 
remains unknown.  
Here, we demonstrate that there is molecular, spatial, and temporal distance 
between adhesion-mediated signaling events and PKA activity during cell migration and 
establish a link between leading edge PKA activity and cellular tension. We show that 
leading edge PKA activity correlates with the spatial distribution of cellular traction 
forces and that disruption of actomyosin contractility uncouples the spatial correlation 
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between cellular forces and PKA activity. We establish that leading edge PKA activity is 
regulated by cellular tension and show that locally-applied mechanical forces elicit 
localized increases in PKA activity. Moreover, we demonstrate the requirement of 
leading Ca2+ events through the stretch-activated Ca2+ channel (SACC) TrpM7 in the 
generation of cellular traction forces and leading edge PKA activity.  These results 
establish PKA as part of a mechanosensitive pathway that governs cell migration, and 
provide new insights into the mechanoregulation of cell migration. 	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4.2 Materials and Methods 
4.2.1  Cell Culture and Transfections 
SKOV-3 and WI-38 cells obtained from American Type Culture Collection 
(ATCC) were maintained in antibiotic-free Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) and were subcultured 
every 3-4 days at a 1:5 ratio to keep the cells sub-confluent. Cells were transfected using 
Fugene6 (Promega) according to the manufacturer’s protocol.  In brief, cells were plated 
into 35mm dishes at 60-70% confluence the day prior to transfection so that they were 
75-85% confluent at the time of transfection.  Fugene6 and Opti-MEM were warmed to 
room temperature and 6µl of Fugene6 was diluted into 100 µl Opi-MEM, vortexed, and 
incubated 5min at room temperature (RT).  A total of 1.5 µg of plasmid DNA was added 
to the diluted Fugene6 at a 1:4 ratio (1. 5µg DNA/6 µl Fugene6), vortexed, and incubated 
for 15 min at RT.  The transfection solution was then added drop-wise to cells and 
images were acquired 48 hr post-transfection.  
4.2.2 Cell Spreading and Migration assays 
 To monitor cell spreading, cells were prepared and cultured as previously 
described.  Briefly, cells were serum starved overnight, trypsinized, quenched with 
1mg/ml soybean trypsin inhibitor (24), washed via centrifugation (500 rpm for 5 min), re-
suspended in DMEM 1% BSA, and rocked for 1hr before plating on fibronectin coated 
(10 µg/ml) glass-bottom imaging dishes.  The cells were allowed to settle to the bottom 
of the dish for 10min at 4˚C before imaging as described below.   
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 The same conditions as described above were used to monitor migrating cells 
with the exception that the cells were allowed to adhere and spread for 3 hr at 37˚C 
before imaging.  For all experiments, the cells were maintained at 37˚C in serum- and 
growth factor-free media unless otherwise noted.    
4.2.3 FRET Imaging 
pmAKAR3 was imaged in SKOV-3 cells as previously described.  SKOV-3 cells 
expressing the PKA biosensor, pmAKAR3, were rinsed twice and maintained in HEPES-
buffered saline solution containing (in mM): 134 NaCl, 5.4 KCl, 1.0 MgSO4, 1.8 CaCl2, 
20 Hepes, and 5 D-glucose (pH 7.4) without serum, unless otherwise specified. Cells 
were imaged on a Nikon Eclipse TE-2000E inverted microscope with a 60×/1.4NA Plan 
Apo oil-immersion objective lens using the appropriate fluorophore-specific filters 
(Chroma Technology Corp, Rockingham, VT) and an Andor Clara charged coupled 
device camera (Andor Technologies, South Windsor, CT) controlled by Elements 
(Nikon) software. CFP, YFP and FRET images were acquired with 400-700 ms 
exposures and 2x2 binning for each acquisition at 60 sec intervals. Images in each 
channel were subjected to background subtraction, and ratios of yellow-to-cyan color 
were calculated using the BiosensorsFRET ImageJ plugin. Pseudocolor images were 
generated using a custom written ImageJ look-up table (LUT). 
4.2.4 Correlating edge velocity and PKA activity 
 Corrected FRET ratio time-lapse movies were fed to the Quantitative Imaging of 
Membrane Proteins (QuimP11) package (http://go.warwick.ac.uk /bretschneider/quimp) 
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software that analyzed edge dynamics and calculated edge velocity.  Additionally, the 
software generated 2 dimensional morphodynamic plots of edge velocities along the cell 
edge over time and computed autocorrelation coefficients of edge dynamics.  Once edge 
dynamics were analyzed, the corrected FRET ratio images were analyzed by QuimP11 to 
sample the FRET ratios within 10 µm from the cell edge.  The software generated 2 
dimensional heat-maps of PKA activity along the cell edge over time and calculated 
cross-correlation coefficients at different time-lags to determine when peak PKA activity 
events were occurring in relation to peak protrusion events.  QuimP11 was also used to 
display time coded depth stacks to depict cell movement over time in a single image. 
4.2.5 Focal adhesion analysis 
 Cells co-expressing pmAKAR3 and mCherry-Paxillin or mCherry-FAK were 
imaged to monitor both focal adhesions and PKA activity. Images were acquired at 60 
sec intervals.  Focal adhesion pixel intensities and lifetimes were calculated by manually 
thresholding adhesions and measuring pixel intensities, adhesion assembly and 
disassembly rates, and lifetimes of individual adhesions in time-lapse movies. Pearson’s 
correlation coefficients were generated using the Intensity Correlation Analysis ImageJ 
plugin, and average values are represented as mean ± S.E.M. 
4.2.6 Subcellular fractionation and western blotting 
 To isolate nuclear, cytoplasmic, and membrane fractions, cells were collected in 
ice-cold fractionation buffer (250 mM sucrose, 20 mM HEPES (pH 7.4), 10 mM KCl, 1.5 
mM MgCl2, 1mM EDTA, 1 mM EGTA, and 1 mM DTT). The cells were passed through 
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a 25-gague needle 10 times and incubated on ice for 20 min. The nuclear pellet was spun 
out at 3000 rpm for 5 min.  The supernatant containing the cytosolic and membrane 
fractions was saved. The nuclear pellet was washed in 500 µl fractionation buffer by 
resuspending the pellet and passing through a 25-gague needle 10 times. The washed 
nuclei were spun at 3000 rpm for 10 min and the pellet was resuspended in NP-40 lysis 
buffer, incubated for 10 min on ice, cleared by centrifugation (14,000 rpm for 10 min), 
and the supernatant was saved. The cytosolic and membrane fractions were spun at 8,000 
rpm to remove any nuclear carry-over and the supernatant was saved and spun at 40,000 
rpm for 1 hr in an ultracentrifuge. The supernatant was reserved as the cytoplasmic 
fraction, and the pellet was washed in 400 µl fractionation buffer and re-spun at 40,000 
rpm for 45 min. The supernatant was discarded and the pellet (membrane fraction) was 
resuspended in NP-40 lysis buffer.  
 Protein concentration was calculated using the BCA assay (Peirce) and equal 
amounts of protein were loaded onto a 7.5% gel and separated for 1 hr at 150 volts. The 
gel was transferred to a PVDF membrane for 1 hr at 100 volts. The membrane was 
blocked in 5% non-fat dry milk and incubated with anti TrpM7 (1:500) and anti-Lamin 
A/C (1:1000) antibodies overnight at 4˚C. Antibodies were detected using HRP-
conjugated species-specific secondary antibodies and ECL reagent (Peirce), and 
membranes were exposed to film. 
4.2.7 Immunofluorescence 
For visualization of, actin, paxillin, and phosphorylated PKA substrated (pPKA 
subst.), cells were fixed in 3.7% formaldehyde in TBS for 15 min, permeabilized for 5 
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min in TBS containing 0.25% triton X 100, blocked with TBS containing 3% BSA either 
for 1 hr at RT or overnight at 4°C then incubated with mouse anti-paxillin (1:500, BD 
Transduction) and rabbit anti-pPKA subst. (1:400, Cell Signaling) primary antibodies for 
1 h at RT. After washing 3 x 5min with TBS, cells were incubated with Alexa-647 
coupled donkey anti-mouse, Alexa-594 coupled donkey anti-rabbit secondary antibodies 
(1:400), and Alexa-488 conjugated phalloidin (1:100) for 1 hr at RT.  After washing 3x5 
min and rinsing in ddH2O, coverslips were mounted onto glass microscope slides (25) 
using a small volume of PermaFluor mountant (Thermo Scientific). Epifluorescence 
images were captured though 10, 20, 40, and 60X Plan Apo objectives on a Nikon 
Eclipse TE-2000E inverted microscope as described above.  
4.2.8 Pseudopod Preparation 
This technique was performed as previously described.  Briefly, starved cells 
were re-plated onto fibronectin-coated 3µm-pore polycarbonate membranes in Costar 
Transwell inserts for 2 hr.  EGF (40 ng/ml) was added to the bottom chamber as a 
chemoattractant for 45 min and where indicated, pharmacological agents were added to 
the bottom chambers for 20 min. To harvest pseudopods (Pd), inserts were washed in ice-
cold PBS, cell bodies (CBs) were removed from the upper surface, and the pseudopodia 
(Pd) on the underside were scraped into lysis buffer. Alternatively, Pd were removed, and 
CB on the upper surface were harvested. Lysates were cleared by centrifugation and 
protein content quantified by bicinchoninic acid (BCA) assay (26).  
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4.2.9 PKA Kinase assay 
CB and Pd preparations harvested in ice-cold homogenization buffer (50 mM β-
glycerophosphate (pH 7.4), 1.5 mM EGTA, 1 mM DTT) were sonicated on ice and 
clarified by centrifugation at 4˚C for 10 min.  Protein content was quantified by BCA 
assay (26) and 10 µg of lysate was used for each kinase reaction.  Kinase reactions were 
performed in 20 µl volumes in PKA kinase activity buffer containing a final 
concentration (in mM) of: 25 β-glycerophosphate pH 7.4, 1.25 EGTA, 10 MgCl2, 0.5 
DTT, and 0.1 ATP. 0.045 µg/ml of the GFP-tagged RRRRS (R4S) substrate was used to 
monitor PKA kinase activity in the presence and absence of 1.5 µg/ml of the 
pseudosubstrate region of the endogenous Protein Kinase A inhibitor (PKI).  Reactions 
were mixed and incubated for 30 min at RT before being stopped by the addition of 
laemmli sample buffer.  The samples were then boiled for 10 min and separated by SDS-
PAGE.  Kinase activity was monitored by detecting the phosphorylation of the R4S 
peptide (~28kD) using an antibody against phosphorylated PKA substrates. 
4.2.10 Preparation of polyacrylamide gels and surface conjugation of microspheres.  
25 mm glass coverslips were briefly flamed and incubated with 0.1N NaOH for 
15 min.  25 µl (3-aminopropyl)-trimethoxysilane (APTMS) was smeared on the 
coverslips and incubated for 3 min at RT and the coverslips were washed 3x5 min in 
ddH2O and dried via aspiration.  Once dried, the coverslips were incubated with 500µl 
0.5% glutaraldehyde 30 min.  The glutaraldehyde was removed and a 25 µl drop of a 
0.5/0.05% acrylamide/bis-acrylamide solution with APS and TEMED was added to the 
activated coverslip.  The drop was covered in a RainX (ITW Global brands, Houston, 
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TX) treated 22 mm coverslip and allowed to polymerize for 7 min.  Once polymerized, 
the RainX treated coverslip was removed and the hydrogel was washed 3x5 min in PBS.  
The gel surface was derivitized with the heterobifunctional cross-linker Sulfo-SANPAH 
as previously described, and 0.2 µm red-fluorescent (Ex/Em) carboxy-modified latex 
microspheres were conjugated to the gel surface by incubating a sonicated suspension of 
the beads (1:200 in 50 mM HEPES pH 8.5) on the gels for 30 min. The gels were rinsed 
3x5 min with 50 mM HEPES pH8.5 to remove all nonattached beads and incubated with 
20 µg/ml fibronectin (diluted in 50 mM HEPES pH 8.5) at 37˚C for 45 min. The gels 
were post-fixed with 0.5% glutaraldehyde for 1 hr at RT and quenched in NaBH4 before 
plating cells in complete media.  
4.2.11 Traction Microscopy 
 
Cells adhered to the hydrogels overnight in complete media and were washed 
twice and maintained in HEPES-buffered saline as described above.  Coverslips were 
mounted in imaging chambers and fluorescent beads images were captured though a 20x 
Plan Apo objective on a Nikon Eclipse TE-2000E inverted microscope as described 
above.  Bead images were acquired before and after clearing cells by the addition of 
Trypsin/EDTA (0.5%).  Cell outlines were generated by either using the YFP image from 
cells expressing pmAKAR3 or a transmitted light image, in cases where cells were not 
transfected.  A mechanical stage allowed for multi-cell analysis for each experiment. 
Bead images were registered to correct for stage drift and image pairs were used to 
generate bead-displacement fields using the particle image velocemetry (PIV) ImageJ 
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plugin.  Traction fields were computed using constrained FTTC (ImageJ) based on the 
calculated bead displacement and Young’s moduli of the gel substrate. The mean traction 
force within the cell was used to generate average cellular traction. 
4.2.12 TFM/FRET correlation analysis 
  To correlate cellular traction forces and PKA activity, both readings were 
captured simultaneously and analyzed independently.  Once heat maps of both PKA 
activity and traction forces were generated, standard image correlation analysis was 
performed.  This analysis was made possible because the two signals are rendered as 8-
bit gray-scale images and higher pixel intensity corresponds with either higher PKA 
activity or higher traction forces.  Lookup tables are assigned to the images after analysis 
for ease of interpreting biosensor and TFM data. Mander’s correlation coefficients and 
intensity correlation quotients were generated using the Intensity Correlation Analysis 
ImageJ plugin, and average values are represented as mean ± S.E.M. Intensity correlation 
quotient (ICQ) analysis has been described in detail elsewhere. In brief, ICQ is defined as 
the ratio of positive (Ai-a)(Bi-b) products divided by the overall products subtracted by 
0.5, where a and b are the means of each signal intensity and Ai and Bi are the intensity 
of each individual pixel. As a consequence, the ICQ varies from 0.5 (co-localisation) to -
0.5 (exclusion) while random staining and images impeded by noise will give a value 
close to zero. Generally, ICQ values from -0.05-+0.05 indicate random non-covariance 
between two signals, 0.05-0.1 indicate weak covariance, and >0.1 indicate strong 
covariance.  
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4.2.13 Durotaxis assays and cell stretching 
 To impart mechanical tension on single cells, cells were seeded on 
polyacrylamide hydrogels and allowed to adhere overnight.  A glass pipette was lowered 
50µm from the cell periphery and was held above the surface of the gel until tension was 
to be applied to the cell.  The pipette was lowered to engage the gel and the stage was 
moved 20µm using a mechanical stage.  This technique was used to ensure that similar 
levels of stress were imparted to cells between different experiments.   
4.2.14 Whole-cell configuration patch-clamp recording of TrpM7 currents 
 TrpM7 currents were measured as previously described (27). Briefly, patch-clamp 
experiments were performed in the conventional whole-cell configuration using an 
Axopatch 200B amplifier. During experiments, cells were bathed in a solution containing 
in mM: 140 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 10 Glucose, pH 7.4. Patch 
pipettes were filled with solutions either free of Mg2+ (in mM: 140 Cs-glutamate, 8 NaCl, 
10EGTA, 10 HEPES ph 7.2) or containing 1 mM Mg2+ (in mM; 140 Cs-glutamate, 8 
NaCl, 10 EGTA, 1.5 MgSO4, 10 HEPES, pH 7.2). Once filled with the pipette solution, 
patch pipettes had resistances between 2-4 MΩ.  Whole-cell currents were recorded 
during 500 ms voltage ramps between -100 to + 100 mV delivered every 30 sec from a 
holding potential of 0 mV. Currents were normalized to membrane capacitance (pA/pF).  
Electrophysiological signals were low-pass filtered at 1kHz and digitized at 10 kHZ. 
Voltage offsets of +17.2 mV and +16.9 mV (for Mg2+ free and Mg2+-containing solutions, 
respectively), resulting from the liquid junction potential of the solutions, were corrected 
prior to experiments using the amplifier circuitry. All patch-clamp experiments were 
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performed at room temperature and currents were analyzed using Clampex software 
(Axon Instruments). 
4.2.15 Calcium imaging  
Cells were either loaded with the cell-permeable calcium indicator, Fluo4 (5 µM 
for 5 min and 37˚C), immediately before imaging, or transfected with a genetically 
encoded calcium sensor 48hr prior to imaging. Cells were rinsed twice in HEPES-
buffered saline solution containing (in mM): 134 NaCl, 5.4 KCl, 1.0 MgSO4, 1.8 CaCl2, 
20 Hepes, and 5 D-glucose (pH 7.4) and re-fed with HEPES-buffered saline solution for 
imaging. Images were acquired every second for 30 min.  To quantify local changes in 
calcium concentrations, the change in Fluo4 calcium indicator intensity was summed 
from at least 60 images. Linescan analysis of the change in calcium concentration across 
the leading edge was used to show the spatial distribution of calcium transients.      
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4.3 Results 
4.3.1 Leading edge PKA activity is regulated by AC and PDE activity. 
 Canonical PKA activation occurs though the activation of a heterotrimeric G-
protein coupled receptor (GPCR) that is linked to Gαs. Active Gαs binds and activates 
adenylyl cyclase (AC) which converts ATP into cAMP and elevation of intracellular 
cAMP activates PKA. To test if the canonical activation of PKA was required for leading 
edge PKA activity, cells expressing pmAKAR3 were treated with either inhibitors or 
activators of the PKA regulation machinery.  Leading edge PKA activity was quantified 
by measuring the size and frequency of leading edge PKA activity events before and after 
pharmacological manipulation. Maximal activation of PKA, through cAMP elevation, 
was accomplished by treating the cells with 100 µM 3-isobutyl-1-methylxanthine 
(IBMX) and 50 µM forskolin (Fsk) and resulted in an increase in both the size and 
frequency of leading edge PKA activity events (Fig. 1 A). To assess the individual 
contributions of either AC or PDE activity, cells expressing pmAKAR3 were treated with 
either an activator of AC activity or broad-spectrum PDE inhibitor (IBMX). Interestingly, 
activation of AC activity with 50 µM Fsk increased leading edge PKA activity event 
frequency without changing the size of the events (Fig. 1 B). Conversely, inhibition of 
PDE activity significantly increased the size, but not frequency, of leading edge PKA 
activity events (Fig. 1 C). Furthermore, inhibition of AC activity with 2’,5’-
Dideoxyadenosine (DDA) significantly decreased both the frequency and size of leading 
edge PKA activity events (Fig. 1 D) and inhibition of PDE 4, but not PDE3, significantly 
reduced the size of PKA activity events while having no effect on their frequency (Fig. 1 
	   151	  
E and F). These results suggest that leading edge PKA activity events require cAMP and 
that AC activity is required to initiate leading edge PKA activity events while PDE 
activity regulates their dynamics and geometries. To test the role of G-protein signaling 
on leading edge PKA activity, cells co-expressing pmAKAR3 and either a genetically-
encoded minigene inhibitor (28) of Gαs activity (mCh- Gαs) or its scrambled control 
(mCh- GαR) were assayed for leading edge PKA activity.  Expression of the active 
inhibitor (mCh- Gαs) significantly reduced the size of leading edge PKA activity events 
compared to the scrambled control.  Importantly, control experiments showed that cells 
expressing the Gαs inhibitor were unable to respond to isoproterenol challenges 
demonstrating the efficiency of this reagent to inhibit signaling through Gαs.   
4.3.2 Peripheral PKA activity is high during cell migration but not cell spreading. 
 Previous work has demonstrated the requirement for integrin engagement and 
activity on leading edge PKA activity. One of these studies, in particular, utilized Chinese 
hamster ovary (CHO) cells (that do not natively express α4 integrins) stably expressing 
the α4 integrin subunit cultured on the CS1 fragment of fibronectin which lacks the RGD 
sequence and specifically engages α4 integrin. Additionally, they also cultured CHO cells 
(lacking α4β1 intergrins) on purified fibronectin to specifically engage α5β1 integrins.  
This study showed that the engagement of either α4 or α5 integrins was required for 
increased leading edge PKA activity and that inhibition of integrin engagement with 
blocking antibodies significantly reduced both cell motility and leading edge PKA 
activity. Other previous work showed that the leading edge-specific phosphorylation of 
α4 integrins by PKA was crucial for cell migration, and emphasizes the cross-talk 
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between leading edge PKA activity and integrin activity. Additional reports, including 
data from our lab, show that accumulation of PKA activity and subunits to the leading 
edge of migrating cells occurs through the directed spatial distribution of PKA to the 
leading edge through AKAPs, specifically through AKAP-Lbc. Though these reports 
provide strong evidence demonstrating the requirement for integrin engagement and 
activation for leading edge PKA activity, the discrete molecular mechanism coupling 
integrin engagement to PKA activity has not been elucidated. To test the regulation of 
integrin-mediated PKA activity, we examined the distribution of PKA activity during cell 
spreading and cell migration. Cell spreading was used as a model of general membrane 
protrusion as previous reports have shown strong similarities between the mechanisms 
governing cell spreading and lamellar protrusion.  Additionally, we used cell spreading to 
increase surface area percentage of the cell that is protruding because as cells spread, the 
entire cell periphery is expanding allowing for analysis of a much larger protrusion area 
than those observed during migration.  We routinely observed an increase in leading edge 
PKA activity during cell migration (Fig. 2 A). Interestingly, above the back-to-front 
gradient in PKA activity, we also routinely observed highly dynamic, localized peaks in 
PKA activity. Surprisingly, during cell spreading, we did not observe peripheral PKA 
activity and there was no substantial centroid-to-peripheral gradient in PKA activity (Fig. 
2 B). We measured the centroid-to-front/periphery increase in PKA activity by analyzing 
linescans of FRET intensity from the centroid to either the front or periphery of migrating 
or spreading cells, respectively (Fig. 2 C). Leading edge PKA activity indices were 
generated by averaging the FRET intensity within the front 10µm of migrating cells (or 
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the outer 10µm of spreading cells) and dividing it by the average FRET intensity within 
10µm of the cell periphery. Using this method, we can compare data from numerous 
different cells over numerous experiments (Fig. 2 D). To ensure that the differences in 
PKA activity seen between cell migrating and cell spreading was not due to differences in 
edge dynamics, spreading and migrating cells were analyzed using edge detection and 
analysis software.  The software allows for the detection of cell edge dynamics and can 
be used to determine the rate of protrusion/retraction cycles at the cell edge (Fig. 3). 
Importantly, there was no discernable difference in edge dynamics between migrating 
and spreading cells (Fig. 2 E). Edge retractions (Fig. 2 E, black arrow) occurred ~120 sec 
after maximal protrusions (Fig. 2 E, green arrow). To corroborate these data, SKOV-3 
cells were plated on fibronectin coated glass coverslips for either 10 min or 4 hr (to 
analyze spreading or migrating cells, respectively), fixed, and processed for 
immunofluorescence microscopy.  Cells were stained using either an antibody against the 
consensus PKA phosphorylation site (pPKA subst, RXXS/T) or the focal adhesion 
protein paxillin (Pxn, Fig 2 F). There was a substantial increase in the fluorescent 
intensity of pPKA substrate staining at the cell periphery in migrating cells that was 
absent in spreading cells. These results demonstrate that there are instances when 
integrins are engaged and the cell is protruding, but there is very little PKA activity. 
These data are the first to show that there might be molecular distance between integrins 
and PKA activity, and emphasize the necessity to further investigate the connection 
between integrin-associated adhesions and PKA activity during cell migration. One 
hypothesis that results from these data is that PKA activity is only elicited when 
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adhesions mature. During cell spreading, nascent focal contacts are rapidly turned over as 
the cell continuously expands.  These focal contacts do not form into mature adhesions as 
they do during cell migration (Fig 2 F, top panel), and could explain the differences in the 
patterns of PKA activity.  
4.3.3 Leading edge PKA activity does not correlate with leading edge focal adhesion 
dynamics.  
To directly assess the connection of integrin-associated events downstream of 
nascent focal contacts with PKA activity, migrating cells displaying full focal adhesion 
lifetimes (assembly, peak, and disassembly) were assayed for both PKA activity and 
focal adhesion dynamics.  To do this, PKA activity was monitored using live-cell 
microscopy of pmAKAR3 and focal adhesion dynamics were measured by co-expressing 
mCherry-Paxillin in cells migrating on fibronectin (Fig. 4 A).  The back-to-front gradient 
in PKA activity persisted in the presence of overexpressing paxillin, and moderate levels 
of pmAKAR3 expression did not affect normal focal adhesion dynamics (Fig 4 A, insets). 
Paxillin was used as a marker of focal adhesions because it recruits to focal adhesions 
early in the maturation process and remains through the entirety of the adhesion lifetime 
(5). To quantify the spatiotemporal correlation between focal adhesion dynamics and 
PKA activity, leading edge focal adhesions were tracked over time and an interrogation 
region of interest (ROI) that was 50% larger than the area of the adhesion was used to 
track pmAKAR3 FRET ratios under the same cellular regions (Fig. 4 B). Paxillin 
displayed full adhesion lifecycles including assembly, peak, and disassembly phases (Fig. 
4 C, red line) while PKA activity showed little, if any, variation in the same regions. 
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Additionally, interrogation ROIs were placed around areas of dynamic leading edge PKA 
activity events and mCherry-paxillin intensities were monitored under the same ROIs 
(Fig. 4 D). Interestingly, there was no apparent co-variation between the intensity of 
mCherry-paxillin and peak PKA activity events (Fig. 4 E). To ensure that an increase in 
focal adhesion intensity correlated with the recruitment of signaling events known to be 
regulated by focal adhesion dynamics, cells were co-transfected with mCherry-paxillin 
and YFP-dSH2 ((29) yellow fluorescent protein fused to two tandem SH2 domains that 
bind phospho-tyrosine, Fig. 4 F).  We saw strong co-variations of paxillin intensity and 
the intensity of YFP-dSH2 during the assembly, peak, and disassembly of focal adhesions 
(Fig. 4 D). Quantification of Pearson’s correlation coefficients showed a strong positive 
correlation between mCherry-paxillin and YFP-dSH2 but there was a lack of correlation 
between pmAKAR3 FRET ratios and mCherry-paxillin (Fig. 4 E). These results 
demonstrate leading edge PKA dynamics and the onset, maturation, or dissolution of 
focal adhesions, and thus direct adhesion-mediated signaling, are not spatiotemporally 
correlated in migrating cells.  There is, however, still a requirement for integrin 
engagement such that integrins are necessary but are not sufficient for activating leading 
edge PKA.  As these results were contrary to our hypothesis that direct signaling events 
from adhesions regulate leading edge PKA activity, we sought alternative explanations 
for how leading edge PKA is regulated during cell migration. We considered some of the 
known differences between cell spreading and cell migration, which showed the most 
disparate patterns in peripheral/leading edge PKA activity.  One such difference is the 
requirement for actomyosin-dependent cellular contractility during cell migration that is 
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absent in cell spreading (30-32). Not only does actomyosin contractility occur 
downstream of initial integrin engagement, myosin isoforms are relegated to specific 
subcellular regions and traction forces have been shown to be spatially distributed 
throughout migrating cells (33,34).  Additionally, previous studies have described 
mechanisms of mechanical regulation of cAMP/PKA (23,35). Thus, we hypothesized that 
actomyosin-mediated cellular contractile forces regulate leading edge PKA activity.  
4.3.3 Spatial distribution of cellular traction forces and PKA activity during cell 
migration 
 To determine the spatiotemporal correlation between cellular traction force 
generation and PKA activity, cells expressing pmAKAR3 were analyzed by simultaneous 
FRET and traction force microscopy in the absence and presence of the myosin-II 
ATPase inhibitor, blebbistatin (Fig. 5). The reported cytotoxic effects of short wavelength 
light-induced blebbistatin break-down products were not a significant issue in these 
experiments as there was only one image taken after exposure to blebbistatin, and the 
image of the beads (red-shifted) was acquired before CFP/YFP acquisition. The 
movement of red-fluorescent 0.2µm spheres covalently linked to the surface of 
deformable polyacrylamide hydrogels was calculated using Particle Image Velocemetry 
(PIV, Fig. 5 A, left) and the stiffness of the polyacrylamide hydrogels (25 kPa) was used 
to calculate traction forces using Fourier Transform Traction Cytometry (FTTC, Fig. 5 A, 
middle; (36,37).  Migrating cells exhibited high traction forces at sites of protrusion 
under control conditions and these traction forces were significantly inhibited in the 
presence of blebbistatin (Fig. 5 A). Interestingly, PKA activity was localized to discrete 
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subcellular locations that appeared to overlap with regions of high traction forces and 
both PKA activity and traction forces were attenuated when the cells were treated with 
blebbistatin (Fig. 5 A and Fig. 6).  Importantly, during cell spreading, peak traction forces 
are significantly reduced compared to peak traction forces during migration (Fig. 6). To 
quantify the degree of overlap between PKA activity and traction forces, linescan 
analysis from the cell centroid to the cell periphery was performed (Fig. 5 B).  Under 
control conditions there was a front-to-back gradient in PKA activity, with the highest 
FRET ratio occurring within 10 µm of the leading edge, which was accompanied by a 
front-to-back gradient of traction forces (Fig. 5 B).  TFM and FRET images were subject 
to intensity correlation analysis to determine the degree with which the images mirror 
changes in traction forces and PKA activity.  Under control conditions, there was a high 
degree of overlap between TFM and FRET images that was ablated in the presence of 
blebbistatin (Fig. 5, B-D). To further characterize the degree to which PKA activity and 
traction forces vary together, an intensity correlation quotient (ICQ) was generated 
(38,39). The ICQ provides a single value indicating the covariance of two signals that can 
be used for statistical comparison. Mean ICQ values of -0.05 to +0.05 indicate random 
distribution of the two signals, +0.05 to +0.1 indicate moderate covariance, and ICQ > 
0.1 indicates strong covariance (Fig. 5 E). Under control conditions, the mean ICQ for 
traction forces and PKA activity was 0.22 ± 0.022 and was significantly reduced to 0.032 
± 0.021 when the cells were treated with 25 µM blebbistatin (Fig. 5 F). These data 
indicate that PKA activity and traction forces are coupled in space and that inhibition of 
actomyosin contractility significantly inhibits leading edge PKA activity, traction forces, 
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and the covariance of PKA activity with traction forces. These data suggest that the 
mechanism regulating leading edge PKA activity involves actomyosin contractility and 
cellular force generation that occurs downstream of initial adhesion-mediated signaling 
events.  
4.3.4 Leading edge PKA activity is regulated by cellular tension. 
 Because actomyosin contractility was required for peripheral PKA activity during 
traction force measurements and leading edge PKA activity is required for cell migration, 
we sought to determine the regulation of leading edge PKA activity by actomyosin 
contractility during cell migration. To directly test the role for actomyosin contractility on 
leading edge PKA activity, migrating cells expressing pmAKAR3 were monitored by 
time-lapse microscopy in the absence and presence of 25 µM blebbistatin, 20 µM ML-7, 
and 10 µM Y-27632 to inhibit myosin-II-ATPase activity, myosin light-chain kinase 
activity, and Rho-associated protein kinase activity, respectively (Fig. 7 A and B). These 
pharmacological manipulations all converge on inhibiting actomyosin contractility and 
strongly suggest that any effects seen are due to inhibition of cellular contraction and not 
a single molecular pathway. Quantification of leading edge PKA activity indices showed 
that inhibition of actomyosin contractility significantly decreased leading edge PKA 
activity (Fig. 7 B). Moreover, there was a time-dependent decrease in leading edge PKA 
activity that was calculated by averaging PKA activity within 10 µm of the leading edge 
for 10 min before and 10 min after blebbistatin treatment (Fig. 7 B, inset). To quantify 
the effect of blebbistatin on edge dynamics and PKA activity, morphodynamic maps of 
protrusion and retraction velocities at the leading edge along with PKA activity within 10 
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µm of the cell edge were generated using QuimP11 morphometric analysis software (Fig. 
7 C).  Notably, there was a rapid decrease in edge dynamics upon treatment with 
blebbistatin (Fig. 7 C, top) and there was a rapid and steady decrease in leading edge 
PKA activity (Fig. 7 C, bottom). 
 To ensure that the effect of blebbistatin on inhibiting PKA activity was not due to 
cytotoxicity or a loss in cell adhesion integrity, mCherry-paxillin and PKA activity were 
monitored in blebbistatin-treated cells (Fig. 7 D). Notably, focal adhesions remained 
intact up to 15 min after blebbistatin treatment where PKA activity precipitously 
decreased over the same time (Fig. 7 D).  To quantify loss of PKA activity and focal 
adhesions after treatment with blebbistatin, individual adhesion intensities and leading 
edge PKA regions of interest were measured after blebbistatin treatment.  The average 
rate (slope of the best-fit line) at which the FRET ratio decayed was significantly higher 
than the rate of the loss of mCherry paxillin (Fig. 7 D, blue and red lines, respectively).  
Each slope was near zero before blebbistatin treatment indicating that the effects seen 
were not artifacts due to photobleaching. To corroborate these data, cells were plated on 
fibronectin coated coverslips, allowed to adhere, spread and migrate for 4 hr, and were 
subsequently treated with DMSO as a vehicle control or 25 µM blebbistatin for 20 min 
before being processed for immunofluorescence microscopy (Fig. 7 E).  Linescan 
analysis of the leading edge of DMSO-treated cells revealed similar results to those seen 
in Fig. 2 where pPKA substrate immunostaining was increased at the cell periphery (Fig. 
7 F, black line), however, there was an abolition of this pattern in the presence of 25 µM 
blebbistatin (Fig. 7 F, red line).  To ensure that changes in peripheral pPKA staining were 
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not due to overall decreases in protein content at the cell periphery in the presence of 
blebbistatin, the pPKA signal was normalized to the amount of actin in the same 
linescans.  Similar results were observed in cells treated with other inhibitors of 
actomyosin contractility with unique molecular targets (i.e Y2637 to inhibit ROCK, and 
ML-7 to inhibit MLCK) suggesting that leading edge PKA activity is regulated by 
actomyosin contractility and not just a single molecular pathway (data not shown). These 
data demonstrate, for the first time, that actomyosin contractility is required for leading 
edge PKA activity during cell migration.   
4.3.5 Localized increase in cellular tension induces PKA activation in an actomyosin 
dependent manner. 
In an effort to more closely examine the relationship between actomyosin 
contractility and PKA activity, we sought to test the hypothesis that dynamic increases in 
cellular tension increase PKA activity. If PKA activity is inhibited by the global 
inhibition of actomyosin contractility, then increases in cellular tension/actomyosin 
contractility should elicit increases in PKA activity.  We have recently shown that 
increases in the mechanical properties of the cellular microenvironment induce the 
activation of myosinII and elicit migration in the direction of increased ECM tension in 
SKOV-3 cells. To monitor PKA activity in response to changes in ECM stiffness, cells 
expressing pmAKAR3 were plated on fibronectin-coated deformable 25 kPa 
polyacrylamide hydrogels and stretched with a microneedle to elicit local increases in 
cellular tension (Fig. 8 A and B). Cells were sectioned into quartiles (Fig. 8 B, yellow 
dotted lines) and changes in PKA activity were monitored in each quartile (Fig. 8 C, 
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colors correspond to quartiles). Upon acute mechanical stretch, there was a rapid and 
robust increase in PKA activity in the direction of stretch (Fig. 8 C, red bar), and stretch-
induced activation of PKA was inhibited when the cells were pretreated with 25 µM 
blebbistatin for 10 min (Fig. 8 D).  These results show that direct mechanical stimulation 
can activate PKA activity and that actomyosin contractility is required to translate the 
mechanical stimulus into a biochemical (i.e. activation of PKA) response.  If PKA 
activity requires actomyosin-mediated cell contractility, then there must be a 
mechanoreceptor that senses the stiffness of the ECM and transfers that rigidity sensing 
to the cell contractile machinery. One such mechanoreceptor that has recently been 
implicated in cell migration is the stretch activated Ca2+ channel, transient receptor 
potential melastatin 7 (TrpM7).   
4.3.6 TrpM7-mediated calcium flickers are present at the leading edge of migrating 
cells. 
To test whether Ca2+ currents through TrpM7 are involved in regulating leading edge 
PKA activity, we first confirmed that TrpM7-mediated Ca2+ currents could be detected in 
our hands in a system in which the dynamics of leading edge Ca2+ signals has been 
extensively described. WI-38 human lung fibroblasts were patch-clamped and whole-cell 
currents were acquired using a ramp protocol where 20 consecutive sweeps of -100 to 
+100 mV ramps were performed 30 sec apart. TrpM7 displays a unique ‘run-up’ outward 
rectification current over time (Fig. 9 A, gray lines) that eventually reaches a peak. As 
TrpM7 is permeable to both Ca2+ and Mg2+ inhibition of Ca2+ currents can be ablated in 
the presence of high Mg2+. Indeed, there was a loss of ‘run-up’ currents (Fig. 9 A, red-to-
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yellow lines) and an inhibition of maximal outward rectification (Fig. 9 B) in the 
presence of 1 mM Mg2+ in the patch pipette. Current density (pA/pF) was used to 
compare electrophysiological data between cells to account for variations in cell size. The 
presence of TrpM7 was confirmed by immunofluorescence microscopy where TrpM7 
was localized to the leading edge membrane of migrating cells (Fig. 9 C and D). TrpM7 
protein was detected (Fig. 10 A) and whole-cell TrpM7 patch-clamp experiments were 
repeated in SKOV3 cells (Fig. 10 B and C) where similar channel properties were 
observed, demonstrating that both SKOV3 and WI-38 cells express functional TrpM7 
channels. To test whether Ca2+ flickers through TrpM7 were localized to the leading edge 
of migrating cells as previously reported, WI-38 cells were loaded with the Ca2+ indicator 
Fluo4-AM and changes in Ca2+ were summed over time (Fig. 9 E). Leading edge Ca2+ 
events were readily detected in control transfected cells and cells expressing Wild-type 
TrpM7 (WT-TrpM7, Fig. 9 E) and, as shown in Fig. 11, mimicked the amplitude and 
kinetics of the aforementioned Ca2+ flickers (Fig. 11) Importantly, expression of a 
dominant negative TrpM7 (dn-TrpM7) that contains mutations in the channel pore that 
render it unable to conduct Ca2+ showed few, if any, leading edge Ca2+ flickers (Fig. 9 E 
and F). We routinely detected whole-cell Ca2+ oscillations and Ca2+ events that were 
unaffected by dn-Trp expression and not localized to the leading edge. Though 
interesting, we currently have no explanation for the source or physiological effect of 
these dn-TrpM7 insensitive Ca2+ oscillations.  
4.3.7 TrpM7-meadited Ca2+ flickers regulate traction force generation, leading edge 
PKA activity, and stretch activation of PKA. 
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Since TrpM7 is localized to the leading edge (Fig. 9 C and D) and is known to 
regulate actomyosin contractility, and since actomyosin contractility regulates leading 
edge PKA activity (Fig. 7), we sought to determine if TrpM7-mediated Ca2+ flickers 
regulate actomyosin-dependent leading edge PKA activity. To test whether Ca2+ influx 
through TrpM7 was required for traction force generation, TFM was performed on cells 
expressing WT- or dn-TrpM7. Traction forces required extracellular Ca2+ influx as 
chelation of extracellular Ca2+ with EGTA significantly inhibited maximal traction force 
generation (Fig. 12 A). Additionally, cells either expressing dn-TrpM7 or treated with 
blebbistatin displayed significantly lower maximal traction forces than either control cells 
or cells expressing WT-TrpM7 (Fig. 12 A). WI-38 cells display a back-to-front increase 
in PKA activity (Fig. 12 B, top) with the highest activity occurring within 10 µm of the 
cell edge (Fig. 12 C, black line). Importantly, this gradient was also dependent on 
actomyosin contractility (Fig. 13). Leading edge PKA activity required TrpM7 channel 
activity as cells expressing dn-TrpM7 (Fig. 12 B, bottom) did not exhibit a back-to-front 
increase in PKA activity (Fig. 11 C, blue line). Quantification of numerous cells revealed 
that the leading edge PKA activity index in cells expressing dn-TrpM7 was significantly 
lower than either non-transfected cells or cells expressing WT-TrpM7. Since stretch-
activation of PKA requires actomyosin contractility (Fig.8) and TrpM7 regulates 
intracellular contractility (Fig. 12 A), then TrpM7-mediated Ca2+ entry should be 
required for stretch-activation of PKA. To test this, cells expressing pmAKAR3 were co-
transfected with either WT-TrpM7 or dn-TrpM7, plated on flexible hydrogels, and 
stretched with a glass microneedle as in Fig. 8. Quantification of the change in FRET 
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ratios in the direction of stretch was done as in Fig. 8 and inhibition of TrpM7 channel 
activity significantly inhibited stretch-activation of PKA (Fig. 12 E and F). These results 
suggest that TrpM7 is a primary receiver of mechanical stimuli and TrpM7 activity is 
required for sensing localized increases in ECM stiffness by activating actomyosin 
contractility and, ultimately, PKA. 
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4.4 Discussion 
Taken together, these data demonstrated a role for actomyosin-mediated 
regulation of leading edge PKA activity and are the first to implicate PKA in a 
mechanosensitive pathway during cell migration.  Moreover, our data demonstrate the 
necessity but insufficiency for integrin engagement to directly regulate leading edge PKA 
activity.  It is important to note that changes in any one of the experimental conditions 
(i.e. cell-type or ECM ligand) might elicit differences in the precise molecular 
mechanism governing leading edge PKA activity, and these differences remain to be 
tested. These considerations notwithstanding, we reveal mechanistic insight into integrin-
mediated leading edge PKA activity and demonstrate a connection between actomyosin 
contractility and leading edge PKA.  
The current work establishes the connection between leading edge PKA activity 
and actomyosin contractility, but the discrete molecular targets of increased cellular 
tension that lead to localized PKA activity remain to be tested. It is possible, though 
unlikely, that PKA is activated by direct mechanical stimulation that pulls the regulatory 
subunits away from the catalytic subunits, and thus activates the kinase in a cAMP-
independent manner.  A more likely hypothesis is that canonical regulators of the 
cAMP/PKA pathway (G-protein coupled receptors, adenylyl cyclases, or 
phosphodiesterares) are mechanically regulated.  Indeed, there are reports of stretch-
sensitive GPCRs that can activate Gs, and experiments utilizing fibronectin-coated 
magnetic beads demonstrated that magnetic twist of these integrin-engaged beads lead to 
activation of PKA through stimulation of Gs (40,41).  Though the vast majority of 
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stretch-sensitive GPCRs activate Gq and would require a circuitous route leading to PKA 
activation (42) the mechanoregulation of leading edge GPCRs remains an intriguing area 
of investigation.   
Another possibility is that Ca2+ entry through TrpM7 could lead to localized Ca2+ 
transients that influence the PKA activation machinery. There is, indeed, precedence for 
the cross-talk between Ca2+ signals and PKA during cell migration (43), and Ca2+ 
currents have been shown to precede increases in traction forces in migrating fish 
karatocytes (44,45). Importantly, Ca2+ can activate several AC isoforms through Ca2+-
calmodulin and other AC isoforms are inhibited by Ca2+ (46). Interestingly, Ca2+ entry 
through Orai1-STIM1 has been shown to regulate AC8 activity and Orai1 has recently 
been shown to bind directly to AC8 and confer specificity between localized Ca2+ signals 
and increases in cAMP (47,48). Moreover, a recent report by Tsai et. al. showed that 
store-operated Ca2+ entry (SOCE) via STIM1 and Oria1 was localized to the leading edge 
of leader cells during endothelial sheet migration in response to growth factor stimulation 
(49).  Though there are reports that elegantly demonstrate that Ca2+ oscillations also 
regulate the PKA activation machinery, the co-regulation of Ca2+ and PKA activity 
during cell migration has only just begun to be investigated. Importantly, the storied 
cross-talk between Ca2+ and cAMP can be mediated by AKAPs (28) and AKAPs are 
necessary for maintaining leading edge PKA activity gradients (1,3) These findings 
provide an enticing explanation for the requirement of both localized Ca2+ signals and 
PKA-AKAP interactions at the leading edge of migrating cells.   
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TrpM7 has recently been shown to regulate actomyosin contractility and cell 
adhesion, and its role in cell migration has been elegantly described as the Ca2+ channel 
responsible for generating leading edge Ca2+ ‘flickers’ that determine migratory 
directionality. Though significant strides have been made concerning the role for TrpM7 
in regulating cellular contractility and Ca2+ events during migration, an examination of 
the role of TrpM7-mediated Ca2+ entry on traction forces and PKA activity has remained 
untested until present.  
In addition to conducting electrochemical stimuli and transducing mechanical 
forces, TrpM7 contains a carboxy-terminal α-kinase domain that regulates actomyosin 
contractility (50). Here, we show that inhibition of TrpM7 channel function, and not 
kinase activity, regulates cellular force generation, which suggests that TrpM7 channel-
enzyme function and regulation might be different during various cellular processes. 
These unique properties in conjunction with the requirement for localized Ca2+ signals 
and actomyosin contractility during cell migration emphasize the importance in 
understanding the regulation of TrpM7 during cell motility. In addition to its recently 
discovered role in regulating cell migration (51), TrpM7 has recently been implicated in 
the initiation of Ca2+ sparks, regulation of actomyosin contractility, and the formation of 
invadosomes in neuroblastoma cells (52). We have recently demonstrated that PKA 
activity is localized to the leading edge of invading epithelial ovarian cancer cells (3) and 
that these cells are exquisitely sensitive to changes in the mechanical properties of the 
ECM (submitted manuscript). Thus, TrpM7-mediated Ca2+ events might play a similar 
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role to that described here in regulating leading edge PKA activity and rigidity sensing 
during cancer cell invasion.  
Lastly, integrin activation has long been known to elicit increases in Ca2+, and 
activation of PKA downstream of adhesions is known to increase the activity of Ca2+ 
channels including the ryanodine receptor and voltage-dependent Ca2+ channels (53-55). 
Though these studies have focused on PKA’s regulation of Ca2+ in excitable cells (i.e. 
neurons and muscle cells), the presence of numerous spatially distinct Ca2+ events in 
migrating epithelial cells and fibroblasts suggests that localized Ca2+ events in addition to 
TrpM7 and SOCE can regulate, through PKA dependent or independent mechanisms, 
several facets of migration and justifies the continued efforts in eliciting the source and 
function of distinct Ca2+ event during the migration of traditionally non-excitable cells.  
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Figure 1. Leading edge PKA activity requires AC and PDE activity. SKOV3 cells 
expressing pmAKAR3 were treated with the indicated compounds (A, 100 µM IBMX 
and 50 µM Fsk; B, 50 µM Fsk; C, 100 µM IBMX; D, 100 nM DDA; E, 25 µM Rolipram; 
F, 10 µM Milrinone) and representative images of the leading edge before and after 
treatment are shown. Leading edge PKA activity event size and frequency were 
quantified and are shown adjacent to the corresponding representative images. 	  











Figure 2. Peripheral PKA activity is high during cell migration, but not during cell 
spreading.  SKOV-3 cells expressing pmAKAR3 were imaged via FRET microscopy 
and representative pseudocolored FRET/CFP images of migrating (A) and spreading (B) 
are shown and areas of protrusion are magnified in the insets. (C) Linescan analysis of 
the change centroid-to-front FRET ratio was performed on migrating (red) and spreading 
(blue) cells. Leading edge PKA activity indices were generated for migrating (n=16) and 
spreading (n=10) cells. (E) Edge velocity was calculated using QuimP11 and spline fits 
representing the average auto-correlation of protrusion speed.  (F) SKOV-3 cells plated 
on fibronectin-coated glass coverslips for either 3 hr (left column) or 30 min (right 
column) were fixed and processed for immunofluorescence using antibodies against 
paxillin (Pxn) or phosphorylated PKA substrates (pPKA sub.).  Dotted line (F, middle 
row) represents an example of lines used to determine the intensity of pPKA sub. staining 
at protrusive edges of both migrating and spreading cells. Linescans were averaged (F) 
and are displayed as mean ± S.E.M. (n=14 cells for each condition).  	  




























Figure 3. SKOV3 cells exhibit predictable protrusion-retraction cycles. Leading edge 
dynamics are depicted as color-coded time projections using QumP11.  Edge velocity 
was calculated along the leading edge and is represented in a motility map where positive 
edge velocity (red) and negative edge velocity (blue) correspond to protrusions and 
retractions, respectively. 



























Figure 4. Focal adhesions and leading edge PKA activity do not colocalize in 
migrating SKOV-3 cells. Migrating SKOV-3 cells co-expressing pmAKAR3 and 
mCherry-paxillin were plated on fibronectin coated imaging dishes.  (A) Representative 
paxillin (Pxn) and pseudocolored FRET/CFP (pmAKAR3) images are shown and the 
leading edge is magnified in the insets with cell outline plotted for reference (scale bar = 
100µm). (B) Images of a single paxillin-containing focal adhesion during assembly, peak, 
and disassembly (top) with overlapping pseudocolored FRET/CFP (bottom). (B, right) 
The changes in either paxillin fluorescence intensity or FRET ratios were plotted over 
time. (C) Images of dynamic PKA activity and the corresponding paxillin images are 
shown with ROI plotted as reference. (C, right) The changes in either FRET ratios or 
paxillin fluorescence intensity were plotted over time. (D, left) YFP-dSH2 and paxillin 
intensities were tracked over time during focal adhesion assembly, peak, and disassembly 
are shown. (D, right) Pearson’s coefficients of the covariance of Paxillin with either YFP-
dSH2 (Pxn/dSH2) or pmAKAR3 (Pxn/pmAKAR3) are during focal adhesion assembly, 
peak and disassembly are shown as mean ± S.E.M (Pxn/dSH2 n=10, Pxn/pmAKAR3, 
n=13). *Though data for this figure were provided by Dr. Tamara Williams for 
manuscript submission, I have repeated these data and obtained similar results. 


























Figure 5. PKA activity and cellular traction forces are spatiotemporally correlated. 
Cellular traction forces and PKA activity were measured on cells that were transfected 
with pmAKAR3 and plated on fibronected-coated polyacrylamide hydrogels surface-
conjugated with fluorescent 0.2 µm latex spheres. (A) Bead displacement vectors were 
calculated using Particle Image Velocimetry (PIV) software in ImageJ (left). Bead 
displacement was transformed into a traction force map using Fourier-transform traction 
cytometry (FTTC, ImageJ) and cell outlines were plotted for reference (A, middle).  
pmAKAR3 corrected FRET intensity was calculated and pseudocolored images are 
shown (A, right). Linescan analysis of both traction forces and FRET intensity from the 
cell centroid to the cell periphery were plotted for cells either untreated (B) or treated 
with 25µM blebbistatin (C).  Pixel-by-pixel image correlation analysis was performed 
using the intensity correlation analysis software (ImageJ) to produce Mander’s overlap 
coefficients and average Mander’s correlation coefficients are plotted as mean ± S.E.M. 
(D, n=7 cells for each condition).  Intensity correlation analysis software was also used to 
generate and intensity correlation quotient (ICQ).  Hypothetical curves of intensity over 
distance are used to illustrate high covariance, and thus, positive ICQ values (E, top) and 
low covariance (E, bottom).  ICQs between traction force maps and PKA activity maps 
are summarized as mean ± S.E.M (F, *p<0.001).   

















Figure 6. Cellular traction forces are low in early cell spreading. (A) Transmitted 
light (top) and normalized force maps (bottom) of cells either untreated or treated with 25 
µM blebbistatin, or either migrating or spreading. (B) Quantification of the peak traction 
forces during either in cells treated with blebbistatin and either cell migrating or 
spreading.  










Figure 7. Actomyosin contractility regulates leading edge PKA activity and edge 
velocity. (A) Migrating SKOV-3 cells expressing pmAKAR3 and mCherry-paxillin were 
plated on fibronectin coated imaging dishes and monitored by live-cell microscopy 
before and after treatment with 25µM blebbistatin,. (B) Leading edge PKA activity 
indices were calculated in the absence and presence of 25 µM Blebbistatin (Blebb), 10 
µM ML7, and 10 µM Y-27632 (n=10). (B, inset) The change in FRET ratio over time is 
depicted before and after treatment with 25 µM blebbistatin. (C) QuimP11 software was 
used to generate protrusion-velocity (top) and PKA activity (bottom) maps within 10 µm 
of the leading edge before and after treatment with blebbistatin. (D) SKOV-3 cells co-
expressing pmAKAR3 and mCherry-paxillin were monitored by live cell microscopy 
before and after blebbistatin treatment and the rate of PKA activity decrease and focal 
adhesion dissolution was quantified by monitoring the change in FRET intensity and 
paxillin intensity, respectively, over time.  Linear regression was used to calculate the 
slope ± S.D (solid lines). (E) Immunofluorescence images of cells plated on fibronectin 
coated glass coverslips treated with either DMSO or 25 µM blebbistatin. (F) Linescans of 
pPKA subs. intensity/ actin intensity were plotted using the dotted lines in panel E.  













Figure 8. Actomyosin contractility is required for localized stretch-induced PKA 
activity. (A) A schematic representation of a cell adhered to a fibronectin-coated 
polyacrylamide hydrogel being subject to microneedle-mediated mechanical stretch. (B) 
pmAKAR3 expressing SKOV3 cells were plated on polyacrylamide hydrogels and 
subject stretch in the direction of the dotted-yellow arrow.  The cell area proximal to the 
stretch was divided into quartiles (yellow-dotted lines) and the changes in PKA activity 
were monitored before and after stretch. (C) The average change in FRET intensity in 
each quadrant is shown as the mean ± S.E.M. and the color of the bars correspond to the 
colors assigned to each quartile. (D) Cells were either not treated or treated with 25µM 
blebbistatin for 10 minutes prior to stretching and the average change in FRET intensity 
in the quadrant adjacent to the stretch is shown as the mean ± S.E.M. (n=8).    






























Figure 9. TRPM7-like whole cell currents are present in WI-38 cells and both 
TRPM7 protein and TRPM7-dependent Ca2+ transients are localized at the leading 
edge of migrating cells.    (A) Whole-cell patch-clamp experiments were performed on 
WI-38 cells with either Mg2+ free (n = 4) black-to-gray) or 1 mM Mg2+-containing (n = 4; 
red-to-orange) solutions in the patch pipette. Whole-cell currents were recorded while 
ramping the membrane potential from -100 mv to +100 mv. (B) Current densities at +100 
mV were quantified in the absence and presence of 1 mM Mg2+. (C) Immunofluorecent 
images of cells plated on fibronectin-coated coverslips showing TrpM7 and actin 
localization. (D) The change in TrpM7 immunofluorescence over 20 µm to the cell front 
from the dotted line in panel C (n = 14). (E) Ca2+ transients were summed in cells either 
non-transfected (control, n = 10), or expressing WT-TrpM7 (n = 13) or dn-TrpM7 (n = 6) 
and F/F0 traces from the designated regions of interest are shown on the right (dotted line 
= 1). 























Figure 10. SKOV-3 cells express functional TrpM7 channels. (A) Cell lysates were 
fractionated into membrane (m), nuclear (n), and cytoplasmic (c) fractions and separated 
by SDS-PAGE. Blots were incubated with the indicated antibodies and the molecular 
weight markers are shown to the right of the blot. (B) Whole-cell patch-clamp 
experiments were performed on SKOV-3 cells with either a Mg2+ free (black-to-gray) or 
a 1 mM Mg2+ (red-to-orange) solution in the patch pipette. Whole-cell currents were 
recorded while ramping the voltage across the membrane from -100 mv to +100 mv. (C) 
Current densities were quantified in the absence and presence of 1 mM Mg2+. 


























Figure 11. Leading edge calcium currents mimic TrpM7 calcium flickers. (A) A 
representative image depicting the sum of F/F0 where F0 = the average intensity of the 
first 5 frames of a time-series movie. (B) 3-D surface plot of calcium events from panel A. 
(C) A trace of a single leading edge calcium event represented as F/F0 where F0 = the 
average of 5 frames before the initiation of the calcium event. (D) Quantification of the 
amplitude of leading edge calcium events in the absence or presence of 1 mM Mg2+ to 
inhibit TrmP7 activity. 









Figure 12. TrpM7-meidated calcium flickers regulate traction force generation, 
leading edge PKA, and stretch-activated PKA activity. (A) Average maximum 
traction force generation was quantified in cells that were untreated (cntrl), expressing 
WT-TrpM7, treated with 20 mM EGTA, expressing dn-TrpM7, or treated with 25 µM 
blebbistatin. (B) Corrected FRET images from non-transfected cells (control) or cell 
expressing either WT-TrpM7 or dn-TrpM7. Linescan analysis of centroid-to-front PKA 
gradients from cells expressing the indicated plasmids (linescans obtained from dotted 
line in panel B). (D) Leading edge PKA activity indices were calculated for cells 
expressing the specified plasmids. (E) Representative images of cell expressing the 
indicated plasmids before (top) and after (bottom) stretch in the direction of the arrow. 
(F) The change in FRET ratios were calculated in the quartile proximal to the direction of 
stretch. 







































Figure 13. Leading edge PKA activity is regulated by actomyosin contractility in 
WI-38 flibroblasts. Leading edge PKA activity indices were quantified in the absence 
and presence of ML-7 and blebbistatin to inhibit intracellular contractility.  
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CHAPTER V: COMPREHENSIVE DISCUSSION 
 
Cell migration is crucial for numerous normal and pathological processes 
including embryogenesis and cancer cell metastasis, and research focusing on the 
mechanisms regulating cell motility can provide valuable insights into the understanding 
of these events. Therefore, the goal of the enclosed work was to describe the importance 
for and regulation of the cAMP-dependent protein kinase (PKA) during ovarian cancer 
cell migration. The work herein describes the first mechanistic analysis of the regulation 
of leading edge PKA activity during cell migration in the context of epithelial ovarian 
cancer cell migration and invasion. Specifically, we show that PKA activity localized to 
the leading edge of migrating cells is required for ovarian cancer cell migration and 
invasion.  Moreover, we show that inhibition of PKA activity and anchoring is 
detrimental to proper focal adhesion dynamics that regulate cell migration, and that 
leading edge PKA activity is dependent on actomyosin contractility.  
The second chapter of this dissertation identified that both the subunits and 
enzymatic activity of PKA are localized to the leading edge of migrating SKOV-3 EOC 
cells, and that this activity is required for proper focal adhesion dynamics, cell migration, 
and invasion. Previous work described the localization of PKA activity to the leading 
edge of numerous cell types (Howe et al., 2005; Lim et al., 2008; Paulucci-Holthauzen et 
al., 2009) and that integrins were required for this localized activity (Lim et al., 2008), 
however, the role of localized PKA signaling in EOC cell migration and invasion was 
unknown. The hypothesis that spatial regulation of PKA activity was required for EOC 
cell motility was based on these previous reports that established its importance in other 
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types of cells in addition to the fact that PKA phosphorylates numerous migration-
associated proteins (Howe, 2004) including members of the focal adhesion complex. We 
found that PKA activity was enriched in the leading edge of both migrating and invading 
cells and inhibition of either PKA activity or its subcellular distribution through AKAPs 
significantly attenuated cell migration. These data defined a role for both type I and type 
II PKA in EOC cell motility and were the first to describe localized PKA signaling 
during cancer cell invasion.     
This study also defined a yet unknown regulatory function of PKA on focal 
adhesion dynamics. Other reports have shown that PKA can phosphorylate adhesion 
proteins including VASP and Fyn (Doppler and Storz, 2013; Yeo et al., 2011) but the 
phenotypic effect of loss of localized PKA activity on adhesion dynamics had not been 
tested. Inhibition of the spatial distribution of PKA activity and PKA activity, itself, 
revealed profound defects in normal adhesion dynamics. Additionally, phosphorylated 
PKA substrates were observed in paxillin-containing focal adhesions. We therefore 
conclude that localized PKA activities during cell migration are required for efficient cell 
motility through a mechanism involving the regulation of focal adhesion dynamics. 
Further research is required to identify the discrete focal adhesion-related proteins that 
are phosphorylated by PKA to regulate adhesion dynamics. To do this, several 
biochemical approaches can be taken. The most general approach to identify PKA 
substrates responsible for regulating cell motility would be to enrich for protrusive 
pseudopodial structures (Cho and Klemke, 2002) and perform phosphoproteomics on 
samples that were either treated with PKA inhibitors or left untreated. To enrich for 
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adhesion-associated proteins, cells could be treated in such a way that removes 
membranes, cytoplasm, and nuclear structures and leaves focal adhesions intact (Kuo et 
al., 2011; Schiller et al., 2011), termed ‘unroofing’. Phosphoproteomics on these samples 
would then reveal a subset of proteins associated with the adhesion complex that are 
phosphorylated by PKA. Interestingly, analysis of the focal adhesome has revealed the 
presence of PKA subunits within this protein complex (Schiller et al., 2011). Should 
adhesion proteins be identified that have PKA phosphorylation sites, mutagenesis studies 
would be needed to determine the precise role of PKA phosphorylation on the identified 
proteins.  It is possible that these proteomic screens could return no focal adhesion-
related PKA substrates. If so, it is possible that PKA phosphorylation could be required 
for targeting proteins either to or from the adhesion complex during the adhesion 
lifecycle. This would suggest that PKA activity was still required for focal adhesion 
dynamics, but the abundance of PKA-phosphorylated proteins would be low in the 
adhesion complex. Another alternative hypothesis is that PKA could be phosphorylating 
proteins known to regulate adhesion dynamics, but are not associated with the adhesion 
complex. Given the importance for localized PKA signaling, the requirement for proper 
adhesion dynamics for cell migration, and the ability of PKA to phosphorylate known 
adhesion proteins, we predict that PKA’s control of cell migration occurs, at least in part, 
through regulating focal adhesion dynamics. Indeed, preliminary studies in the Howe lab 
show that phosphorylated PKA substrates are present at adhesions when cells are 
unroofed (Stephanie Hicks, unpublished data) and that inhibition of PKA activity has a 
greater effect on focal adhesion dynamics within the leading edge than in the cell body 
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(Laura Solomon, unpublished data). These results echo results presented in this 
dissertation and thus, the data within this dissertation provides a foundation for future 
work describing the role of PKA activity on focal adhesion dynamics.  
After publishing the work described in chapter two, we sought to more deeply 
understand the biology regulating EOC cell migration and metastasis in hopes that it 
would provide insight into the possible mechanism governing PKA activity during cell 
migration. Expanding on work done in the breast cancer field (Butcher et al., 2009; 
Levental et al., 2009; Yeung et al., 2005), we tested the hypothesis that EOC cells were 
mechanosensitive. Chapter three of this dissertation details the role of ECM stiffness in 
regulating EOC cell morphology and migration. As an initial experiment, we plated EOC 
cells on flexible polyacrylamide hydrogels with varying stiffness and monitored cell 
morphology and migration. Our data show that there is a positive correlation between 
increased stiffness and increases in cell size, adhesion size, stress-fiber width, actomyosin 
contractility and directional migration. Additionally, EOC cells migrated in the direction 
of direct mechanical stretch indicating that they respond to increases in ECM tension by 
migrating toward areas of increased tension, a finding in disagreement with a recent 
paper showing EOC cells preferred to migrate on softer ECMs (McGrail et al., 2014). 
Though conflicting, our data together with McGrail et. al. establish that EOC cells do 
respond to changes in the mechanical properties of their ECM. Most relevant for the 
pathogenesis of ovarian cancer, we also show that the disaggregation of multicellular 
EOC spheroids (the minimal metastatic unit of ovarian cancer) increases as a function of 
increased ECM stiffness. Though we show an ECM stiffness-dependence for EOC cell 
	   195	  
behavior, the effect of ECM stiffness and the contribution of EOC cells on remodeling 
the ECM in the context of ovarian cancer metastasis remains to be tested.  Various assays 
can be utilized to determine the role of EOC cells on reorganizing the ECM. Specifically, 
EOC cell spheroids can be embedded into collagen matrices of varying compliance and 
second harmonic generation imaging can be used to determine the collagen structure after 
incubation in the presence of EOC cells. Additionally, our lab has become proficient at 
dissecting sections of mouse peritoneum, and EOC cell spheroids can be plated on native 
tissues to monitor adhesion, dispersion, and interaction with the ECM. Moreover, if EOC 
cells are thought to contribute to the reorganization of the ECM, cell lines deficient in 
matrix cross-linking proteins such as lysyl oxidase and tissue transglutaminase, proteins 
known to be upregulated in EOC, can be analyzed as described above. Other efforts in 
the lab are focused on measuring the mechanical properties of tumor-associated 
peritoneum (Stephanie Hicks) and will provide valuable information regarding the effect 
of EOC cells on ECM stiffness. The data presented in chapter three are the first to 
describe that increased ECM stiffness induces EOC cell motility, and these observations 
provide the groundwork for future research determining the contribution of EOC cells on 
remodeling the EOC tumor microenvironment.  
Since PKA is required for EOC cell migration and invasion, and increased ECM 
stiffness positively regulates cell motility, we speculated that ECM tension might regulate 
PKA activity. Initial observations showed that PKA activity was low at the periphery of 
spreading cells and that there was no significant correlation between PKA activity and 
focal adhesion dynamics. These results were contrary to our initial hypothesis and 
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expanded what was currently known about integrin-mediated PKA activity at the leading 
edge of migrating cells (Lim et al., 2008). Specifically, Lim et. al. showed that integrin 
engagement and activation was required for localized PKA activity. Our preliminary data 
suggested that there was molecular, spatial, and temporal distance between initial early 
adhesion dynamics and PKA activity, and accentuated the probability that molecular 
mechanisms other than integrin engagement were required for leading edge PKA activity. 
As alluded to above, we hypothesized that ECM tension could regulate leading edge PKA 
activity through a mechanism involving increased actomyosin contractility. This 
hypothesis is supported by the notion that cells increase their contractile state when their 
ECM environment becomes stiffer (Ingber, 2006) and that EOC cells increase myosin 
activity when they are plated on stiffer substrates. Our data show that increases in ECM 
tension elicit PKA activity and that actomyosin contractility is required for leading edge 
PKA activity. These data establish PKA in a mechnosensitive pathway that governs cell 
migration. A previous report showed that PKA regulates RhoA activity through 
phosphorylation and activation of Rho-GDI, which, in turn, regulates protrusion 
retraction cycles at the leading edge of migrating cells (Tkachenko et al., 2011). The 
authors note that both maximal PKA activation (Tkachenko et al., 2011) and maximal 
traction force generation (Ji et al., 2008) occur ~20s after maximal protrusion, and 
hypothesize that cell protrusions mechanically activate PKA through adhesion-mediated 
mechanotransduction. Though they propose this mechanism, they provide no direct 
evidence to suggest that leading edge PKA activity is regulated through mechanical 
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forces. We fill this knowledge gap by directly assessing the effect of actomyosin 
contractility on leading edge PKA activity.  
In addition to actomyosin contractility, we also show that leading edge PKA 
activity requires the activity of adenylyl cyclases (ACs), phosphodiesterases (PDEs), and 
G-proteins. These data provide an interesting line of investigation whereby actomyosin 
contractility regulates the PKA activity machinery possibly at the level of G-proteins 
(Figure 1).  Despite these interesting connections, the precise molecular target for 
actomyosin on the PKA activation machinery remains to be tested. One hypothesis is that 
actomyosin contractility regulates cAMP production through AC activity. There is an 
established back-to-front increase in cAMP concentration in migrating cells (Lim et al., 
2008) and analysis of the cAMP biosensor, pmICUE2, in the presence and absence of 
actomyosin inhibitors could give valuable insights to where actomyosin is exerting its 
effect. Additionally, stretch-induced increases in cAMP (assessed via pmICUE2) could 
be monitored to determine the direct effect of mechanical activation of ACs. If PDEs are 
affected by actomyosin contractility, then PDE activity should be affected by inhibition 
of actomyosin contractility. To do this, PDE activity can be measured in lysates prepared 
from cells that were either left untreated or treated with inhibitors of actomyosin 
contractility. A recent novel bioluminescence-based method for detecting PDE activity in 
cell lysates utilizes the generation of AMP by PDEs and subsequent conversion of AMP 
to ATP via adenylate kinase-mediated phosphorylation of AMP and pyruvate kinase-
mediated phosphorylation of ADP (in excess CTP) to produce ATP. The ATP then reacts 
with luciferin to produce bioluminescence (Younes et al., 2011). Additionally, a similar  
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Figure	  1.	  Model	  depicting	  the	  hypothesized	  connection	  between	  leading	  edge	  Ca2+	  events,	  cellular	  contractility,	  and	  PKA	  activity	  during	  cell	  migration.	  	  	  	  
assay can be done on cells that are grown on varying ECM stiffnesses to test the 
effect of ECM tension on PDE activity. AC activity can be positively regulated through 
G-protein coupled receptors (GPCRs) that are linked to Gαs, and so actomyosin 
contractility could be eliciting its effect on PKA activity at the level of the G-protein or 
GPCR. There is precedence for the mechanical stimulation of Gαs and cAMP signaling 
through twisting integrins (Alenghat et al., 2009) and provides evidence supporting our 
hypothesis that actomyosin contractility regulates the PKA activation machinery. To 
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directly test the ability of actomyosin contractility to regulate Gαs activity, cell lysates 
from cells either pre-treated or not with inhibitors of actomyosin contractility can be 
probed with activation-specific antibodies against Gαs (Zhang et al., 2012). 
Our data also outline the dependence of actomyosin-mediated traction force 
generation on calcium entry across the plasma membrane through the stretch-activated 
calcium channel, TrpM7. We demonstrate that not only is TrpM7 required for traction 
force generation, but also for leading edge PKA activity and stretch-activation of PKA. 
Taken together we conclude that PKA activity at the leading edge of migrating cells 
occurs downstream of TrpM7-mediated calcium entry, actomyosin contractility, and 
activation of the canonical PKA activation machinery.  Of particular interest, given the 
connection between Ca2+ and PKA described herein, is the possible cross-talk between 
these two second messenger systems. Indeed, it has been shown that localized Ca2+ 
transients regulate the spatial distribution of PKA through AKAPs and AC activity 
(Willoughby et al., 2012) and there are several connections between PKA and calcium 
during cell migration (Howe, 2011).  More research will be required to fully understand 
the connection between localized calcium transients and PKA activity during cell 
migration. Preliminary data from our lab suggests that not only is calcium required for 
PKA activity, but PKA can also phosphorylate ion channels known to be necessary for 
cell migration, namely TrpM7 and Orai1 ((Howe, 2011) and unpublished data from 
Tamara Williams). If PKA phosphorylates TrpM7 and Orai1, and localized calcium 
transients can regulate AC activity and PKA through AKAPs, then AKAPs might serve 
as molecular scaffolds at the leading edge of migrating cells to tightly control Ca2+ 
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transients and PKA activity. To test the requirement for localized PKA activity on 
leading edge Ca2+ events, Ca2+ can be monitored in cells treated with specific inhibitors 
of PKA-AKAP interactions. Though we have outlined the requirement for PKA-AKAP 
interactions during EOC cell migration, identification of migration-associated PKA-
AKAP complexes have yet to be realized. Leading edge PKA complexes can be 
identified by immunoprecipitating known migration-or cytoskeletal-associated AKAPs 
(i.e. AKAP-Lbc, Ezrin, or Gravin) and analyzing the immune complex by mass-
spectroscopy. Identification of leading edge PKA-AKAP complexes could provide 
valuable insights into the discrete molecular mechanism governing leading edge PKA 
activity and Ca2+ events (Figure 1).  
The data in this dissertation raise several new questions to the fore and provide 
the foundation for future research exploring the connection between Ca2+ activities, 
actomyosin contraction, and the spatial distribution of PKA activity during cell migration. 
Of particular interest and potentially high impact is the connection between actomyosin 
contractility and PKA activity. The data herein establish that leading edge PKA activity is 
dependent on actomyosin contractility, and elucidation of the molecular target for 
actomyosin contractility within the PKA activation machinery will link these two 
fundamental cell processes. Additionally, our data establish a mechanistic connection 
between leading edge PKA activity and Ca2+ signals. Defining the molecular details that 
connect these pathways would link these two ubiquitous second-messenger systems 
during cell migration. My parting perspective is this; given the high morbidity and 
mortality associated with EOC, it is necessary to have a fuller understanding of the 
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underlying cell biology governing EOC. These findings could have the potential to have a 
significant effect on the course of the disease and on uncovering targets for novel 
therapeutics. 	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